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31.1 The human circadian system 
Due to the rotation of the earth around its axis in approximately 24 hours (slightly varying 
across the year due to the elliptical orbit around the sun and the oblique axis of the Earth 
relative to the orbital plane), most organisms that live on Earth have to deal with the never 
ending sequences of day and night. To predict these day and night changes, almost every 
species has evolved an internal endogenous ‘biological clock’ which generates rhythms of 
about 24 hours, which are called ‘circadian rhythms’. The biological clock of humans and many 
other mammals is located in the central nervous system in the medial basal hypothalamus, 
saddling on the optic chiasm, in the Suprachiasmatic Nucleus (SCN). From the SCN peripheral 
clocks throughout the brain and the body are synchronised via the autonomic nervous 
system (see figure 1). In diurnal mammals, the SCN normally sets the preferred timing for 
sleep at night and activity during daytime and synchronizes other endogenous circadian 
rhythms, such as rhythmically released hormones like melatonin from the pineal gland (see 
next paragraph ‘melatonin’), ACTH from the pituitary gland, and corticoids from the adrenal 
gland. These hormones also contribute to the (circadian) synchronisation of a multitude 
of other physiological and psychological functions. Melatonin and other time signals like 
food availability and systemic cues, provide feedback to the SCN (see figure 1). In order 
to keep the SCN entrained to the natural alternation of light and darkness, it needs to be 
synchronized daily. Therefore the SCN is influenced by ‘zeitgebers’. The term ‘zeitgeber’ was 
first used by Jürgen Aschoff and is defined as an external cue that can entrain or synchronize 
a biological clock (Aschoff 1954). The most important zeitgeber for the SCN is light (reviewed 
in Meijer and Schwartz 2003, see also paragraph ‘light and the human clock’). In the absence 
of zeitgebers, the SCN will ‘free-run’ with its own endogenous period. Therefore the SCN 
needs to be adjusted daily to the 24-hour light-dark schedule. This adjustment of period and 
phase of the SCN under the influence of the light-dark cycle is called ‘entrainment’.
4Figure 1. Schematic overview of circadian regulation in the human body. Source: Max-Planck Istitute 
of Biophysical Chemistry
 
1.2 Light and the human clock
The human clock and therefore also its output markers are highly influenced by light. Light 
enters the body via the eye where it hits photoreceptors which are located in the retina 
(see Figure 2). These photoreceptors contain photopigment molecules which are linked to 
ion channels. They respond to light exposure by capturing a photon and by changing their 
3-dimensional configuration. This leads to a change in the influx of ions in the respective 
photoreceptor cell and thereby in the membrane voltage difference of the cell. Depending 
on the photoreceptor cell type, this in turn leads to action potentials in the cell itself or 
in downstream cells that respond to the electrical changes in the photoreceptor cell. 
Although rods and cones (the classical photoreceptors specialized for vision) do contribute 
to the translation of the light signal to the SCN, they are not absolutely required. The most 
important photoreceptors for the clock are a subset of specialized photosensitive retinal 
ganglion cells (pRGC’s, Berson et al. 2002, Hattar et al. 2002, Hattar et al. 2003, Hatori and 
Panda 2010), since entrainment to light is lost when these cells are not present (Hatori 
et al. 2008). These pRGC’s contain the photopigment melanopsin, which contributes 
to the process of entrainment. When the melanopsin gene is knocked-out, entrainment 
5is partially lost, showing that rods and cones do contribute to entrainment (Hattar et al. 
2003). Melanopsin is particularly sensitive to short wavelength/blue light (see also section 
‘sensitivity of the circadian system to blue light’). pRGC’s have connections to the SCN via 
the retinohypothalamic tract (reviewed in von Schantz et al. 2000). When the SCN neurons 
are activated in response to light, a cascade of reactions eventually leads to the expression 
of mPER1 (Reppert & Weaver 2002). The mPER1 clockgene will influence the so-called 
transcription translation feedback loop (TTFL, reviewed in Bell-Pedersen et al. 2005) of cell 
clockgenes and will in this way adjust the rhythmic pattern of SCN activity to light. Cells in 
the SCN will immediately start to fire when the animal is exposed to light, no matter if it is 
day or night, and light can therefore acutely inhibit or stimulate secretion of hormones. See 
next paragraph. 
Figure 2. A magnification of photoreceptors in the retina and the location of the ‘photoresponsive 
retinal ganglion cells’ pRGC’s.  A small population of these widely dispersed pRGC’s, projects to the 
SCN. pRGC’s are light responsive because of the protein melanopsin (not shown). They also receive 




Melatonin is a hormone synthesized from tryptophan and is mainly produced and secreted 
by the pineal gland. The synthesis of melatonin occurs exclusively during the evening & 
night (except for individuals with extreme clock phases), which is the reason that melatonin 
is also called ‘hormone of the night’. Melatonin concentration in the body starts to rise 
in the evening, peaks during the night, and starts to decline again in the early morning. 
This rhythmic melatonin synthesis is directly regulated by the SCN. During the day the SCN 
inhibits the production of melatonin by inhibiting the firing rate of the paraventricular 
nucleus (PVN). At night the firing rate of the SCN is much lower and therefore this inhibition 
stops. Then the PVN stimulates the pineal gland to produce melatonin (reviewed in Buijs et 
al. 2003). Although individual differences in melatonin rhythms and patterns can be large, 
within individuals the pattern is quite stable from day to day (Klerman et al. 2002, Revell et 
al. 2005b, Burgess et al. 2015). Therefore the onset of melatonin secretion is considered 
6to be one of the most reliable markers of the phase of the human biological clock (Lewy 
et al. 1989 & 1999, Klerman et al. 2002, Revell et al. 2005b, Arendt 2005, Van Someren & 
Nagtegaal 2007, Benloucif et al. 2008).  
 
The influence of light on the clock can be seen through phase shifts of physiological 
circadian rhythms, like the rhythm of melatonin. This phase shift of the melatonin rhythm 
can be measured with different markers (Lewy et al. 1999), of which the time at which the 
melatonin concentration starts to rise in very low light intensities <10 lux is called the ‘dim 
light melatonin onset’ (DLMO) and is known as the most reliable one (Lewy et al. 1980, 
1985). Many studies have found that light in the morning induces a phase advance of DLMO 
(Dijk et al. 1989, Buresova et al. 1990, Samková et al. 1997, Gordijn et al. 1999, Danilenko 
et al. 2000, Revell et al. 2005a) whereas light in the evening induces a phase delay of DLMO 
(Kräuchi et al. 1997, Gordijn et al. 1999, Zeitzer et al. 2000, Gronfier et al. 2004). There 
are also some indications that light during the day can stimulate the melatonin production 
during the night (Park & Tokura 1999, Takasu et al. 2006). This may contribute to sleep 
consolidation and it might (through feedback mechanisms) increase the amplitude of the 
clock signal of the SCN. Chapters 3, 5 and 7 will address this topic. 
1.4 Individual differences in sleep/wake rhythms 
Sleep patterns vary widely among the human population as demonstrated by the broad 
distribution of the midpoint of the sleep episode on free days (MSF, Roenneberg et al. 2003, 
2004, 2007; Zavada et al. 2005). Probably, the industrialization and artificial lighting are 
most responsible for this broad distribution in human sleep habits. It has indeed been found 
that sleep/wake rhythms become less variable when humans sleep in natural light-dark 
conditions (Wright et al. 2013).
  
There are many people (74% of the adult Dutch population) who sleep and wake up 
later during weekends than during the workweek (Gordijn et al. Dutch sleep database 
unpublished). Despite this fact, work and school schedules typically start early in the day. 
Therefore, these schedules may lead to a mismatch of endogenous circadian rhythms 
and external environmental rhythms (Zavada et al. 2005, Roenneberg et al. 2007). Late 
sleep onsets (controlled by the endogenous clock, SCN) combined with early wake times 
(controlled by the external social clock) will also lead to an accumulation of a substantial 
sleep deficit during the work week in late chronotypes. This is reflected by difficulty in waking 
up (Giménez et al. 2010, van der Werken et al. 2010), being alert at school (van der Vinne, 
Zerbini et al. 2015) and work, and in health problems (Wittman et al 2006, Morgenthaler et 
al. 2007, Phillips 2009, Rüger & Scheer 2009). The next paragraph will address the causes 
and consequences of these health problems.
71.5 Costs for late chronotypes: ‘social jetlag’ 
Shifting sleep and activity patterns between work days and free days because of social 
demands has been termed ‘social jetlag’ (Roenneberg 2004, Wittman et al 2006). ‘Social 
jetlag’ can be quantified by calculating the absolute difference between mid-sleep on 
workdays (MSW) and mid-sleep on free days (MSF): ΔMS= [MSF-MSW] (Roenneberg 2004). 
Because the MSF of late chronotypes is later than their MSW, social jetlag would be higher 
in late than in early chronotypes. Indeed, sleeping late is highly and positively correlated 
with social jetlag at least in Germany/ Austria/Switzerland (Wittman et al 2006) and in the 
Netherlands (Gordijn et al. Dutch sleep database unpublished, see figure 3).
Figure 3. The relationship between social jetlag and sleep timing. Black circles are derived from Gordijn 
et al. Dutch sleep database (unpublished). deltaMS= social jetlag= mid-sleep time on free days – mid-
sleep time on workdays. MSFsc= mid-sleep time on free days, corrected for accumulated sleep debt 
on workdays. N=8063, R2= 0.88.
Not only is being a late chronotype related to all kinds of physical health problems 
(Wittman et al. 2006, Morgenthaler et al. 2007, Phillips 2009, Rüger & Scheer 2009), it is 
also related to mental health problems; for example, late chronotypes report psychological 
and psychosomatic disturbances more often than intermediate or early chronotypes do 
(Mecacci and Rocchetti 1998, Gianotti et al. 2002). In addition, late chronotypes experience 
more mental exhaustion and show higher depression scores (Chelminski et al. 1999, Gianotti 
et al. 2002, Takeuchi et al. 2002, Wittman et al 2006). Wittman and colleagues (2006) 
found that these correlations between chronotype and health status are highest for young 
people between 14-25 years. This may be due to the fact that adolescents tend to be later 
chronotypes than other age groups (Carskadon et al. 1999, Roenneberg et al. 2004, 2007). 
Furthermore, late chronotypes consume more stimulants (alcohol and coffee) and are more 
8often habitual smokers than are early chronotypes (Adan 1994, Mecacci & Rochetti 1998, 
Thaillard 1999, Wittman et al. 2006, Wittman et al. 2010).  
By definition, social jetlag is minimal in people who have approximately the same sleep 
timing on work- and free days.  Since this is not the case for the majority of the population, 
many people may suffer from social jetlag.  A large number of people in the population could 
therefore theoretically benefit from earlier sleep timing on free days. One way to achieve 
this is through advancing the biological clock, thereby advancing endogenous circadian 
rhythms including the melatonin rhythm, and sleep.  
A study in Groningen showed that both extremely early and extremely late types (the latter 
probably resembling DSPS patients) are sensitive to the phase advancing properties of light, 
if scheduled at the individual’s optimal phase in the morning (Gordijn et al. 2006). Light 
exposure in the morning is often proposed as the most effective method to treat a delayed 
sleep phase (Barion & Zee 2007, Morgenthaler et al 2007, Bjorvatn & Pallesen 2009). 
However, the optimal parameters for light therapy to have the best treatment outcome 
have not been identified. The next paragraph as well as chapter 2 and 3 of this thesis will 
address and test potential parameters to optimize light therapy. 
1.6 Potential parameters to optimize light therapy
As mentioned in the paragraph on ‘light in the human clock’, the pRGC’s, containing the 
photopigment melanopsin, are most important for the entrainment of the human clock to 
light. pRGC’s are particularly sensitive to blue light (Berson et al. 2002, Hattar et al 2002, 
Hattar et al. 2003). Indeed, many studies report that the clock system is most sensitive for 
short wavelength light of 440-490 nm (blue) seen in both light-induced phase shifts as well 
as light-induced melatonin suppression (Brainard et al 2001, Thapan et al 2001, Lockley et al 
2003, Warman et al 2003, Wright et al 2004).  
pRGCs do not only project to the SCN, but also to the intergeniculate leaflet (IGL) and the 
olivary pretectal nucleus (OPN). Together with the SCN, these areas are associated with 
circadian entrainment, regulation of sleep-wake states, arousal and alertness responses. 
Thus, it is likely that these pRGCs are also responsible for the alerting effects to (blue) 
light (Cajochen et al. 2005, Lockley et al. 2006, Revell et al. 2006, Vandewalle 2007,2013). 
Because the circadian system, as well as the alertness system are so sensitive to blue light, 
light sources with blue light have the potential to be very effective in light therapy. In all 
studies reported in this thesis we made use of blue light sources, namely the portable Philips 
GoLite BLU HF3320 (chapter 2,3), or a blue lightstrip mountable on top of a computer screen 
(280x25 mm2) (chapter 4,5,6) which were both developed by Philips Consumer Lifestyle, 
Drachten, The Netherlands. The effects of these blue lamps were compared to the effects 
of a control condition with standard environmental light (chapter 4), or to conditions with 
other light sources, like a placebo light (amber color) (chapter 3), or to bright light (chapters 
5,6). The circadian system is not only sensitive to a specific colour of light; the individual 
timing, duration and intensity of light are other important factors of light influencing the 
9response of the circadian system. Chapter 2 addresses these factors in more detail and 
presents a test of whether the duration of light exposure can be shortened if these factors of 
light are combined in an individualized optimal way. The final goal of successful light therapy 
to advance sleep in late sleepers, should not only be a successful phase shift of the circadian 
rhythm, but also a successful and stable shift of the sleep/wake rhythm, with preservation 
(or improvement) of performance during the day (chapter 3).
1.7 Light therapy and sleep
One could say that the influence of the mammalian clock is most clearly visible in the 
alternation of the sleep-wake or rest-activity cycle.  Still, sleep itself (as visualized in EEG 
recordings) has hardly been studied in light therapy protocols. 
The theory is that sleep timing and intensity are regulated by two processes (Borbély 1982), 
Daan et al. 1984). The first process, called “S”, represents the need for sleep as it increases 
during waking and dissipates during sleep. S is derived from a physiological variable: the 
slow wave activity (SWA) in the Electroencephalogram (EEG) of non-REM slow wave sleep 
(SWS). It is assumed that S gradually increases during wakefulness. When S reaches a 
certain threshold during wakefulness, this triggers sleep onset. After falling asleep, S will 
gradually decrease towards a lower threshold, which induces awakening. The thresholds, 
called process C, are influenced by the SCN which drives their circadian oscillations (see 
also figure 4). Under normally entrained conditions, the trigger to go to bed results from a 
combination of an increasing sleep pressure during waking and the declining threshold in 
the evening. Similarly, awakening results from the combination of a declining need for sleep 
and an increasing wake threshold. 
Figure 4. The 2-process model of sleep regulation (Borbély 1982, Daan et al. 1984). S (vertical axis) 
represents the need for sleep.  It increases during waking (W) and decreases during sleep (S). Its 
variation is restricted to a range of values determined by the circadian process C (dotted lines), which 
is not constant over time but varies with the time of day. 
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Because of these sleep regulating processes, two mechanisms can be proposed to explain 
the impact of light on sleep quality. Stimulation of the SCN (Process C) by light during the 
day may lead to a more pronounced day-night signal which may in turn lead to a more 
robust sleep-wake rhythm with consolidated sleep. With increased amplitude of the 
electrical discharge rhythm of the SCN, the impact of the SCN on melatonin production 
in the pineal gland is also expected to change. In Chapter 5 it is examined whether the 
melatonin production indeed is affected by extra light during the day. 
The second mechanism by which light can influence sleep regulation is based on the fact 
that light during the day stimulates areas in the brain involved in alertness (with connections 
to sleep areas). This may possibly result in a higher homeostatic sleep drive (Process S) and 
consequently deeper, more consolidated sleep (Mistlberger et al. 2005). Chapter 5 will also 
examine whether the homeostatic sleep drive is affected by extra light during the day. The 
effects of light on alertness during this study have been examined as well and these results 
will be presented in Chapter 6.
With this thesis I would like to gain more knowledge in the optimization of light therapy. 
This knowledge can be used to adjust or boost the circadian clock, improve sleep during the 
night and well-being during the day. At the same time it will reveal which individual (clock) 
characteristics are important for this optimization of light therapy. And finally, in this thesis 
I hope to find some answers to the fundamental questions behind the mechanisms of the 
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It is known that light in the morning is able to induce phase advances of the endogenous 
clock, however most studies have tested the phase advances in highly controlled laboratory 
conditions. At home the environmental lighting is more variable. In theory, a high intensity 
short morning-light pulse in the short-wavelengths-range (blue light) should be capable of 
inducing phase advances. If this is also true in a home setting, this could be a firm basis 
supporting light treatment in late chronotypes who suffer from a late sleep phase. In a study 
carried out in summer, 11 normal to relatively late  (habitual midsleep 4:15- 6:09 hours) 
chronotypes (age range 23-27y, 4f/7m) participated in two conditions: (1) 1 baseline day 
followed by 3 consecutive days of 30 min. blue morning-light pulses, (2) 1 baseline day 
followed by 3 consecutive days of 60 min. blue light pulses. Blue light was applied by use 
of the Philips GoLite BLU (HF3320, blue leds, intensity at the cornea 2306 melanopic-lux, 
300 lux, 3.65 W/m2). During all four evenings, subjects were asked to protect themselves 
from light exposure (<10 lux). The response of the melatonin rhythm, calculated as a shift in 
dim light melatonin onset (DLMO), to a single 30 min. light pulse varied between subjects 
and resulted in a non-significant phase advance of 15 (±48) min. (t10= 1.04 P=0.33), and a 
significant advance of 30 (±41) min to a single 60 min. light pulse . (t10= 2.40 P<0.05). After 
3 days of light exposure both in the 30- and in the 60 min. light pulses condition significant 
phase advances of DLMO were observed; 49 (±58) min. (t10= 2.80 P<0.05) and 59 (±29) 
min. (t10= 6.9 P<0.001) respectively. No significant differences were found in the DLMO 
shifts between conditions. In addition there was a trend for a lower sleepiness score directly 
after waking up after using light for 3 days in both conditions (t10= 3.38 P=0.096, 60 min. 
and (t10= 4.10 P=0.070, 30 min.). A preliminary analysis of actimetry data indicated some 
support for an effect on sleep timing. The data support the conclusion that light pulses of 
30 min in the morning on three consecutive days, in a home setting, in combination with 





In humans, the endogenous clock, located in the Suprachiasmatic Nuclei (SCN) in the 
hypothalamus, is responsible for generating oscillations with a period of approximately 24h 
in physiological, behavioural and psychological variables. In order to keep these circadian 
rhythms entrained to the natural alternation of light and darkness, this clock needs to be 
synchronized daily. Light is the main synchronizer, also called ‘Zeitgeber’, for entrainment 
of our clock; the exposure to light induces phase shifts of our clock resulting in either a 
delaying (biological rhythms shift to a later clock time with light exposure in the evening) 
or advancing (biological rhythms shift to an earlier clock time with light exposure in the 
morning) direction (Daan & Pittendrigh 1976, Beersma & Daan 1993). Since light is a potent 
Zeitgeber, the use of light therapy to treat circadian rhythm sleep disorders is a potentially 
effective treatment (Barion & Zee 2007, Morgenthaler et al 2007, Bjorvatn & Pallesen 2009). 
However, most studies have tested the phase shifting effects of light in highly controlled 
laboratory conditions. At home, the situation is completely different. Subjects are exposed 
to a highly variable environment with large fluctuations in daytime light exposure, natural 
light exposure in the sleeping room etc.  The current study was set up to test whether short 
pulses of light in the morning, in such a highly varying environment, are able to induce 
significant phase advancing shifts of circadian rhythms within 1-3 days to make it useful to 
treat late timing of biological clocks and sleep phases.   
The sleep-wake cycle in humans is one of the rhythms that show a clear 24h pattern; the 
generation of this 24-rhythm is partly under control of the biological clock (Borbély 1982, 
Daan et al 1984, Dijk & Czeisler 1994). If exposed to a regular light-dark cycle, the sleep-
wake cycle will be entrained; in other words, sleep would occur at the same phase of the 
light-dark cycle each day. In reality, sleeping out of phase with the external light-dark cycle, 
especially sleeping late, is very common in our civilized society and is related to health 
problems (Roenneberg et al 2007, Roenneberg et al 2012, Wittman et al 2006, Touitou 
2013). A large number of people may therefore benefit from a correction of their clock and 
sleep timing. Because light is so effective in phase shifting the clock, it is often proposed as 
the most effective method to advance a late sleep phase (Barion & Zee 2007, Morgenthaler 
et al. 2007, Bjorvatn & Pallesen 2009). However there is no general accepted protocol for 
the optimization of light therapy. 
There are several factors that are important in optimizing light therapy. One is the correct 
timing of light. Phase response curves (PRC’s) have been measured to quantify the induced 
phase shift of the biological clock as a function of the time at which the subject is exposed 
to light. The most complete phase response curve (PRC) in humans has been published 
by Khalsa and colleagues (2003). The authors found the maximum phase advance when 
applying the center of a long 6.7-hour light pulse 9 hours after the start of the rise of 
melatonin, also known as the ‘dim light melatonin onset’(DLMO). In a laboratory study of St. 
Hilaire and coworkers (2012) a PRC with a 1-hour white light pulse was tested.  The results 
revealed that also for pulses of 1 hour the largest phase advances are found when timing the 
18
center of the light pulse around 9 hours after DLMO. 
The intensity and duration of light exposure are other important factors in optimizing 
light therapy; both these factors contribute in a non-linear, dose dependent manner to 
the magnitude of a phase shift. Zeitzer et al. (2005) constructed a dose response curve 
for light intensity with long (5 h) light pulses. They found that high intensity full spectrum 
white light doses (9500 lux) generated the largest phase shifts. Under these conditions, 
saturation of the logistic regression curve occurred already at one tenth (1000 lux) of the 
intensity of a maximum dose. This dose still generated a phase shift of 90% of the maximum. 
Under natural circumstances people are not dark adapted and they may need higher light 
intensities to show similar phase shifts.   
The dose response curve for the duration of a light pulse is also not linear. The 1h light pulses 
in the study of St. Hilaire et al (2012) in humans elicited a maximal phase advance of 1.2h, 
which is 44% of the response of 2.7h generated by the 6.7h light exposure in the study of 
Khalsa et al (2003). Such diminishing responses to extended stimulation are considered the 
result of adaptation processes, therefore the beginning of a light pulse is most important for 
the phase shifting effects (Beersma et al. 2009).
In addition to timing, intensity and duration, a fourth important factor that can be used 
to optimize light therapy are the spectral characteristics of the light source. There is 
accumulating evidence that both light-induced phase shifts - as well as the suppression of 
melatonin - are most sensitive to light with short wavelengths: 440-490 nm, or blue light 
(Thapan et al 2001,  Lockley et al 2003, Warman et al 2003, Wright et al 2004, Brainard et 
al 2008, Smith et al. 2009, Brainard et al. 2015). This sensitivity to blue light is due to the 
protein melanopsin, located in the “photosensitive retinal ganglion cells” (RGC’s) (Berson et 
al. 2002, Hattar et al 2002). This photopigment is most reactive to ~480nm light (Hattar et 
al 2002, Enezi et al. 2011, Bailes & Lucas 2013). In a recent study, a comparison was made 
between the PRC obtained by Khalsa and colleagues (2003) to 6.7h full spectrum white light 
with the PRC to blue light pulses (monochromatic 480 nm light) of similar duration (6.5) 
(Rüger et al. 2013). Although the blue light pulse contained only 0.4% of the energy of the 
full spectrum white light pulse, no significant differences could be found in the magnitude 
of the phase shifts.  
Since blue light is very effective in shifting our circadian system, it may potentially decrease 
the intensity and duration of light therapy needed for an optimal effect and therefore 
improve therapy compliance, and final treatment success.  
Therefore the hypothesis of this study is, whether optimally timed, short light pulses of 30 
minutes per day with a high blue photon density, applied by the subjects themselves at 
home, are able to shift the circadian rhythm of melatonin. If so, it can be an effective tool in 




Subjects were recruited from the student population of the University of Groningen, the 
Netherlands, via newspaper- and internet advertisements. Thirteen healthy subjects (seven 
men and six woman, mean age (±SD) 23.9 ± 1.9 years) were selected and completed the 
protocol. During the analysis, two subjects were excluded due to non-compliance and 
possible improper timing of the light pulses as a consequence; analysis is performed on 11 
subjects (4f/7m, mean age (±SD) 24.1y ± 1.6y, range age 23-27y). Selection of subjects was 
based on the following criteria: Subjects had to be healthy without suffering from depressed 
mood (Beck Depression Inventory-II, Dutch version, (BDI-II_NL) < 8; Beck et al., 1996 & 2002), 
did not report sleep disturbances, were non-smokers, did not consume too many drinks 
with caffeine (no more than 8 units per day) or alcohol (no more than 10 units per week), 
did not work in night shifts, did not cross more than two time zones in the preceding three 
months and were not colour blind (tested with an Ishihara colour blindness test). Female 
subjects were only included if they were using hormonal contraceptives. Chronotype was 
determined using the habitual mean midsleep (hMS, this is the clock time at the midpoint 
between sleep onset and sleep end), based on 7 days of data weighted for day of the week 
(Munich Chronotype Questionnaire (MCTQ)); (Roenneberg et al. 2003). Subjects were 
selected if their habitual midsleep was between 4:15- and 6:09- hours, indicating normal to 
moderately late chronotype for the age category of 20-30 years (based on the MCTQ 2008 
NL database, Gordijn et al. unpublished). This selection was on the premise that inducing 
possible phase advances of endogenous rhythms and sleep would be more advantageous 
for relatively late people. The average hMS in the selected subjects in this study was (±SD) 
5:00 ± 35 minutes. All subjects were Dutch citizens from birth and fluent in Dutch. All 
subjects gave written informed consent and were compensated for their participation. The 
experimental protocol was approved by the Medical Ethics Committee of the University 
Medical Center Groningen. 
Melatonin profiling day
In order to estimate the optimal timing of the blue light pulses, the experiment started 
with a ‘melatonin profiling day’ in our human time isolation facility centre, Groningen 
(NL). Subjects arrived 10 hours before their habitual midsleep and left 5 hours after their 
habitual midsleep (used as an individual reference time). They collected a total number of 
twelve saliva samples in dim light (<10 lux) during the evening or in darkness during short 
moments of awakening in the night and early morning. Saliva was collected by chewing on 
a cotton swab (Salivette®, Sarstedt BV, Etten-Leur, NL). At least 1 ml. of saliva per sample 
was collected every hour during the time subjects were awake and every two hours during 
scheduled sleep time.  The saliva samples were centrifuged and frozen at -80°C for further 
analysis. Melatonin concentration was assessed by radioimmunoassay (RK-DSM; Bühlmann 
Laboratories, Alere Health, Tilburg, The Netherlands). The inter assay variance was 11.3% 
for the low concentrations and 12.2% for the high concentrations. The intra assay variance 
was 10.7% for the low concentrations and 10.0% for the high concentrations.
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A bimodal skewed baseline cosine function was fitted through the individual data points 
(Van Someren & Nagtegaal 2007). The maximum value of the fitted curve of each individual 
was set at 100% and used to normalize each curve. Dim Light Melatonin Onset (DLMO) was 
calculated as the moment at which the melatonin rhythm crosses the 25% value of this 
fitted maximum by linearly interpolating the raw values preceding and following the 25% 
value. The average DLMO time on the melatonin profiling day was 22:20 (± 0:15 SEM).
Experimental design
Subjects participated in two experimental conditions in a random order: a 30 minute and a 
60 minute blue light pulse condition. The first experimental condition started at least one 
and not more than 2 weeks after the ‘melatonin profiling day’. This allowed for full recovery 
from the sleep interruptions during that day.  Each condition consisted of 4 consecutive 
days, starting with 1 baseline evening/ night followed by 3 mornings with light pulses (Figure 
1).
Figure 1.  Schedule of the experimental design (melatonin profile day is not shown). The 2 experimental 
weeks are shown by the columns. Experimental days of an experimental week are indicated by bars. 
An experimental week consisted of 1 baseline day and 3 test days with 3 light pulses.
There was at least 1 week and not more than 2 weeks of no interventions in between 
conditions. All light pulses and measurements were conducted at home. During the week 
prior to each condition, subjects were asked to schedule their sleep according to their 
habitual sleep timing. This was checked with actigraphy and data from 8 subjects was 
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available. During the week before starting the experiment hMS was on average (±SD) 2 min. 
(± 13) earlier than the hMS calculated from the MCTQ questionnaire. From these data it 
seems fair to conclude that the participants had consistent sleep habits prior to the start of 
the experiment. During each experimental condition, subjects received instructions when 
to go to sleep, when to stay in dim light and how and when they had to expose themselves 
to the blue light pulses. Sleep timing during the experimental weeks was adjusted to the 
timing of the light pulses in order to allow for 8 hours of sleep (Figure 1). Effect of the light 
pulses on the melatonin rhythm was measured by analyzing saliva samples collected after 
1 pulse i.e. on the 2nd evening and after 3 pulses i.e. on the 4th evening and compared to 
melatonin pattern at the baseline evening i.e. 1st evening. During these evenings, subjects 
were required to collect the saliva samples themselves (Figure 1, starting at -3 and ending 
+1 hours relative to DLMO calculated from the melatonin profiling day) in dim light (<10 
lux). This resulted in 5 samples per evening. Subjects were asked to write down the exact 
timing of each saliva sample collection; no single timing point deviated more than 5 min 
from the time point in the instructions. Subjects already knew how to collect saliva, because 
they had prior experience during the melatonin profiling day in the lab. At home, they were 
instructed to stay in dim light starting one hour prior to the first sample, and not change 
posture 5 minutes prior to and during collection of the sample. They were not allowed to 
drink anything else than water, nor to eat during the sampling period, starting one hour 
prior to the first sample. They were instructed to rinse their mouth 15 minutes prior to each 
sample.
Light exposure 
Subjects were asked to expose themselves to either the 30 min or 60 min high intensity blue 
light pulses by sitting in front of a GoLite Blu lamp with an angle of 45° (Philips GoLite BLU 
HF3330, peak transmission at 470 nm, intensity at the cornea 2306 (melanopic)-lux (see Lucas 
et al 2014 for an explanation of the unit ‘m-lux’), 300 lux, 3.65 W/m2)) during 3 consecutive 
mornings. Light exposure was scheduled 9h after DLMO (Figure 1), as determined from the 
melatonin profiling day. Because the average DLMO time on the melatonin profiling day was 
22:20 (± 0:15 SEM), light exposure started at 07:20 (± 0:15 SEM) on average.
During all four evenings of each condition, including the one evening without saliva 
collection, subjects were asked to stay in dim light (<10 lux).
Rest-activity and light measurements 
In order to quantify the timing and quality of the 24-h profile of rest and activity, subjects 
wore an activity monitor, called Actiwatch® (AW2, Philips/Respironics, Fypro, Geffen, NL), 
on the non-dominant wrist during the experimental weeks. The AW2 is an activity-recording 
device that measures wrist movements to quantify the rest-activity cycle and it records 
environmental light exposure. The device has the appearance and the weight of a watch 
(without a clock). Subjects were asked to wear the AW2 all day and night. 
While analyzing the data of all 13 subjects, we carefully inspected the sleep offset times 
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of the AW2 data. We excluded 2 individuals who did not wake up within one hour of the 
instructed wake-up time. We concluded that these subject did not comply to the instructions, 
and could not have had their light exposure at the proper time. In addition, to measure 
properly light exposure and to be able to check for compliance of the light treatment 
the subjects wore either a Lightwatcher (Object Tracker, Vienna, Austria) or a Daysimeter 
(Lumen Tech Innovations, New York, USA).  Unfortunately, because of failure of devices, the 
differences between devices and the way of wearing the devices, a complete data analysis of 
environmental light exposure in a quantitative way was not succesful. In those cases where 
we could analyze whether subjects received a light pulse at the proper time, compliance 
was 100% in the 60-min light pulse condition (10 subjects) and on average 87% in the 30-
min light pulse condition (1 pulse could not be recognized in 4 out of 7 subjects). Since this 
was a within study and compliance in the observed data was 100% in the 60-min condition, 
it was concluded that the missing pulses in the 30 min condition were most likely due to not 
wearing the device in the proper direction, more than that subjects did not obey the rules. 
Questionnaires
Each morning of the experimental days, subjects were asked to complete a sleep diary. 
The diary consisted of a list of questions about sleep timing, sleepiness and sleep quality. 
Subjects rated their sleep quality with marks (from 0= very bad to 10= excellent). Subjective 
ratings of sleepiness were scored with the Karolinska sleepiness scale (KSS) (Akerstedt 
and Gillberg, 1990). Ratings on the KSS range from 1 to 9, with 1 meaning very alert and 9 
meaning very sleepy. Subjects had to rate their sleepiness immediately after waking up and 
after the experimental light exposure.
Statistical analysis
For the differences in timing of DLMO, sleep onset, sleep offset, sleepiness and sleep quality 
between conditions, a repeated-measures ANOVA was used with one factor for condition 
(2 levels; 30 min and 60 min) and one factor for the number of pulses (4 levels; 0-3). If the 
factor ‘condition’ or the interaction of ‘condition * pulses’ was significant, a ‘simple contrasts’ 
test (equal to a paired sample T-test) was included to the ANOVA to see how many pulses 
were needed to see significant differences between conditions. The conditions were also 
tested separately for the effects of the number of pulses. This was done with a repeated-
measures ANOVA with one factor for the number of pulses and ‘simple contrast tests’ were 
used to compare the number of pulses to zero pulses (baseline day). The significance level 
was defined as p=0.05. All parameters were tested two-tailed. 
Results
DLMO shifts 
Salivary melatonin levels rose in the evenings of all three nights in the two conditions (Figure 
2). The 25% level of the maximum fitted value (definition of DLMO, see methods) is indicated 
by the black horizontal lines. The median DLMO times in the condition with 30 min. light 
pulses were 23:02h (baseline day i.e. 0 pulses), 22:47h. (2nd day i.e. after 1 light pulse) and 
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22:24h (4thday i.e. after 3 light pulses). The median DLMO times in the condition with the 
60 min. light pulses were 23:23h (0 pulses), 22:50h (after 1 light pulse) and 22:08h (after 3 
light pulses).  See also Figure 2.
Figure 2. The ascending part of the melatonin curve during three different nights. The 25% of the 
amplitude is indicated by the horizontal black lines. A: 30-min light pulse condition. B: 60 min. light 
pulse condition. Symbols represent the median values within the groups. Shaded areas represent the 
45% -55% percentile intervals.
Exposure to one 30 min. light pulse, actually timed 8.4 (SD 1.2) hours after baseline DLMO 
the night before, did result in a non-significant phase advance of the melatonin rhythm of 15 
(± 15 min. SEM) (t10= 1.04 P=0.33).  Exposure to one 60 min. light pulse, timed 8.2 (SD 0.8) 
hours after baseline DLMO the night before, resulted in a significant phase advance of 30 (± 
12 min. SEM) (t10= 2.40 P<0.05). The actual timing of the first light pulses in the 30 min blue 
light pulse condition and the 60 min blue light pulse condition, although both a bit earlier 
than the scheduled 9h after DLMO, did not significantly differ from each other (t=0.90, df 
= 10, P=0.39). After 3 days of light exposure both 60- and 30 min. light pulses were able to 
elicit significant phase advances of the melatonin rhythm; a phase advance of 49 min. (± 
17 min. SEM) (t10= 2.80 P<0.05) resulted from exposure to three 30 min. light pulses and 
a phase advance of 59 min. (± 8.7 min. SEM) (t10= 6.9 P<0.001) from exposure to three 60 
min. light pulses (Figure 3). Interestingly, no significant differences were found between the 
DLMO shifts after 30 min. light pulses and 60 min. light pulses: neither the shifts after one 
pulse (F1,10 = 0.96 P=0.35) nor after three consecutive days with light pulses (F1,10 = 0.291 
P=0.65) were found to be significantly different from each other. 
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Figure 3. The shift in DLMO in minutes on day 2, i.e. after one light pulse and on day 4, i.e. after three 
light pulses compared to baseline.  Positive values mean phase advances, negative delays. Significant 
shifts are indicated by * # P<0.05, ##P<0.001.
Sleepiness patterns over the week
In order to see possible differences in the decline in sleep inertia, participants were asked 
to provide their sleepiness scores with the Karolinska Sleepiness Scale (KSS score) 5 minutes 
after waking up, as well as 30 minutes after waking up or after using the GoliteBLU lamp 
for 30 or 60 minutes. The decline in sleep inertia was found to be significant on all days , 
however no differences in sleep inertia decline were found for the interaction of the number 
of pulses and conditions (Pulses X Condition F3,8 =0.81, P= N.S). There were small trends 
for different KSS scores immediately after waking up after 2 and 3 pulses. In the 60 min. 
condition there was a trend for a lower KSS score immediately after waking up after 3 pulses 
5.9 (± 0.5 SEM) (t10= 3.38 P=0.096) compared to baseline KSS score 6.4 (± 0.5 SEM). A 
similar trend for a decline in sleepiness immediately after waking up was observed in the 
30 min light condition; after 2 pulses the KSS score was on average 6.6 (± 0.5 SEM) (t10= 
4.23 P=0.067) and after 3 pulses  6.1 (± 0.6 SEM) (t10= 4.10 P=0.070),  compared to the 
average baseline KSS score 7.6 (± 0.5 SEM). The sleepiness scores in the 30 min. and 60 min. 
light pulse conditions were not significantly different from each other, not immediately after 
waking up (F1,10 = 2.89 P=0.12), nor after using the GoliteBLUE lamp  (F1,10 = 0.98 P=0.35). 
Sleep timing 
To optimize the timing of the light pulses and to allow for 8 hours of sleep per night, subjects 
received individual instructions when to go to bed and when to wake up. Therefore, sleep 
timing was influenced by scheduled sleep and wakeup times. However, subjects were 
allowed to sleep and wake up earlier (not later) if they wanted. After the experiment, the 
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actual sleep timing was determined from data from the Actiwatch (AW2) that subjects wore 
on all experimental days, or from the sleep diary, if data from the AW2 was not available, 
which was the case for 4 out of 11 subjects. Sleep timing data, i.e. average (± S.E.) sleep 
onset and sleep offset times for the baseline night and for the nights after one, two or three 
light pulses are shown in Table 1. Sleep times in the 30 min. and 60 min. light conditions were 
not significantly different from each other, not for sleep onset (F1,10 = 0.17 P=0.69), nor for 
sleep offset (F1,10 = 1.90 P=0.20). Both experimental conditions resulted in a significantly 
earlier sleep onset compared to baseline (table 1), though this was obtained later i.e. after 
3 pulses in the 30 min. light pulse condition and already after 1 pulse in the 60 minutes 
condition.
Sleep Quality
Objective sleep quality was analysed from the data of the AW2’s (table 1). Due to failures 
of the AW2’s in data collection, data on sleep quality of only 7 subjects (2f/5m) could be 
analysed. Objective sleep quality measures were sleep onset latency (SOL), sleep duration 
(Duration), the number of awakenings per hour (Awakenings/h.) and minutes awake after 
sleep onset (WASO). The subjective sleep quality rating (SQR) was asked for in the sleep 
diary on experimental days (table 1). 
 
The 30 min. - and 60 min. conditions were only found to be significantly different for sleep 
onset latency (SOL) (F1,6 = 10.9 P<0.05). This difference may have been caused by the longer 
sleep onset latency on the baseline day in the 30 min. condition. For the other sleep quality 
parameters there were no significant differences between conditions: sleep duration (F1,6 
= 0.50 P=0.51), number of awakenings/h. (F1,6 = 0.29 P=0.61), WASO (F1,6 = 1.15 P=0.33), 
SQR (F1,10 = 0.45 P=0.52). Compared to baseline, sleep duration was longer for the 60- and 
30 min. conditions on the 2nd and 4th day respectively. Sleep onset latency was shorter on 
the second day (after one light pulse) in the 30 min. condition compared to the baseline day. 
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Again, this may have been caused by the longer sleep onset latency of the baseline day in 
the 30 min. condition. 
Discussion
This study demonstrates that three optimally timed, high blue light intensity, short pulses 
(30 min.) , applied in a home situation, accompanied by dim light prior to sleep, are able 
to significantly phase advance the melatonin rhythm. The phase shifting effects of these 
three short blue light pulses are not significantly different from the effects of the positive 
control condition with three longer (60 min.) blue light pulses. The effects on the sleep-wake 
rhythm and morning sleepiness were also not significantly different between the 30-min 
and the 60-min blue light pulse conditions.  
The idea that short light pulses are able to influence the circadian system is not new. However, 
up till the present study positive findings were based on the effects of short light pulses mostly 
in highly controlled lab conditions. A dose response study of light pulse duration by Chang 
and colleagues (2012) revealed that the melatonin rhythm can be phase-delayed by a single 
light pulse in the evening of only 12 minutes. A more recent study of Gabel and colleagues 
(2013) showed that the melatonin rhythm can also be phase-advanced by a single blue light 
pulse in the morning of only 20 min. Both these studies were carried out with subjects living 
in a controlled situation with a dimly lit environment outside the light exposure period. In a 
recent other home setting study (Saxvig et al 2014) the effects of 30-45 min of bright white 
light were tested in 10 subjects suffering from Delayed Sleep Phase Disorder. In that study, 
light was administered in one out of  four different conditions, including a control condition, 
at waking up in a protocol wherein subjects received instructions to wake up one hour earlier 
each day until the preferred rising time was reached during a 2-week period. Unfortunately 
possible effects of the treatment on DLMO could be assessed in only 4 subjects and no 
statistical effect of light was observed in this small group. Analysis of actigraphy data on 
sleep parameters during the second week of treatment did not show a significant difference 
between the four conditions. 
In our study we asked the subjects to stay in dim light during the evenings, both to be 
able to accurately estimate the onset of melatonin, and to prevent a possible counteracting 
effect of evening light exposure on the phase shifting effect of the morning light pulse. It is 
possible that protection to evening light by itself has played a role in the observed phase 
advance, but this has not been tested.  Nevertheless, it seems unlikely that an almost one 
hour phase advance is the result of four consecutive dim light evenings alone. The current 
study confirms the results of the controlled lab studies (Chang et al 2012, Gabel et al 2013) 
and supports the conclusion that a combination of short light pulses of 30 minutes in the 
morning and dim light in the evening is also capable of advancing the melatonin rhythm 
when applied in a home situation with no real control over environmental light. This is the 
situation in which light treatment for circadian rhythm sleep/wake disorders predominantly 
will take place. 
27
The main focus of the present study was to test the effects of short blue light pulses on the 
melatonin rhythm. Therefore the setup of the study was not meant to test the effects on 
sleep, and actimetry data could be obtained in only 7 out of 11 subjects. For this reason, 
the results on the effects of the experimental conditions on sleep should be interpreted 
with caution. Nevertheless, in addition to the shift in the melatonin rhythm there was also 
a small, but significant shift (30-40 min.) in sleep onset time.  This shift was not significantly 
different for the 30- and 60 min. light pulse conditions.  The shift in sleep onset time might 
reflect a shift in the circadian pacemaker, or be the effect of the shift of the melatonin 
rhythm, or the fact that the participants were instructed to wake up earlier than that they 
normally did (higher sleep pressure in the evening), or a combination.  
Another finding was a trend for a reduction of sleepiness in the morning. Not only after light 
exposure, but even directly at waking up, probably resulting from a shift of the circadian 
pacemaker influencing sleep propensity and daytime alertness (Dijk & Czeisler 1994). 
In contrast to the previous lab study of Gabel et al (2013), who showed a significant phase 
advance after 1 20-min light pulse, the current home study shows more individual variation 
in phase advances in response to shorter light pulses, resulting in a non-significant phase 
advance after 1 30-min light pulse. The larger variation may result from the different 
environmental circumstances, as the lighting conditions are variable at home while more 
constant in the lab. In addition, due to less controlled conditions, both in light exposure 
and in accurate timing of saliva collection, the estimation of DLMO may be more variable 
by itself, resulting in the non-significant shift after one day with a 30-min light pulse in this 
study.
 
Indeed, light in the morning is not the only factor responsible for the phase-advancing 
effects of light. The studies of Hébert et al. (2002), Chang et al. (2011) and Giménez et al. 
(2014) revealed that the ‘light history’ is also important for the responsiveness to light. 
Participants in lab conditions with dim light environments are more dark adapted and are 
therefore more sensitive to light (Hebert et al. 2002, Chang et al. 2011). Even in a real-
life setting, but with a reduction in blue light exposure through blue reducing contact 
lenses, it is possible to influence the non-image forming responses to light (Giménez et al. 
2014).  Another important factor for an optimal substantial phase advance is the complete 
pattern of light-dark exposure during the rest of the day (Appleman et al. 2013, Burgess 
et al. 2013). Especially low light levels in the evening are essential for an optimal phase 
advance. It is even possible to phase advance the melatonin rhythm without extra light in 
the morning. When subjects are forced to sleep 2-3 hours earlier than they normally do, 
in other words, if they do not receive light in the evening their melatonin rhythm can also 
be phase advanced (Gordijn et al. 1999, Sharkey et al. 2011). Although the subjects were 
told to dim their lights during the experimental evenings of the current study, there may 
have been variation in these evening light settings. Besides, there were no light restrictions 
during the remaining part of the day, and this study was carried out in summer. Therefore, 
the light exposure patterns between individuals and between days must have been very 
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different and these differences in prior light history may have influenced the phase shifts. It 
is against this background of varying daytime and evening time light exposure that we still 
found significant phase advances with three days of only 30 min extra blue light exposure 
in the morning. This emphasizes the conclusion that blue light therapy in the morning is 
potentially highly effective as a treatment for circadian rhythm sleep disorders with a late 
sleep phase. 
A limitation of this home study is the lack of objective compliance data for all subjects both 
to the light therapy/dark instructions and to the strict timing of the collection of saliva for 
melatonin analysis. The data that were obtained supported the fact that subjects indeed 
followed instructions to a large extent, but a 100% certainty is not possible. For a follow-
up study, it is interesting to specifically monitor the extra light that is received during the 
light therapy session in relation to environmental light conditions over the whole day, to 
investigate whether this indeed plays a role in the efficacy of morning light treatment. 
The attempt to do this in the current study failed due to technical problems. Also the lack 
of a control condition without experimental light exposure is a limitation of the study. 
Expectations of subjects have been demonstrated to influence light treatment effects in 
depression studies (Putilov & Danilenko 2005, Flory et al. 2010, Knapen et al 2014) and it is 
possible that the instructions of sleep scheduling or being admitted to the study protocol 
by itself influenced the observed effects. Although an optimal ‘placebo light’ condition to 
control for expectations and for the effects of the experimental conditions is not possible in 
studies on the effects of light therapy, including a control condition with a ‘placebo lamp’ 
with the same visual brightness in a next study is definitely needed.  
Conclusion
From the current study it is clear that optimally timed, short duration, high intensity blue 
light pulses of 30 min. have high potential to be effective when used in a light therapy 
design for phase advancing the circadian system. This includes both a proper instruction 
of when and how long to use the light, as well as when to protect from light, e.g. in the 
evening. A light therapy protocol for clinicians would benefit from a more easy instruction 
for the timing of light than in the current study where timing of light was relative to DLMO. 
Since the phase angle of DLMO and sleep seems to be highly variable, especially in late 
chronotypes (Sletten et al 2010), this issue should be solved in additional experiments. Also 
to be able to generalize the effects of these short blue light pulses to the population, larger 
groups- and more variation within participants is needed. Finally, to be clinically relevant, it 
still needs to be demonstrated whether also the sleep-wake rhythm and sleep architecture 
will improve in response to blue light therapy and if morning sleepiness at waking up can 
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Many people in our modern civilized society sleep later on free days compared to work 
days. This discrepancy in sleep timing will lead to so-called ‘social jetlag’ on work days with 
negative consequences for performance and health. Light therapy in the morning is often 
proposed as the most effective method to advance the circadian rhythm and sleep phase. 
However, most studies focus on direct effects on the circadian system and not on post-
treatment effects on sleep phase and sleep quality. In this placebo-controlled home-study 
we investigated if blue-light, rather than amber light therapy, can phase shift the sleep phase 
along with the circadian rhythm with preservation of sleep quality and performance.  
We selected 42 participants who suffered from ‘social jetlag’ on workdays. Participants 
were randomly assigned to either high intensity blue light exposure or amber light exposure 
(placebo) with similar photopic illuminance. The protocol consisted of 14 baseline days 
without sleep restrictions, 9 treatment days with either 30-min blue light pulses or 30-
min amber light pulses in the morning along with a sleep advancing scheme and 7 post-
treatment days without sleep restrictions. Melatonin samples were taken at days 1,7,14 
(baseline), day 23 (effect treatment), day 30 (post-treatment). Light exposure was recorded 
continuously. Sleep was monitored through actigraphy. Performance was measured with a 
reaction time task. 
 
As expected, the phase advance of the melatonin rhythm from day 14 to day 23 was 
significantly larger in the blue light exposure group, compared to the amber light group 
(84 min. ± 12 (SEM) and 48 min. ± 11 (SEM) respectively; (t36=2.23, P<0.05). Wake-up time 
during the post-treatment days was slightly earlier compared to baseline in the blue light 
group compared to slightly later in the amber light group (-21 min. ± 8 (SEM) and +12 min ± 7 
(SEM) respectively; F1,35=9.20, P<0.01). The number of sleep bouts was significantly higher 
in the amber light group compared to the blue light group during sleep in the treatment 
period (F1,32=4.40, P<0.05). Performance was significantly worse compared to baseline at 
all times during (F1,13=10.1, P<0.01) and after amber light treatment (F1,13=17.1, P<0.01), 
while only in the morning during post-treatment in the blue light condition (F1,10=9.8, 
P<0.05). 
The data support the conclusion that blue light was able to compensate for the sleep quality 
reduction and to a large extent for the performance decrement that was observed in the 
amber light condition, both probably as a consequence of the advancing sleep schedule. 
This study shows that blue light therapy in the morning, applied in a home setting, supports 





Sleeping out of phase with the external light-dark cycle, especially sleeping later, has become 
a common habit in our civilized society. Despite the fact that workdays and schooldays 
typically start early in the day, many people go to bed late and try to compensate for the 
sleep deficit by extending their sleep on free days. From a large database of 55000 people 
it was indeed calculated that the average wake up time on free days was 2 hours later than 
on work days (Roenneberg et al. 2007). In addition, a recent analysis of a  Dutch survey 
on sleep habits found that 74 % of the adult population sleep later on free days than on 
workdays (n=8074, Gordijn, unpublished). As a result of the discrepancy in sleep timing on 
workdays and free days, many adults experience a so-called weekly ‘social jetlag’ (Wittman 
et al. 2006).  
As with a ‘normal’ jetlag resulting from travelling to different time zones, sleeping at the 
wrong internal phase can disturb bodily rhythms (Rajaratnam & Arendt 2001, Rüger & 
Scheer 2009, Baron & Reid 2014). This may lead to stress and health problems. Indeed, 
correlational studies have indicated that if the amount of ‘social jetlag’ is higher, people 
have a higher risk of living an unhealthy lifestyle, being overweight, and experiencing stress-
related problems and even depression (Wittman et al. 2006, 2010, Roenneberg et al. 2012, 
Merikanto et al. 2013, Touitou 2013). Furthermore, people with a late sleep phase are highly 
represented in the population (for 60% the midpoint of sleep on free days is at 4:30 or later, 
Roenneberg et al. 2007) and they have a higher chance for a larger social jetlag (Wittman 
et al. 2006). A large number of people in the population may therefore benefit from a 
correction of their timing of sleep.  
Light therapy in the morning is often proposed as the most effective method to advance a 
late sleep phase (Barion & Zee 2007, Morgenthaler et al. 2007, Bjorvatn & Pallesen 2009). 
Indeed in a clinical setting, light exposure in the morning has been shown to be effective 
in advancing circadian rhythms of ‘delayed sleep-wake phase disorder’ (DSPD) patients. 
Home therapy studies for the treatment of DSPD used light exposure of 2 hours in the very 
early morning (Rosenthal et al. 1990) or directly after habitual wake up (Lack et al. 2007). 
More recent DSPD therapy studies examined the effect of shorter light pulses (30 min-2 h. 
Gradisar et al. 2011, 30-45 min. Saxvig et al. 2014), starting directly after waking up, along 
with a sleep advancing protocol with strict sleep schedules. Light therapy itself does not 
always seem to be crucial for the therapeutic effect: a recent study found that even a sleep 
advancing protocol alone can already phase advance the circadian rhythm of late sleepers 
(Sharkey et al. 2011).
 
The experimental set-up to test morning light therapy is highly variable in the aforementioned 
DSPD studies and not well studied in late chronotypes in general. Furthermore, there is no 
generally accepted optimal protocol that can be applied at home (reviewed in Schroeder 
& Colwell 2013). Another issue is the lack of studies with good control conditions, since 
placebo lamps do not really exist. Last but not least, although the goal of light therapy in 
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late chronotypes is to shift sleep and to improve daytime functioning, the focus of most 
studies has been on shifting melatonin as an output marker. The post-treatment effect on 
sleep phase itself has hardly been studied, and daytime functioning after light treatment has 
hardly been reported.  
The rationale of using light therapy to shift sleep is based on the theory that it can 
influence the synchronization of sleep by adjusting process C of the ‘2 Process model’ of 
sleep regulation (Borbély 1982, Daan et al. 1984). In humans and many other organisms, 
process C is highly controlled by the central master clock in the brain, the suprachiasmatic 
nucleus (SCN) (reviewed in Moore 2007). There is accumulating evidence that light at least 
influences process C as the SCN is predominately synchronized by light (reviewed in Meijer 
and Schwartz 2003 and in Moore 2007).
 
Phase shifts of the SCN can be approached by measuring shifts of physiological circadian 
rhythms, of which the shift of melatonin onset measured in very low light intensities <10 
lux (dim light melatonin onset, DLMO) is currently known as the most reliable marker (Lewy 
et al. 1989 & 1999, Klerman et al. 2002, Revell et al. 2005b, Arendt 2005, Van Someren & 
Nagtegaal 2007, Benloucif et al. 2008).  Many studies have found that light in the morning 
induces a phase advance of dim light melatonin onset (Dijk et al. 1989, Buresova et al. 1990, 
Samková et al. 1997, Gordijn et al. 1999, Danilenko et al. 2000, Revell et al. 2005a) whereas 
light in the evening induces a phase delay (Kräuchi et al. 1997, Gordijn et al. 1999, Zeitzer 
et al. 2000, Gronfier et al. 2004). These time dependent effects of light are summarized in 
a phase response curve (PRC) as extensively analyzed in rodents by Daan and Pittendrigh 
(1976). PRC studies have found an optimum for the phase advancing effects of long and 
short (blue) light pulses when starting the light exposure 9 hours after DLMO (Khalsa et al. 
2003, St Hilaire et al. 2012, Rüger et al. 2013). It has also been shown that the beginning of 
a light pulse is most important for the phase advancing effect (Beersma et al. 2009) which 
supports the idea that light pulses given approximately 9 hours after DLMO will be effective 
in phase advancing circadian rhythms. 
 
Besides the timing of light exposure there are other important factors that influence the 
effectiveness of light on the SCN. Important factors are intensity (Zeitzer et al. 2005), spectral 
composition (Berson et al. 2002, Lockley et al. 2003,) and duration (Chang et al. 2012) of the 
light exposure. To optimize the final treatment success (and thereby the compliance to light 
therapy) it is important to find the optimal combination of these factors. 
We tested the effect of duration in a pilot study (Geerdink et al. 2012) and we found 
that high intensity short blue light pulses of 30 minutes timed 9 hours after DLMO on 3 
consecutive days were able to advance the melatonin rhythm by 50 minutes. Importantly, 
we found that the effect on the melatonin rhythm of those three 30 min. blue light pulses 
was not significantly different from the effect of three 60 min. blue light pulses. Therefore 
we concluded that we could use these short 30 min. high intensity blue light pulses to phase 
advance the circadian rhythm in a home-setting protocol.
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To test if short 30 min. high intensity blue light pulses cannot only be used for phase 
advancing the melatonin rhythm but also for treating a late sleep phase, the main question 
of the present study was whether these light pulses were able to advance sleep timing with 
preservation of sleep quality and daily performance. We tested the effects of blue morning 
light pulses against amber morning light pulses, which we considered to serve as a ‘placebo’ 
condition. 
Material and Methods 
Participants
Participants were recruited from the northern population of the Netherlands, via newspaper 
advertisements, posters at the faculties of the University of Groningen and internet 
advertisements. People were invited to only respond to the advertisement if they felt they 
were suffering from sleeping later on free days compared to work days and if they really 
wanted to change this. Therefore two of the selection criteria were, a calculated social jetlag 
(Wittman et al. 2006) of more than 1 hour and a calculated shorter sleep duration during 
workdays compared to free days (calculated from the MCTQ, Roenneberg et al. 2003). Other 
selection criteria were: being healthy, between 18-65 years old, not suffering from sleep 
problems other than late sleep, not colorblind or visually impaired, not consuming too many 
cigarettes (more than 10 per week) and not consuming too many drinks with caffeine (more 
than 8 a day) or alcohol (more than 10 per week), not working in night shifts and not having 
been in other time zones in the preceding three months, not being severe dysphoric or 
depressed (BDI-II rating <16 (Beck et al., 1996 & 2002)). Female subjects were only included 
if they were using hormonal contraceptives. All subjects were Dutch citizens from birth and 
fluent in Dutch. All subjects gave written informed consent and were compensated for their 
participation. The experimental protocol was approved by the Medical Ethics Committee 
of the University Medical Center Groningen. We selected 42 participants for this study (23 
females, 19 males) with a mean age of 21.4 years (SD +- 6.5).  For a detailed description of 
subject characteristics see table 1.
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Experimental design 
All participants were quasi-randomly assigned (balancing for age, gender, chronotype) to 
a sleep advancing protocol supported by either high intensity blue light or amber light 
(control) with similar photopic illuminance (see ‘Light exposure’ section for details). 
None of the subject characteristics was significantly different between groups (see Table 
1). 
The protocol consisted of 30 days in total and was completely performed at home. All 
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participants started with 14 baseline days with no sleep instructions. This was followed by 
9 intervention days with either 30-min blue light pulses or 30-min amber light pulses in the 
morning along with a sleep advancing scheme. The scheme was based on the habitual sleep 
offset of days 4-10 in the baseline period, and consisted of 1 hour advance every 3 days. This 
scheme was followed by 7 post-treatment days without sleeping instructions and no use of 
light treatment devices (see figure 1). The study was carried out from June 2011 until April 
2012. Participants were evenly divided over conditions per season.
Figure 1. Scheme of the experimental design. Consecutive days are indicated by rows.
In order to quantify effects on the melatonin rhythm, saliva samples were taken on the 
evenings of days 1 and 7 (pre-baseline), day 14 (baseline), day 23 (effect intervention) and 
day 30 (post- treatment effect). Saliva collection started 5 hours prior to habitual bedtime. 
Subjects were asked to stay in dim light (intensity at which they can just read, < 10 lux), 
starting 1 hour prior to the first sample. In addition, they were asked to wear blue light 
blocking glasses (Uvex S1933X, Skyper Safety Eyewear). On days 14, 23 and 30 participants 
were instructed to not only collect saliva during the evening but also from habitual sleep 
onset until waking up (1 sample per 2 hours). In addition, 3 additional samples (1 per hour) 
were taken after habitual sleep offset in the morning on days 14, 23, 30. This resulted in 13 
samples in total on these days. Saliva was collected with cotton swabs (Salivette®, Sarstedt BV, 
Etten-Leur, The Netherlands). Melatonin concentration was assessed by radioimmunoassay 
(RK-DSM; Bühlmann Laboratories, Alere Health, Tilburg, The Netherlands). The limit of 
detection was 0.3 pg/mL. Intra-assay variation was 15.9% at a low melatonin concentration 
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(mean = 2.0 pg/mL, n = 17) and 13.1% at a high melatonin concentration (mean = 24.5 pg/
mL, n = 15). Interassay variation was 13.1% at low melatonin concentration (mean = 2.0 
pg/mL, n = 16) and 15.0% at high melatonin concentration (mean = 21.4 pg/mL, n = 16). A 
bimodal skewed baseline cosine function was fitted through the individual data points of 
the baseline curve on day 14 (Van Someren & Nagtegaal 2007). The maximum value of the 
fitted baseline curve of each individual was set at 100%. Dim Light Melatonin Onset (DLMO) 
was calculated as the moment at which the melatonin rhythm crosses the 25% value of this 
fitted maximum by linearly interpolating the raw values preceding and following the 25% 
value.  
During the whole protocol sleep was monitored with the Actiwatch Spectrum monitor 
(Philips Respironics Inc., Murrysville, USA). Participants completed sleep diaries including 
sleepiness measurements 5 and 30 minutes after waking up (Karolinska Sleepiness Scale, 
KSS). Cognitive performance was measured with a 3-min reaction time task (Psychomotor 
Vigilance Task, PVT) on a handheld minicomputer (HP Ipaq114) on the last 3 baseline days 
(day 12, 13, 14), on the middle treatment days (day 19, 20, 21) and on 3 post-treatment 
days (day 27, 28, 29). Performance was measured at four time points during the day, namely 
during the morning (30 minutes after wake up), at noon (12:00), at late afternoon (18:00) and 
during the evening (23:00). Due to large differences in sleep times between free days and 
work days, which is typical for this population, comparisons of sleepiness and performance 
between light conditions were limited to workdays only. 
Participants received an instruction book with a detailed scheme what they had to do on 
specific days. In addition, participants received text messages (or phone calls) when they 
needed to make appointments with the researchers (day 1, day 10, day 23, day 30) and they 
received a text message reminder the day before starting with light therapy (day 14). 
Compliance
Before analyzing the data, we carefully checked compliance of the subjects by inspection 
of the light data and the actigraphy data during the treatment days. Subjects wore glasses 
or a hairband with a light sensor, Daysimeter (Lumen Tech Innovations, New York, USA), 
which measured spectral characteristics of light at the eye level. The Daysimeter employs 
two photosensors which separately measure a photopic (visual) and a short-wavelength 
(‘blue’) response to optical radiation. This ‘blue’ light sensor has peak sensitivity at short 
wavelengths (460 nm, 80 nm full-width-half-maximum bandpass), near the peak of the 
spectral sensitivity of the human circadian system (Rea et al. 2005, 2010). The device also 
records activity (movement). These ‘Daysimeters’ were used to monitor the compliance 
to the instructions of when to use the experimental light, and were also used to measure 
the exposure to natural and artificial light sources during the day. A program in ‘Matlab’ 
(Mathworks, version R2014b) was developed to detect if there were differences with 
respect to light intensity during the mornings of every experimental day. Compliance of the 
participants was checked according to the timing of light exposure with the lamps. Subjects 
were excluded from the database if they started the light exposure more than  30 minutes 
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too early or too late on average (over the 9 treatment days). We excluded 2 participants 
(blue light condition) because of this criterion. In 5 of the 42 subjects, technical failures 
prohibited the use of the light exposure data for this purpose. In those cases we used the 
actigraphy data instead, by inspecting the sleep offset times during the treatment days. We 
excluded subjects who did not show any activity for 3 or more days within 30 minutes after 
the timepoint at which they were instructed to wake up. We had to exclude 1 extra subject 
(amber light condition) because of this criterion. Eventually the data of 39 participants (Blue 
N=18, Amber N=21) have been  used for analyses. A check for sleep timing compliance 
during the 9 treatment days revealed that subjects indeed shifted their sleep offset by 2 
hours in both groups: Habitual sleep offset was on average 09:12 AM (0:14) in the blue 
group and 09:00 AM (0:17) in the amber group during days 4-10 at baseline. Average wake-
up time over the last 3 days of the treatment period was 07:08 (SEM 0:14) in the blue group 
and 07:06 (SEM 0:13) in the amber group.  
Light treatment 
In our previous pilot-study we found that 3 optimally timed light pulses of 30 min high 
intensity blue light were able to shift the melatonin rhythm for about 50 minutes (Geerdink 
et al. 2012). Therefore in this study we used 30 minutes of light therapy, which is easy to 
comply with in a home situation. Subjects were instructed to expose themselves to either 
30 min high intensity blue light (Philips GoLite BLU HF3320, peak transmission at 470 nm, 
intensity at the cornea 2306 melanopic-lux (Lucas et al. 2014), 300 photopic lux, 3.0 W/
m2) at a distance of 40 cm and angle of exposure of 45°), or to control 30 min amber light 
with similar photopic illuminance (adapted Philips GoLite HF3320, peak transmission at 590 
nm, intensity at the cornea 70 melanopic-lux, 250 photopic lux, 0.5 W/m2).  Timing of the 
light pulse was based on the subjects’ habitual sleep schedule during baseline days 4-10 
measured by actigraphy and on the subjects’ preferred timing of sleep after the treatment. 
The last three light pulses were set at the preferred sleep offset and the timing of the light 
exposure was set one hour earlier every 3 days. In order to get sufficient sleep, sleep timing 
was scheduled to shift along with the light therapy (see also figure 1).  On average, subjects 
started with the first light pulse 7.9 hours (± 0.1h) after habitual sleep onset. At the end of 
the study the actual timing according to DLMO on the night prior to the first light pulse could 
be calculated. Light was administered on average 10.4 hours, 9.4 hours and 8.4 hours (± 
0.2h) after baseline DLMO on respectively the first days (day 15-17), middle days (day 18-20) 
and last days (day 21-23) of the treatment period (which is close to the optimal timing for 
phase advances, see introduction). Based on the middle 3 light pulses, light exposure timing 
with respect to baseline DLMO was not significantly different between the two groups 
(t36=0.22, P=0.83), namely on average 9.5h (± 0.2h) in the blue condition, and on average 
9.3h (± 0.2h) in the amber condition.
Environmental light measurements 
Before analysing any result, we first checked if the daily environmental lighting conditions 
were not significantly different between conditions. All light measurements were monitored 
with the Daysimeter light sensor (see the compliance section for more information). This was 
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done since not only morning light is of influence on our circadian system; it is the complete 
pattern of light exposure during the whole day that is responsible for phase shifting effects 
(Appleman et al. 2013, Burgess et al. 2013b). Especially low light levels in the evening are 
essential for an optimal phase advance. 
Light exposure levels of the subjects in the two groups were compared to check for possible 
behavioral differences that could result in differences in light exposure other than the actual 
light treatment. Light levels were calculated on the treatment days during the morning 
(06:00-12:00), afternoon (12:00-18:00) and evening (18:00-24:00). Due to technical failures, 
light data of 27 subjects (13 in the blue group, 14 in the amber group) were analyzed. 
Sleep analyses 
During the whole protocol sleep was monitored with the Actiwatch Spectrum monitor 
(Philips Respironics Inc., Murrysville, USA) and analyzed afterwards with the Respironics 
Actiware 5 software. Objective estimates of sleep quantity and sleep integrity were defined 
by the following parameters: ‘Sleep onset latency’ (SOL), sleep duration, ‘minutes awake 
after sleep onset’ (WASO), number of sleep bouts (as a measure for sleep consolidation) and 
sleep efficiency (defined as (sleep time – SOL- WASO)/sleep time*100%). It should be noted 
that sleep integrity as measured with actimetry is different and never as accurate as sleep 
integrity measured with polysomnography (reviewed in Ancoli-Israel et al. 2003). Especially 
SOL is often underestimated with actigraphy (Chae et al. 2009, O’Hare et al. 2015). Still, as 
differences within individuals are compared, it is possible to evaluate the changes in relation 
to these sleep parameters over the different periods.  
Statistical analyses 
For all the variables, group means (described as ‘mean ± SEM’) were tested against each 
other. For differences between conditions concerning melatonin concentrations (dim light 
melatonin onset, area under the curve) independent sample t-tests were used. Paired sample 
t-tests were used to test the differences of the melatonin concentrations between baseline 
and the end of treatment and between baseline and after post-treatment per condition. If 
more parameters needed to be tested, like with the sleep analysis, a repeated-measures 
ANOVA for each parameter was used with one within subjects factor for ‘period’ (3 levels; 
baseline, treatment, posttreatment) and  one between subjects factor for ‘condition’. If the 
interaction of ‘condition * period’ was significant, a ‘simple contrasts’ test (equivalent to a 
paired sample T-test) was included to the ANOVA to see which period was different from 
the baseline period. For the performance analysis an extra factor for ‘time of day’ (4 levels; 
morning, noon, afternoon, evening) was included. The significance level was defined as 
p=0.05. All parameters were tested two-tailed. 
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Results
Environmental light levels during the morning, afternoon and evening 
No significant differences were found for the average photopic illuminance levels between 
conditions during the morning (blue group; 519 lux/min. ± 90, amber group; 548 lux/min. ± 
82) (t25=-0.25, P= 0.81), nor during the afternoon (blue group; 1664 lux/min. ± 271, amber 
group; 1425 lux/min. ± 233) (t25=0.67, P=0.51), nor during the evening (blue group; 96 lux/
min. ± 31, amber group; 132 lux/min. ± 30)  (t25=-0.85, P=0.40).  
With respect to the ‘blue light’ illuminance levels, a significant difference between 
conditions was found during the morning. The ‘blue’ morning light exposure measured by 
the Daysimeters (see the Material & Methods section) was found to be significantly higher 
in the blue light therapy group (blue group; 1485 ‘blue lux’/min. ± 193, amber group; 965 
‘blue lux’/min. ± 144) (t25= 2.2, P<0.05), while not significantly different between the two 
conditions during the afternoon (blue group; 3208 ‘blue lux’/min. ± 514 , amber group; 2581 
‘blue lux’/min. ± 435) (t25= 0.94, P= 0.36) nor during the evening (blue group; 163 ‘blue lux’/
min. ± 62 , amber group; 226 ‘blue lux’/min. ± 58) (t25= -0.74, P= 0.47). This difference in 
blue light exposure in the morning between groups is explained by the light treatment itself.
 
Effects on the melatonin rhythm: DLMO 
The average dim light melatonin onset times on the days that the saliva samples were taken 
are shown in Figure 2A. Day 14 was the day before the light exposure period started and was 
considered as the baseline day. Although on average a slight delay for both groups from day 
1-7-14 seems to occur (10 min. (± 12) in the blue light condition and 17 min. (± 13) in the 
amber light condition), the DLMO times on day 14 were not significantly different from day 
1 and day 7 for both conditions (blue, F1,2= 0.18 P=0.83, amber F1,2= 1.16 P=0.33).  
Compared to day 14, a significant phase advance was observed on day 23 (after 9 days of 
light exposure) in both groups (Figure 2A and 2B). DLMO shifted on average by 48 min (± 
11) (t19= 4.56, P<0.001) in the group that received amber light and by 84 min (± 12) (t17= 
6.95, P<0.001) in the group that received blue light. The shift in the blue light group was 
significantly larger than the shift in the amber light group (t36 = 2.23, P<0.05, Figure 2B). 
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Figure 2. The average (±SEM) DLMO times on different days of the protocol. Average DLMO times on 
day 23 differed significantly from the average DLMO times on day 14, *P<0.001. B: The average (±SEM) 
DLMO shifts from baseline. ‘Treat-B’= DLMO shift from baseline after treatment in the blue light 
condition, ‘Treat-A’= DLMO shift from baseline after treatment in the amber light condition *P<0.05. 
‘Post-B’= DLMO shift from baseline after the post-treatment period in the blue light condition, ‘Post-A’= 
DLMO shift from baseline after the post-treatment period in the amber light condition. 
At day 30, DLMO delayed (shifted back) in both groups compared to day 23 (Figure 2A 
and 2B, 70 min. (± 16) in the blue light condition t17 = -4.26, P<0.01, 48 min. (± 8) in the 
amber light condition t19= -6.01, P<0.001). The DLMO shifts from day 23 to day 30 were 
not significantly different from each other (t36 = -1.26, P=0.22). DLMO at day 30 was not 
significantly different from baseline, neither for the blue group (t17= 0.90, P=0.38) nor for 
the amber group (t19= 0.06, P=0.95, Figure 2B).
Effects on the melatonin rhythm: Area under the curve 
The levels of the melatonin concentrations were expressed as the percentage of the fitted 
maximum on day 14 for each time point per individual on days 14, 23, 30. Then the average 
melatonin profiles were calculated for each condition. It was not possible to estimate maxima 
for all participants, because some participants missed 2 samples or more at the time points 
at which the maximum melatonin concentration was expected. Therefore for this analysis, 
16 participants have been included in the blue light condition and 17 in the amber light 
condition. The average pattern of the melatonin curves for day 14 and day 23 are depicted 
in Figure 3A for the blue condition and in Figure 3B for the amber condition. 
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Figure 3. A: The average melatonin profiles on day 14 (±SEM) and day 23 (±SEM) in the blue condition 
in percentage relative to the fitted maximum of day 14 (see for more details the methods section). 
The area under the curve was significantly larger on day 23 compared to day 14 *P<0.05. B: The 
average melatonin profiles on day 14 (±SEM) and day 23 (-SD) in the amber condition. No significant 
differences were found. The level at 25% of the maximum melatonin concentration is indicated by the 
horizontal black lines.
The average area under the curve of the melatonin pattern at night in the blue light condition 
was significantly higher; on average +15% (± 5%), after light therapy compared to the area 
under the curve during the baseline night: (t15 = -2.24, P<0.05, Figure 3A). This was not the 
case for the amber light condition. There was even a trend for a decrease in the area under 
the curve after amber light therapy; on average -6% (± 8%) lower compared to baseline (t16 
= 1.70, P=0.10, Figure 3B). The change in the area under the curve between day 14 and day 
23 was significantly different between both conditions (t31 = 2.74, P<0.05). 7 days after 
treatment (on day 30) the areas under the curve were no longer significantly different from 
day 14, neither for the amber condition; on average +4% (± 8%)   (t16 = -0.19, P=0.85), nor 
for the blue condition; on average +8 (± 11%)  (t15 = -0.60, P=0.56) (data not shown). There 
was also no significant difference between conditions for the area under the curve on day 
30 (t31 = 0.43, P=0.67).
Effects on sleep timing 
Estimates of sleep timing and quality (as measured with actigraphy, analyzed with Respironics 
Actiware 5) were calculated as the average over the first 14 days in the baseline period, 
over the 9 days of the treatment period and over the 7 days post treatment period. The 
differences between the treatment period and baseline period as well as the differences 
between the post treatment period and baseline period were tested between the two 
conditions (Table 2).
 
During the treatment period, sleep onset time and wake up time in both the blue light 
condition and the amber light condition significantly advanced compared to the baseline 
work-days period, see Table 2.  During treatment no significant differences between 
conditions in sleep time advances were found although there was a trend for a slightly earlier 
sleep offset in the blue light condition (sleep onset F1,35 = 0.09, P=0.76, sleep offset F1,35 
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= 3.47, P=0.07). No differences between conditions were expected during the treatment 
period as the effects were mainly due to the instructions of the sleep phase advancing 
protocol and the instructions on the timing of light exposure. In contrast, during the post-
treatment period (wherein the participants could freely choose their sleep timing) wake-up 
time was significantly different between both conditions (sleep offset F1,35 = 9.20, P<0.01). 
The average wake up time slightly delayed in the amber light group and was still significantly 
advanced in the blue light group compared to baseline (see Table 2).
Effects on Sleep quality
Objective estimates of sleep quantity and sleep quality (as measured with actigraphy, 
analyzed with Respironics Actiware 5) were defined by the following parameters: ‘Sleep 
onset latency’ (SOL), sleep duration, ‘minutes awake after sleep onset’ (WASO), number of 
sleep bouts (as a measure for sleep consolidation) and sleep efficiency (defined as (sleep 
time – SOL- WASO)/sleep time*100%).
 
The effects on these estimates of sleep are shown in Table 2. Sleep duration was longer 
for participants in the amber group during both the treatment and post-treatment period 
compared to the baseline period, whereas it was shorter during treatment and not different 
during post-treatment compared to baseline for participants in the blue group. During 
treatment also WASO was significantly increased compared to baseline and sleep efficiency 
was significantly lower for participants in the amber group. This was not the case in the 
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blue light group. The number of sleep bouts was significantly higher during sleep in the 
treatment period for the participants in the amber light group compared to the number of 
sleep bouts during sleep in the blue light participants (F1,32 = 4.40, P<0.05). These results 
may indicate that participants in the amber group had less consolidated sleep during the 
treatment period compared to subjects in the blue light group. 
Sleepiness Scores 
Sleepiness scores as measured with the Karolinska Sleepiness Scale, were measured every 
day of the protocol, 5 min. after waking up and 30 min. after waking up. Compared to the 
first 14 baseline days, the sleepiness scores (Table 3) were not different between conditions 
during treatment as well as during post-treatment; neither at 5 minutes after waking up 
(treatment F1,36=0.06, P=0.80, post-treatment F1,36=0.06, P=0.81), nor at 30 minutes after 
waking up (treatment F1,36=1.46, P=0.24, post-treatment F1,36=0.88, P=0.57). During post-
treatment, participants felt significantly less sleepy 5 minutes as well as 30 minutes  after 
waking up in both groups compared to the same timepoints in the baseline period (Table 3, 
blue 5 min. F1,17=7.93 P<0.05, blue 30 min. F1,17=8.24, P<0.05, amber 5 min. F1,17=5.19, 
P<0.05, amber 30 min. F1,17=4.16, P<0.05), though it should be noted that the time points 
at which KSS was measured during the post-treatment period was later in the amber group 
than in the blue group, because participants in the amber group woke up later in this period 
(see ‘effects on sleep timing’).  
The decline of the sleepiness score in the morning, which is related to the phenomenon 
of sleep inertia, was measured as the difference between the KSS score 30 minutes after 
waking up and the KSS score 5 minutes after waking up (Table 3). Compared to baseline, 
participants in the blue group had a significantly larger decline in their KSS score during 
the treatment period (F1,17=7.36, P<0.05), while there was no significant difference with 
baseline for the decline in KSS in the amber group F1,17=1.98, P=0.18). In other words, sleep 
inertia dissipation was larger during blue light treatment than during amber light treatment.
Effects on performance 
Performance was measured by analyzing the average reaction time of a 5 minute psychomotor 
vigilance task (PVT). First the average baseline reaction times of each participant were 
calculated for each of the 4 time points during the day. The reaction times during treatment 
and post-treatment days were expressed as percentage of the baseline reaction time. 
The average percentages of the reaction times for each condition are shown in figures 4A 
(treatment) and 4B (post-treatment). For the statistics the raw reaction times were used. 
In the amber light group, daytime performance was significantly worse during both the 
treatment period (F1,13=10.1, P<0.01, see Figure 4A) and during the post-treatment period 
(F1,13=17.1, P<0.01 see Figure 4B) compared to baseline. During treatment in the blue light 
group, there was a trend that performance was worse in the afternoon (F1,10=4.0, P=0.07, 
see Figure 4A) compared to the afternoon in the baseline period. During the post treatment 
period, performance in the blue group was worse only in the morning (F1,10=9.8, P<0.05, 
see Figure 4B) compared to performance in the morning in the baseline period. 
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Figure 4. A: The relative performance values (reaction time) compared to baseline (baseline was set at 
100%) during light therapy treatment. Performance was significantly worse at all times in the amber 
condition **P<0.01. B: The relative performance values (reaction time) compared to baseline after 
light therapy treatment. Performance was significantly worse at all times in the amber condition 
**P<0.01. Performance was significantly worse during the morning in the blue condition *P<0.05.
Discussion
The focus of this study was to examine the (post-) treatment effects of additional blue light 
(relative to amber light) therapy on top of a sleep phase advancing protocol on both the 
phase of the melatonin rhythm and on sleep and daytime performance. Recent studies have 
found that optimally timed short pulses (30 minutes) of blue light during the morning are 
effective in phase advancing the phase of melatonin (Geerdink et al. 2012, Crowley and 
Eastman 2014). The present study examined whether such 30 minutes light pulses are also 
effective in shifting sleep with preservation of sleep quality and performance in a home-
setting light therapy study. 
Phase advances of dim light melatonin onset 
After both the blue and the amber light therapy protocols, a significant phase advance of dim 
light melatonin onset (DLMO) was observed. The observed phase advances in both groups 
were not unexpected. It has been found that sleep schedules alone can phase advance the 
melatonin rhythm (Gordijn et al. 1999, Danilenko et al. 2003, Sharkey et al. 2011). In a home-
setting, earlier sleep and wake times will also automatically result in an earlier light exposure 
pattern, which in turn will induce a phase advance. Yet, in spite of all the environmental 
influences of a home-setting in the current study, additional blue light on top of the phase 
advancing sleep protocol turned out to be more effective in advancing dim light melatonin 
onset than additional amber light. This can only be explained by the significant difference 
in the amount of short blue wavelengths in the morning in the blue light protocol (2306 
melanopic lux from the device and 1485 ‘blue lux’ measured by the Daysimeter between 
6-12 am) compared to the amber light protocol (70 melanopic lux from the device and 965 
‘blue lux’ measured by the Daysimeter between 6-12am), since exposure to all other white 




Not only the phase advance of the melatonin rhythm was different between the conditions, 
but also the total production of nighttime melatonin was found to be different the first 
night after treatment. In the blue light condition, the total area under the curve of the 
nighttime melatonin pattern was larger after treatment compared to baseline while this 
was not the case in the amber light condition. The possible influence of daytime light on 
nighttime melatonin production has been investigated before. Melatonin concentration has 
been reported to be higher in summer compared to winter (Tarquini et al. 1997). Applying 4 
weeks of bright light for 4 hours a day (10:00-12:00 and 14:00-16:00) to Japanese elderly in 
a nursery home, yielded a larger area under the curve of melatonin concentration compared 
to baseline (Mishima et al. 2001). Three other studies have found a higher amplitude of the 
melatonin rhythm after 3 (Hashimoto et al. 1997, Park & Tokura 1999) or 7 days (Takasu 
et al. 2006) with bright light exposure during the whole day. The present study is the first 
study that shows that even short blue light pulses of 30 minutes (applied for 9 days) in the 
morning can have an effect on melatonin production at night. 
There are several processes that may explain the influence of light during the day on 
melatonin concentration during the night. Light has dual effects on the output of melatonin. 
It regulates the phase of melatonin by resetting the SCN (Khalsa et al. 2003, Rüger et al. 
2006) and light suppresses melatonin concentrations when it is produced (Lewy et al. 1980, 
Zeitzer et al. 2000,), probably via inhibition of the activity of the B-adrenergic receptors 
(Cagnacci et al. 1992). Therefore, the melatonin production could have been increased by 
two processes: either by an increase in the synchronization of single-cell firings in the SCN 
(Meijer et al. 1998, Masubuchi et al. 1999, Harb et al. 2014) and therefore in the amplitude 
of the underlying circadian oscillation, or by an increase in the sensitivity of the pineal gland 
to light signals, which may result in an upregulation of the B-adrenergic receptors.  
 
Sleep timing 
Even though a phase advance of the circadian system is important in a successful phase 
advancing treatment, the primary result of a therapy aiming at advancing sleep should be 
the effect on sleep timing. In this study, during the sleep phase advancing protocol and light 
treatment no significant differences were found in sleep timing between the two groups. 
This was expected as the participants got clear instructions about their sleep timing. It 
also means that differences between groups on other parameters can only be attributed 
to the additional blue light exposure and not to sleep timing differences per se. Despite 
the fact that the DLMO returned to baseline values at the last day of the protocol post-
treatment, participants in the blue light therapy group still woke-up about 30 minutes earlier 
compared to participants in the amber light group during the post-treatment period. It has 
been shown before that voluntary sleep timing can be advanced by morning light therapy 
(Corbett et al. 2012).  However in that study voluntary sleep timing was measured during 
the treatment period only and not after treatment. Another difference between that study 
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and our study was that the treatment period was much longer (3 months). A recent study 
of Saxvig et al. (2014) tested the follow-up effects after three months of continuous use of 
bright light and melatonin capsules, which resulted in earlier voluntary sleep times for the 
group that continued treatment. Still, a follow-up with continuous light therapy is different 
than measuring post-treatment effects directly. To our knowledge this is the first study that 
shows that short blue light pulses in the morning can have a post-treatment effect on sleep 
timing during one week.  
Sleep quality
Low daytime light levels are correlated with poor sleep quality scores (Leger et al. 2011, 
Boubekri et al. 2014), whereas increased light levels during the day are correlated with an 
improvement of sleep quality (Viola et al. 2008, Paul et al. 2015). It should be noted that 
most of these studies included only subjective scores of sleep quality and that studies were 
either only correlational or in case of an experimental setup, light intensity during the day 
was increased without paying attention to its timing. Because of these limitations it is hard 
to say what the mechanisms behind these results were. In the present study, also different 
effects on sleep quantity and quality (measured with actigraphy) between the two light 
therapy groups were found. During treatment, WASO and the number of sleep bouts were 
significantly increased and sleep efficiency was significantly decreased for participants in the 
amber group compared to baseline, while not different in participants of the blue group. At 
the same time sleep duration was increased in the amber group and not in the blue group. 
We speculate that the longer sleep duration in the amber group is a consequence of the 
increased sleep fragmentation, and that the increased sleep fragmentation resulted from 
the induced mismatch between sleep timing and melatonin secretion:  both groups were 
given the instructions to sleep 2 hours earlier by the end of the treatment period, while the 
DLMO of the blue and amber group shifted for 84 and 48 minutes respectively. In a study 
of Lazar and colleagues (2013) it was found that if the phase angle between the dim light 
melatonin onset and habitual sleep onset is shorter, people have a higher insomnia score. 
In the present study higher concentrations of melatonin were reached later in the amber 
group compared to the blue group and the phase angle between dim light melatonin onset 
and sleep was shorter. 
Another explanation, which is more speculative, for more sleep fragmentation in the amber 
group may be found in the effects of the intensity and color of light on sleep homeostasis 
itself through the melanopsin pathway. This effect has not been extensively studied yet, and 
actually only in mice. Nevertheless the results that have been found are clear. If mice are 
lacking the OPN4 gene which is responsible for the expression of melanopsin, the homeostatic 
sleep pressure is much lower and sleep is more fragmented, while the circadian rhythm is 
still present (Altimus et al. 2008, Tsai et al. 2009). Because the melanopsin photopigment 
is responsive to short wavelength light, participants in the amber light group had less and 
participants in the blue group had more melanopsin stimulation, which may have resulted 
in the observed difference in sleep integrity. 
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Sleepiness & Performance
Blue light was more efficient in decreasing sleep inertia after waking up than amber light 
was. It is known that blue enriched light is efficient in keeping humans alert (Hommes & 
Giménez 2015), especially during the night when sleepiness scores are high (Lockley et al. 
2006, Rüger et al. 2006, Phipps-Nelson et al. 2009, Chellappa et al. 2011b, Rahman et al. 
2014). Because the effect is strongest at high sleepiness scores, one would expect that the 
effectiveness of blue light during the day would be highest directly after waking up. The 
results of the present study are indeed in line with this theory. They are also consistent 
with an earlier study of Revell and colleagues (2006), wherein they used light of different 
wavelengths and found that the alerting effect of light with 470 nm (blue light) is strongest 
directly after waking up. 
In contrast, previous studies found no clear effects of blue light during the morning on 
performance tasks. A study of Santhi et al. (2013) found no improvement of reaction times 
with various blue light conditions directly after waking up during the first hours of the light 
pulse. They only found a faster reaction time after 4 hours in the condition that contained 
the highest blue light intensity. Gabel et al. (2013) used 20 minutes of similar blue light in 
the morning, and found no daily improvement of performance at all. It should be noted that 
in these studies the light exposure either started very early (Santhi et al. 2013), or started 
2 hours after wake up and after sleep restriction (Gabel et al. 2013). In the present study, 
we also did not find improved performance in the morning under blue light exposure, even 
though the sleepiness scores were lower. Still, in the blue light group, morning performance 
did also not significantly worsen during treatment, even though the subjects had to wake 
up 2 hours earlier than during the baseline period. In the amber group performance was 
worsened during the whole day in the treatment as well as in the post-treatment period. 
This decrease in performance may be linked to a decrease in sleep quality, as poor sleep 
quality can decrease performance during the day (Bonnet 1989, Miyata et al. 2013). It may 
also be linked to the change in the phase of melatonin in relation to sleep timing (Burgess 
et al. 2013a, Sletten et al. 2015). It was expected that a possible decrease in performance, 
if present, would have been largest during the post-lunch dip (reviewed in Carrier & Monk 
2000). While the amber group had a worsened performance during the whole day, the blue 
group showed only a worsened performance around the afternoon during the treatment 
period. This may be attributed to the post-lunch dip. The post-lunch dip is dependent on an 
interaction between the duration of prior waking and the circadian clock (Bes et al. 2009). In 
this study both of these components are changed. 
Performance was significantly worse in the morning in the post-treatment period, also 
for the blue light group. This may be explained by the changed phase angle between the 
melatonin rhythm and sleep phase after light therapy. The participants in the blue group 
still woke up earlier compared to baseline, while the timing of their melatonin rhythm 
was shifted back to the timing during the baseline period. This especially may have had 
consequences for performance in the morning, as the participants woke up too early in 
relation to their internal clock. 
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Conclusion
The results of this placebo-controlled home- study support the conclusion that blue light 
therapy was able to support a sleep phase advancing protocol by increasing the shift in the 
melatonin rhythm and post treatment sleep phase with (to a large extent) preservation 
of sleep quality and performance. After treatment, the phase advance of the melatonin 
rhythm shifted back to the original values, while sleep timing was still advanced after the 
use of blue light therapy. This confirms that blue light therapy was supportive in shifting the 
sleep phase more than amber light was. Whether the discrepancy between the melatonin 
rhythm and sleep phase after light therapy is desirable is the question, as performance was 
worse during the morning after treatment in the blue light therapy group. To investigate if 
performance can be stabilized and if the effects on sleep are long lasting, more research 
should be done on longer (blue) light therapy protocols with voluntary sleep timing. Also 
the effect of light on sleep homeostasis in humans has to be investigated to acquire more 
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Light has non-image forming effects on alertness and performance in humans. In offices light 
levels might be too low to elicit these effects. Extra artificial light may therefore improve 
alertness and performance of employers in a working environment. In the present study the 
question was whether 3 hours of extra blue light affected alertness and performance, given 
in accordance to the timing of a daily energy dip that subjects reported to experience. The 
study applied a counter-balanced 1-day experimental and 1-day control cross-over design 
in an office environment in 44 participants. On the control day participants were exposed 
to their regular office lighting; on the experimental day, 3 hours of extra blue light were 
added to the regular office light. Blue light was provided by a blue LED-lightstrip (280x25 
mm2; peak transmission 480 nm; prototype Philips, Drachten, The Netherlands) which was 
placed on top of the computer monitor.  In individuals suffering from an afternoon dip, 
extra blue light prevented the usual decrease in cognitive performance, seen in fewer errors 
(F1,12=5.7, P<0.05). Furthermore, it was found that early types performed different from 
late types under light exposure at different times of the day. This study demonstrates that 
in an office environment relatively low intensity blue light can have effects on cognitive 
performance and that the timing of light exposure (when given during the individual’s usual 
energy dip period) can influence these effects. Knowledge about the use of individualized 





Humans are a diurnal species, spending most of their waking time in the light phase of the 
day. Many aspects of our behaviour also depend on light in our environment. The fact that 
light is necessary for vision is evident; however there are also several non-image forming (NIF) 
effects of light. Examples of NIF effects include circadian entrainment, hormone regulation 
(reviewed in Shanahan & Czeisler 2000), pupillary constriction, body temperature and heart 
rate (Scheer et al. 2004, Cajochen et al. 2005) and maybe even modulation of sleep intensity 
(Hubbard et al. 2013, Wams et al. submitted, Geerdink et al. submitted). Light has also 
been found to modulate alertness and cognitive performance (reviewed in Cajochen 2007; 
Chellappa et al. 2011). Despite of all these known NIF effects of light, there are no studies 
that compare the effects of light on alertness and performance during different moments of 
a working day in a field study. This will be examined in the present study.
Earlier studies found that NIF effects are mediated by a third type of photoreceptor in the 
ganglion cell layer of the retina, known as photosensitive retinal ganglion cells (pRGCs) 
(Berson et al. 2002, Hattar et al. 2002). The functional photopigment of the pRGCs is 
melanopsin, an opsin-like protein with a peak spectral sensitivity around 480 nm, which is 
in the blue part of the spectrum (Thapan et al. 2001, Berson et al. 2002, Panda et al., 2005). 
Besides the direct light input to the pRGCs, the cells receive integrate light information 
collected by rods and cones (review Hatori and Panda, 2010). The pRGC’s project to several 
non-image forming related areas of the brain, including the suprachiasmatic nucleus (SCN) 
of the hypothalamus which is considered the principal circadian pacemaker. Other areas are 
for instance the ventrolateral preoptic nucleus (VLPO), the intergeniculate leaflet (IGL), and 
the olivary pretectal nucleus (OPN), which are involved in regulation of sleep-wake states, 
attention, and arousal (Gooley et al. 2003, Morin and Blanchard 2005, Hattar et al. 2006, 
Szkudlarek et al. 2012).
Most research into the alerting and performance improving effects of light have been 
conducted during the late evening and early morning hours (Lockley et al. 2006, Rüger et 
al. 2006, Cajochen 2007, Phipps-Nelson et al. 2009, Chellappa et al. 2011). During the night, 
the largest effects of light on alertness and performance are expected, because in humans 
there is a large decline in alertness and performance as the night proceeds and therefore at 
this time there is the largest improvement possible (Cajochen et al. 1999). 
While the knowledge obtained by studying the effects of light on performance during the 
night is interesting by itself, extra light may be beneficial for dayworkers as well. The daily 
light intensity in offices is often low and low light levels are related to poor well-being, 
health and sleep problems (reviewed in van Bommel et al. 2006, Harb et al. 2014). The 
Dutch lighting norm (www.nsvv.nl, NEN EN 12464-1:2003) includes no criteria for vertical 
illuminance in the office environment, but requires that the horizontal light intensity for 
writing and reading should be 500 lux on the working plane. The result is that the vertical 
illuminance is often only around 250 lux (reviewed in Górnicka, 2008). It seems unlikely that 
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this amount of light exposure is sufficient to improve performance and alertness during 
daytime, because even during night-time it would elicit only limited to medium effects 
(Cajochen et al. 2000, Hébert et al. 2002, Hommes & Giménez 2015). Extra light in the 
office environment may therefore be a way to enhance alertness, performance and well-
being of office day workers.  A few lab studies conducted during daytime showed that bright 
light is able to improve alertness and performance compared to dim light conditions in a 
controlled environment (Bersani et al. 2008, Phipps-Nelson et al. 2003, Rüger et al. 2006). 
That daytime light is also able to enhance the physiology of performance is supported by 
an fMRI-study of Vandewalle and colleagues (2006). Exposure to 21 minutes of bright light 
(>7000 lux) resulted not only in reduced subjective sleepiness scores, but also in enhanced 
thalamic activity, which indicated that it modulated cortical responses. These brain areas 
have been implicated in attention and alertness regulation, which supports the notion that 
light modulates NIF cognitive processes. 
Thus, in a controlled environment it is demonstrated that also during daytime high light 
intensities are able to reduce sleepiness and improve performance. However, in these 
studies participants were often sleep and/or light deprived prior to measurements (Phipps-
Nelson et al. 2003, Rüger et al. 2006, Vandewalle et al. 2006). This is still quite different from 
a working environment, wherein people are already exposed to a certain amount of office 
light and are often not seriously sleep deprived. 
In the study of Smolders and colleagues (2012) the researchers assessed the light effects 
in a semi-natural office setting. In that study they looked at the vitalizing effects of 200 lux 
versus 1000 lux in the morning or the afternoon on both subjective alertness and cognitive 
performance during the day. The results showed that higher intensity light in the morning as 
well as in the afternoon reduced sleepiness and improved cognitive performance. Moreover, 
the cognitive performance effects were more pronounced in the morning condition and near 
the end of the exposure period. Two other field studies (Mills et al. 2007, Viola et al. 2008) 
assessed the effects of blue-enriched white light (17000K) compared to standard white light 
(2700K and 4000K respectively) during daytime on various parameters in retrospect. Over 
longer periods of time they applied questionnaires that included questions concerning sleep, 
sleepiness and performance. Both studies found that under blue-enriched light exposure, 
participants scored higher on all performance parameters compared to the standard white 
light (4000K) condition. Although these studies suggest alerting and performance enhancing 
properties of extra (blue) light, there is not much known about optimal timing of light in 
relation to NIF effects during daytime. Furthermore, it may well be that the optimal timing 
varies between individuals since there is inter-individual variation in energy patterns over 
the day, which is probably related to individual differences in internal time as reflected in 
‘chronotype’ (Carrier and Monk 2000, Roenneberg et al. 2003). The individual variation in 
performance and sleepiness levels over the day is probably a consequence of the interaction 
of the differences in an individual’s biological clock and differences in build-up of sleep 
pressure (reviewed in Blatter and Cajochen 2007). Up till now there are no light intervention 
studies that have taken this individual variation into account. 
61
In summary, previous studies suggest that extra light during the day is an effective and 
relatively easy way to improve alertness and performance, and thereby improve productivity, 
of office employees. However the individualized optimal timing of extra light during the day 
has to be identified. Many subjects are capable of indicating a time of day in which they are 
likely to suffer from a subjective ‘energy dip’, at which they experience a dip in performance. 
In this study, individuals will be exposed to extra light at the time of their daily energy 
dip. Therefore, the aim of this field study was whether relatively low intensity blue light 
timed around one’s subjective energy dip, either during the morning, noon or afternoon, 
had effects on alertness and performance during the workday. In addition, we examined 
retrospectively the possible interaction with different chronotypes. It was hypothesized 
that in this field study, extra blue light would have acute effects on improving sleepiness 
and cognitive performance. Effects can be expected to be larger during periods of lowest 
energy. As a consequence, late chronotypes would be expected to benefit from morning 
light, whereas early types would be expected to benefit from afternoon light. 
Material and Methods 
Participants
Fourty-four healthy participants (m/f, 19/25) were recruited. Subject characteristics are 
summarized in table 1. Participants had to have computer-work for at least 3 hours a 
day, for at least one day a week and had to be available on the same weekday for two 
weeks. Furthermore, participants had to experience a subjective dip in energy either in the 
morning, around lunch or late afternoon, which was characterized by experiencing lower 
performance and an increase in sleepiness compared to the rest of their working day.  
Potential participants completed a general health questionnaire, the Pittsburgh Sleep Quality 
Index (PSQI) (Buysse et al. 1989), the Beck Depression Inventory (BDI-II) (Arnau et al. 2001), 
and the Munich Chronotype Questionnaire (MCTQ, Roenneberg et al. 2003). The MCTQ was 
used to assess chronotype by calculating mid-sleep time on free days, irrespective whether 
they used an alarm clock or not, corrected for accumulated sleep debt on workdays (MSFsc, 
Roenneberg et al. 2004). The energy dip groups differed from each other with respect to 
chronotype; participants with a morning dip or a noon dip had a significantly later MSFsc, 
compared to participants with an afternoon dip (Morning group: MSFsc= 4.9 ± 1.1, Noon 
group= MSFsc 4.7 ± 1.1, Afternoon group: MSFsc= 3.8 ± 1.1, F2,38= 3.63, P<0.05).  Individuals 
with low sleep quality (PSQI > 10) or with a moderate to severe depression score (BDI-II > 
14) were excluded. All participants confirmed to be free of eye disease or psychiatric illness 
and were not on current sleep or photosensitizing medication. Other exclusion criteria were 
travelling over two or more time zones in one month prior to the experiment and having shift 
work in three months prior to the experiment. All participants proved to have normal colour 
vision (Ishahara test) and reported only moderate caffeine (limit at ≤ 8 cups/day, group 
average 2.9 ± 2.5 cups/day) and alcohol (limit at ≤ 10 units/week, yes or no question) intake. 
Since this study has no medical research questions, nor did it use a medical device, according 
to Dutch law no approval of a Medical Ethics Committee was necessary. The researchers 
62
took care that all data were collected according to the institutional rules and regulations of 
research involving humans and data were stored in agreement with the Dutch Personal Data 
Protection Act (‘Wet bescherming persoonsgegevens’, Wbp; 2000). Participants provided 
written informed consent and were compensated for their participation. 
Blue light intervention 
All participants were tested in 2 conditions; a control condition in which they were exposed 
to their regular office lighting, and a blue light condition in which they were exposed to their 
regular office light and on top of that to three hours of extra blue light timed to coincide 
with their individual energy dip. This extra blue light was provided by a blue LED-lightstrip 
(280x25 mm2; Philips, Drachten, The Netherlands) which was placed on top of the computer 
monitor. The light had an intensity of 45 lux, 500 mlux at the level of the eye at a distance 
of 60 cm and a peak wavelength of 480 nm. At this distance the number of blue photons 
that was received was 7e17 m-2 s 1, which has been found to be effective in improving 
performance in the study of Viola et al. (2008) and decreasing sleepiness according to the 
dose response curve published by Hommes and Giménez (2015). The light emitted by the 
blue-LED lightstrip on top of the computer screen was tested by Philips in 76 individuals 
for usage comfort. No eye complaints were reported. The device was classified as exempt 
from risk according to Photobiological Safety Standard IEC 62471:2006. No eye complaints 
were reported.  The spectral composition at eye level was measured with and without 
the lightstrip on a spectrophotometer (Jeti' specbos 1211UV, Sensor = 90degrees Diffusor, 
spectral sensitivity 1 nm: 380-780). Figure 1 shows the spectral composition of the control 
office light conditions and of the extra blue light conditions.  The experimental condition 
contained a much higher intensity in the blue-light area. Participants received instructions 
regarding the timing of the light. The timing was defined according to the experimental 
protocol (see next paragraph). At the scheduled time, the light was turned on by the 
63
participant, after which it turned off automatically after 3 hours. Participants were asked to 
sit in front of the light as much as possible, however they could leave for short intervals (not 
more than 5 minutes per hour) for instance for a toilet visit. 
Figure 1. A: Photograph of the setup of the study at the office with the blue light strip mounted on 
the laptop monitor B: The light spectra based on the lighting in the offices that were included in the 
present study. To two lines represent the spectrum with the blue lightstrip switched on (grey line) or 
the spectrum with the blue lightstrip switched off (black line).
Experimental Protocol
The study was performed in winter between January and February 2013, in the Groningen 
Area, The Netherlands. A 1-day experimental and 1-day control cross-over design was used, 
in a counterbalanced order. The two days (between Tuesday and Friday) had to be on the 
same day of the week for each subject. Not more than 2 weeks in between the conditions 
was allowed. Before the start of the experiment, participants plotted their general energy 
pattern as a function of the time of their working day. Lowered energy was indicated by a 
lowering of the line in this graph. Based on their point of lowest energy, participants were 
assigned to receive 3 hours extra blue light either in the morning, noon, or afternoon. For 
a schematic overview see figure 2 and see table 1 for the subject characteristics of the 3 
groups.
The blue light exposure was checked for compliance by means of a small light sensor (HOBO, 
Mulder-Hardenberg group, Haarlem, The Netherlands) worn as a necklace from waking up 
until going to bed on the testing days.  
Both testing days were identical with regard to the timing and type of measurements. 
Measurements consisted of the Karolinska Sleepiness scale (KSS) (Akerstedt and Gillberg, 
1990) and of cognitive performance tests (see next paragraph), all performed on a Personal 
Digital Assistant (PDA) device. Timing of the measurements was adapted individually to 
timing of the light, see figure 2. In addition, after waking up on the measurement days 
and on the mornings after the measurement days, participants completed a diary which 
64
included questions about their sleep, caffeine consumption and their energy profile of the 
previous day. Caffeine consumption was a question in the diary, because caffeine has an 
effect on alertness and performance (Barry et al. 2005), especially in combination with extra 
light exposure (Wright et al. 1997). 
Figure 2. The average protocol time scheme for the three different groups. The timing of blue light 
exposure was individually adapted to energy dip and to working hours, and therefore different 
between individuals. The timing of the performance tasks was based on the individual timing of 
light and therefore also different between individuals. Each individual within a group completed 
the experimental day as well as the control day. The planning of tasks was the same on both the 
experimental day and the control day. The only difference between the two days was the blue light 
exposure period, indicated by the bars with ‘L’, on the experimental day.
Cognitive performance tasks
At 2 (morning light group) or 3 (noon and afternoon light group) specific times during 
the day (figure 2) participants completed a test block on a handheld minicomputer (PDA, 
HP Ipaq114) that consisted of four cognitive performance tasks in combination with the 
KSS sleepiness questionnaire. The test blocks were scheduled either during and after 
light exposure (morning light group) or before, during and after light exposure (noon and 
afternoon group light group). The timing of the test blocks with respect to light exposure 
were the same in every condition, see figure 2. This means that the ‘before’ test block was 
1 hour before the start of the light, the ‘during’ test block was after 1 hour of turning on 
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the light, and the ‘after’ test block was after 1 hour of turning off the light, except for the 
afternoon group (the last test block was performed after diner at home).
The performance tasks included a Psychomotor Vigilance Task (PVT), a counting Stroop task, 
a Sustained Attention to Response Task (SART) and a 2-back test. Reaction time and number 
of errors were output variables in all tests. 
The PVT is a sustained attention test (Lamond et al. 2008). In each trial, participants were 
presented a 0 on the screen. As soon as the numbers started to increase, a button had to 
be pressed as quickly as possible. The interval between trials varied between 500 and 9000 
ms in order to minimize anticipatory behaviour. The number of trials per test block was 
variable, with a mean of 35.4 trials (sd 3.00). The task lasted 3 minutes (Loh et al. 2004). 
The colour Stroop test is often used to measure selective attention and interference 
sensitivity (MacLeod, 1991). In this counting Stroop, participants were shown sets of 1-4 
identical words and had to select the number of words on the screen, regardless of the 
meaning of the word. This counting Stroop test was chosen, in contrast to a colour Stroop 
test, because environmental light differed in colour between conditions and this might have 
influenced the perception of colour of the words. Stimuli in the counting Stroop test were 
divided into two blocks. The test started with a ‘neutral’ stimuli block, which consisted of 
animal name words. This block was followed by an ‘interference’ block, where number 
words ‘one’ until ‘four’ were written. Upon the presentation of two times the word ‘one’, the 
subject needs to respond with 2, etcetera. The combination of the neutral and interference 
block was repeated 3 times, making for a total of 96 trials. The stimuli were presented for 
1000 ms, with 1000 ms intervals. In total the Stroop lasted for 3 minutes. 
The SART measures response control (Robertson et al. 1997). It is similar to a Go/NoGo 
task, which requires participants to monitor single digits presented rapidly on screen, and 
respond to each one that appears (called a Go target, in the present study to the numbers 
1,2,4,5,6,7,8,9), except for a particular pre-defined digit (called NoGo target, in the present 
study the number 3). Trials were separated by a fixation cross presented for 900 ms, followed 
by the stimulus, which was shown for 250 ms. The SART consisted of 225 trials and lasted for 
approximately 5 minutes.
The 2-back task is used as a measure of working-memory (Owen et al. 2005). It is a task in 
which stimuli (in this case numbers) are presented individually on a computer screen, and 
the participant must indicate if the current stimulus and the nth-stimulus (n=2) prior to 
the present stimulus match. The higher the n, the stronger are the demands of executive 
functioning. The task was comprised of 81 trials, with each stimulus shown for 3000 ms and 
an inter-stimulus interval of 500 ms. The duration of the test was 3 minutes. 
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Data handling
Since participants were in their regular working environment, with their general working 
activities, some tests were not completed at the scheduled times. Participants were 
excluded entirely from a particular analysis if they did not contribute to all test blocks. An 
exception was made for the sleepiness data, in which singular missing values were estimated 
by averaging the values before and after the missing value. We applied this 6 times in 6 
different individuals. For each of the parameters the maximum number of participants was 
used for analyses. Commission and omission errors were removed from the list of reaction 
time values. Errors of commission arise when participants respond before the stimulus is 
given. Errors of omission are those wherein the participants fails to respond to a stimulus or 
respond with an unusually long reaction time which falls outside the normal distribution of 
reaction times for the study population. To check for unusually long or short reaction times 
the distribution of the raw data was plotted, after which outliers could be observed and 
thresholds were set to a maximum of 5% of the data points. Depending on the distribution 
of values, these cut-off criteria could be less than 5%. This resulted in the removal of 0.15 % 
and 5.0% outliers on each side of the N-back distribution; 0.5% and 4.0% outliers on each 
side of the PVT distribution; 5.0% outliers on each side of the SART distribution and 0.1% and 
0.5% outliers on each side of the STROOP distribution. Resulting cut off criteria for reaction 
times per task: PVT <251 ms & >549 ms, STROOP <400 ms & >988 ms, SART <132 ms & >516 
ms, N-back <298 ms & >1381 ms. Additionally, MSFsc scores were plotted as a frequency 
distribution, to see whether the MSFsc scores were normally distributed. Statistical analysis 
showed a normal distribution (P>0.05) on the Shapiro-Wilk test. To obtain an overall picture 
of performance, a composite performance index (CPI) was calculated by combining the data 
of all four performance tests. Both the mean RTs and the percentages of errors of these 
tests were normalized separately for each test by dividing individual values by the average 
value of all subjects, after which the resulting values of all tests were averaged per subject. 
The result was a CPI for mean RT, a CPI for percentage of errors and an overall CPI that 
contains data of both the mean RT and the percentage of errors. A higher value means 
worse performance (higher number of errors and longer reaction time). 
Statistics
SPSS was used for all statistics (Version 15.0, SPSS Inc., Chicago, Illinois, USA). The effects 
of extra blue light for 3 hours were tested for subjective sleepiness, caffeine consumption, 
and for composite performance indices of the cognitive performance tasks (CPI RT, CPI 
percentage of errors, and overall CPI). Repeated measures ANOVA tests were used to test 
for the within-participants main effects of light (control vs. extra blue light) and interaction 
effects of light and time (before light, during light, after light) for each energy-dip time group 
(morning group, noon group, afternoon group) for all parameters. In case of a condition X 
time effect, contrasts were used, since it was hypothesized that turning on and off the light 
might have different effects.  
In addition a repeated measures ANOVA was performed on all data during light exposure, 
with energy-dip group and chronotype as between factors and light condition as the within 
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factor to examine if different chronotypes performed differently during different energy dip 
moments under light exposure. To include chronotype as a between factor, participants 
were divided into chronotype categories according to their MSFsc (early N= 16, intermediate 
N= 10, late N= 15). Three participants did not provide us their MCTQ and were classified 
as chronotype ‘unidentified’. The division was based on the Dutch chronotype database 
(n=8074, Gordijn, pers. communication) and was matched for age and gender. Since caffeine 
consumption was found to be significantly different between the control condition and 
the light condition for the noon group (section ‘caffeine consumption’ of the results), and 
caffeine consumption can influence alertness (ref), this variable was included as a covariate 
in each test. 
Results
Caffeine consumption
In the noon group, less caffeine was consumed on the day with extra blue light compared to 
the control day, on average 2.5 (±0.5) and 3.4 (±0.7) cups respectively, F1,13=6.8, p<0.05). 
For the other groups, there were no significant differences found for caffeine intake between 
the control and energy-dip timed light conditions (morning F1,11=0.80, p=0.39, afternoon 
F1,11=0.66, p=0.43). Still, because caffeine intake has an influence on alertness within 
individuals, the difference in caffeine intake between the control and light day was included 
as a covariate in all subsequent analyses. 
Sleepiness scores (KSS) over the day
The time course of subjective sleepiness, measured with the Karolinska Sleepiness Scale 
(KSS), for the three different groups is depicted in figure 3A. For the morning energy dip 
group it was only possible to evaluate the effect of the blue light on sleepiness during and 
after light exposure since light exposure started immediately after arriving at the office. 
For the noon and afternoon energy dip groups it was also possible to assess the effect of 
turning on the light. To discriminate the acute effects of turning on and off the blue light 
from the effects during the rest of the day, the time points before, during and after light 
exposure were also separately included in the tests. For the morning energy dip group, the 
two time points during light exposure on average at 9:37am (± 32 min.) and at 11:00 am 
(± 62 min.)) and the time point directly after light exposure on average at 12:42 pm (± 40 
min.) were included. For blue light in the morning there was no significant main effect of 
condition for mean reaction time (F1,11=0.01, P=0.95), yet a trend for the interaction effect 
between condition and time (F2,10=4.0, P=0.09) was found. This means that the extra blue 
light tended to induce a larger decline in sleepiness, see Figure 3A left panel.  
For the noon light group sleepiness scores shortly before light exposure on average at 10:54 
am (± 48 min.), during light exposure on average at 12:55 pm (± 41 min.) and at 2:00 pm (± 
45 min) and after light offset on average at 3:45 pm (± 29 min.) showed neither a significant 
main effect for condition (F1,12=2.0, P=0.18), nor interaction effect between condition and 
time (F3,10=0.4, P=0.79), see figure 3A middle panel.
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For the afternoon energy dip group sleepiness scores shortly before light exposure on 
average at 12:54 pm (± 35 min.), during light exposure on average at 2:17 pm (± 42 min.) 
and at 3:59 pm (± 36 min.) and after light offset on average at 5:02 pm (± 38 min.), showed 
a trend for a main effect for condition (F1,14=3.34, P=0.09). Before the light was turned on, 
sleepiness seemed already to be attenuated in the light condition compared to the control 
condition, see Figure 3A.  No interaction effect between condition and time (F3,12=0.6, 
P=0.63) was found, see figure 3A right panel. 
Figure 3. A: The average KSS patterns around light exposure for the group that received either blue 
light exposure in the morning (left, Time X Condition interaction; #P<0.1), blue light exposure around 
noon (middle), or blue light exposure during the afternoon (right, Condition; #P<0.1). The striped grey 
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box represents the average blue light exposure period on the experimental day. Because the timing 
of the blue light (and tasks) was individually adapted to energy dip and working hours, the timing 
of completing the KSS was different between individuals. The vertical error bars represent the S.E. 
of the KSS scores. The horizontal error bars represents the S.E. of the timing of completing the KSS 
scores.  
B: The average composite performance scores (CPI) of reaction time (RT ± S.E.) for the group that 
received either blue light exposure in the morning (left), blue light exposure around noon (middle), or 
blue light exposure during the afternoon (right). For the group that received morning light, there were 
no performance measurements before the light was switched on.  
C: The average composite performance scores (CPI) of number of errors (± S.E.) for the group that 
received either blue light exposure in the morning (left), blue light exposure around noon (middle, 
Time X Condition interaction; *P<0.05), or blue light exposure during the afternoon (right, Condition; 
*P<0.05). For the group that received morning light, there were no performance measurements 
before the light was switched on. 
Performance CPI scores
The composite performance indexes (CPI), composed of the SART, N-back, PVT and STROOP 
tasks of the energy dip groups are depicted in figure 3B and 3C. The CPI of the reaction 
times (RT) shortly before, during and  after blue light exposure are represented in Figure 3B 
and the CPI of the number of errors in Figure 3C. For the morning energy dip group it was 
only possible to evaluate the effect of the blue light on the CPI scores during and after light 
exposure.  With respect to RT no significant effects were found for condition in none of the 
groups (morning: F1,8=0.8, P=0.41, noon: F1,10=0.15, P=0.71, afternoon: F1,12=0.0, P=0.96). 
Also no interaction effect for condition X time with respect to RT were found (morning: 
F1,8=1.3, P=0.29, noon: F2,9=0.7, P=0.52, afternoon: F2,11=0.8, P=0.47). With respect to 
the CPI of the errors in the morning group neither significant differences were found for 
condition (F1,8=0.1, P=0.71) nor significant differences were found for the condition X time 
interaction (F1,8=0.1, P=0.74,). In the noon group no significant difference was found for 
condition (F1.10=0.7, P=0.52), yet a significant difference was found for the condition X time 
interaction (F2,9=6.6, P<0.05), see Figure 3C, middle graph. In the afternoon group there 
was a significant difference for condition (F1,12=5.7, P<0.05), though not for the condition X 
time interaction (F2,11=0.2, P=0.82), meaning that participants in the afternoon energy dip 
group had overall less errors in the blue light condition, even though they already started 
with less errors before the light turned on, see Figure 3C, right graph. 
To test if chronotypes performed differently under blue light exposure in different energy dip 
groups, all the data of the CPI RT and CPI error scores were tested. In this case, energy dip 
group and chronotype were included as between factors and light condition was included 
as a within factor.  For the CPI RT scores no significant differences were found (Condition: 
F1,29=0.0, P=0.95, Condition X Energy dip group X Chronotype: F4,29=0.9, P=0.49). However, 
for the CPI errors a significant difference was found for condition (Condition: F1,29=4.9, 
<0.05) as well as for the interaction effect Condition X Energy dip group X Chronotype 
(Condition X Energy dip group X Chronotype: F4,29=3.0, P<0.05), see also Figure 4. Early 
types performed worse during light in the morning while better during light around noon 
and slightly better in the afternoon. Late types showed no effect of light on performance in 
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the morning and afternoon, but performed better at noon.
Figure 4. The overall composite performance scores (CPI) of the number of errors (± S.E.)  for all 
the energy dip groups (morning, noon, afternoon) deviated for early chronotypes ‘early’ and late 
chronotypes ‘late’ during blue light exposure (Condition; *P<0.05, Condition X Energy dip group X 
Chronotype interaction; *P<0.05). 
Discussion
The present study investigated the acute effects of extra blue light on alertness and 
performance during the working hours especially to overcome an interval with relatively low 
subjective energy. Therefore the extra light was presented during the intervals that subjects 
indicated to experience an energy dip. Furthermore, it was examined whether these effects 
were different for different chronotypes.  
The present data showed that especially people suffering from an afternoon dip seem to 
benefit from extra blue light during this time of the day. In the control condition participants 
performed worse in the sense that they made more errors during the afternoon. In addition 
there was a trend that the increase in sleepiness was attenuated as well. Our observations are 
consistent with the fact that the afternoon is the most common time of increased sleepiness 
in people and at this time sleep latency is at its shortest during daytime (reviewed in Monk, 
2005). Bes et al. (2009) proposed that the afternoon dip is the resultant of a secondary 
increase in need for sleep between the homeostatic build-up of sleep need and a drop in 
the circadian drive for wakefulness. This would suggest that the largest improvement to 
counteract this increased perception of sleep need could be realized during the afternoon, 
and this is consistent with the findings in the present study. 
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For those who received light at noon due to a perceived energy dip at this time, the NIF 
effects were not that clear. Performance, indicated by the number of errors, relatively 
improved in the control condition at the time when light was switched off in the light 
condition. No other effects of light on performance at this time of day were found. Also no 
effect of blue light on subjective sleepiness was found. However, the noon energy dip group 
was the only group in which there was a significant decrease in caffeine consumption during 
the day of the light condition. Similar to light, caffeine has been shown to be effective in 
enhancing alertness and cognitive performance (reviewed in Glade, 2010) and the effects 
are even similar in the brain (Barry et al 2005). It is only possible to speculate about the 
cause of the reduction in caffeine consumption in this group. It would be interesting if this 
decrease is a result of subjects feeling they do not need the caffeine since they experience 
the alerting effects of the light. However, one of the other causes may be that these subjects 
normally consumed the most caffeinated drinks during lunchtime and that they skip these 
during the light condition, as they were asked to remain at their desk as much as possible 
during the period of light exposure. Still, in the blue light condition the participants did not 
show an increase in their sleepiness scores, despite less caffeine intake.  A prospective study 
is needed to test whether the use of extra light during working hours changes the amount 
of caffeine consumption. 
The participants that experienced reduced energy in the morning and were exposed to extra 
light at that time of day did not seem to benefit objectively from the light in the morning, 
even though they felt less sleepy after use of the blue light.  This finding was in contrast to 
expectations, as it was expected that especially late types in the morning energy dip group 
would experience beneficial effects of the light. Especially late types may have suffered from 
so called ‘social jetlag’ and may have accumulated sleep debt during previous working days 
(Wittman et al. 2006). Late types have also a higher chance to receive blue morning light on 
a sensitive part of their clock phase (Rüger et al. 2013). Therefore they had a higher chance 
to experience beneficial effects of light in the morning. In contrast to the present study, 
some studies indeed found positive effects of morning light on alertness and performance 
(Górnicka, 2008; Geerdink et al. 2012, Smolders et al. 2012, Geerdink et al. 2016). Besides 
the fact that these studies used other light sources and durations, an important difference 
with the present study is that in the present study alertness and performance were assessed 
relatively late in the day (after travelling to work) in the working environment of individual 
participants with normal working demands. In one of our previous studies (Geerdink et al. 
2012, Geerdink et al. 2016) we examined the decline in sleepiness at home directly after 
awakening, in late types only, which means that participants had a higher chance for sleep 
inertia (a state of lowered arousal after awakening, Tassi & Muzet 2000). Light is a factor 
that can reduce and/or shorten sleep inertia effects (Tassi & Muzet 2000). Other differences 
between the previous studies and the present study are that in the previous studies 
sleepiness was assessed directly after 30 or 60 minutes of blue light exposure, that a higher 
intensity of light was used, and that the studies were conducted in the home environment 
of the participants (Geerdink et al. 2012, Geerdink et al. 2016). Another study that also 
examined the effects of blue light later in the morning, i.e. two hours after wakening (Gabel 
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et al. 2013), found also no effects of the blue light. It may be that blue light in the morning 
is only effective when it hits the right phase of the clock, and/or when sleep inertia is still 
present. Following up on this reasoning, with morning light exposure less improvement in 
performance would be expected in early types, compared to intermediate and late types, as 
they have an earlier diurnal peak of alertness and performance (Kerkhof et al., 1980; Monk 
et al. 1989).  The relatively late exposure to blue light in the present study for early types, 
may explain why the morning energy dip group did not improve, but not why there is a trend 
for deterioration in performance in this group. Although speculative, a possible explanation 
is overstimulation of brain areas involved in alertness regulation, as these areas are already 
active and may get too much input via the extra blue light in these early types. This is an 
interesting further study perspective by itself.  
Extra blue light appears to have different effects at different times of the working day and the 
effects appear to be different for different chronotypes. This indicates that the mechanisms 
and regulation of alertness and cognitive performance is complex. Future research should 
also examine the effects of extra blue light during periods of low energy during the day 
over more days or for longer periods during one day. It would be interesting to explore if 
this could have more and/or different effects than one day of 3 hours of light exposure. In 
addition, there are indications that extra light during the day may even improve sleep quality 
at night (Aries 2005, Viola et al. 2008, Leger et al. 2011, Geerdink et al. 2016, Geerdink et 
al. submitted), which in turn may result in better performance and alertness during work.
Conclusion
Extra blue light in the work environment seems particularly beneficial for people that 
experience an energy dip in the afternoon, as light during this time stabilized cognitive 
performance. At noon the blue light is effective in improving performance for those 
people that suffer from a dip at this time, but after turning off the light a deterioration in 
performance can be seen, while there appears to be no effect on sleepiness. For those that 
suffer from reduced energy during the first morning hours at work or during noon, the extra 
light does not seem to be helpful and may even have a deteriorating effect, especially on the 
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Light is not only crucial for vision but also influences other aspects of physiology and 
behavior. One well studied aspect of light is its effect on our biological clock which is also 
linked to sleep timing. Yet, the effect of daytime light on nighttime sleep itself has hardly 
been studied in humans. In this within-subject laboratory study participants with mild sleep 
complaints were exposed to three conditions: Either to one day (9-17h) with moderate 
intensity polychromatic ‘office light’, to one day with high intensity polychromatic light, 
or to one day with extra blue LED light on top of the ‘office light’. The influence of this 
daytime light on the clock was measured via analysis of the melatonin rhythm and on sleep 
quality/homeostasis via sleep-EEG measurements. Multilevel regression analyses was used 
to quantify the effects on the accumulation rate of slow wave activity.
Compared to the melatonin onset in the office light condition, the onset was earlier in the 
bright light condition (0.35h, P<0.05) and there was a trend for an earlier onset in the blue 
light condition (0.30h, P=0.07) compared to the office light condition. Sleep efficiency was 
higher (95.8% vs. 92.1%, P<0.05) and the percentage of REM sleep was larger (23.3% vs. 
19.7%, P<0.05) in the bright light condition compared to the office light condition. The 
accumulation rate of slow wave activity during sleep, a measure of sleep pressure decay, 
was significantly higher in the bright- as well as in the blue light condition compared to the 
office light condition. 
Light intensity during the day affects sleep via an effect on the clock and by influencing sleep 




While light is crucial to vision, it also has major influences on other aspects of physiology 
and behaviour. One is the influence of light on our biological clock in the suprachiasmatic 
nuclei (SCN) located in the hypothalamus. The SCN functions as a time reference for many 
bodily rhythms in conjunction with the observed light/dark pattern (reviewed in Meijer and 
Schwartz 2003 and in Moore 2007). Another influence of light is a more direct effect, such 
as has been shown for alertness and performance. Under higher light intensities, alertness 
and performance are increased, no matter if it is day or night (Phipps Nelson 2003, Rüger et 
al 2006, Viola et al. 2008, Smolders et al 2012). In our society, we often do not see so much 
light during the day, as many jobs are indoors and in offices with relatively low artificial light 
levels. The notion that we need more light during the day than we usually see is widely 
spread (e.g. Van Bommel 2006). Indeed, in addition to the positive direct effects of high 
light levels on alertness and performance, serious complaints have been reported to be 
correlated to low daytime light levels. A well-studied complaint is the decrease in mood 
when natural light levels get lower, while there is an improvement in mood when light levels 
are increased, like with successful light therapy in seasonal affective disorder (SAD, Rosenthal 
et al. 1985, Terman et al. 1989, Meesters et al. 1991, Terman & Terman 2005). Recent 
studies found that short pulses of blue-enriched light and blue LED light therapy with low 
photopic light intensities are as effective as bright light therapy in SAD and sub-syndromal 
SAD patients (Gordijn et al. 2012, Meesters et al 2011, Meesters et al. 2016).  A less studied, 
though important complaint is the decrease in sleep quality and the prevalence of insomnia 
complaints when daytime light levels are low (Leger et al. 2011, Boubekri et al. 2014, Harb 
et al. 2014). Viola and colleagues (2008) experimentally changed light levels during the day 
during working hours and they found an improvement of subjectively reported sleep quality 
with higher blue enriched light levels. Also in pathological situations, such as dementia, 
an improvement of sleep quality measured with actigraphy has been reported with higher 
daytime light levels (Riemersma et al. 2008). Two recent studies found positive effects of 
9-14 days of treatment with extra light during the day on objective sleep quality in healthy 
participants, measured with actigraphy during the night (Paul et al. 2015, Geerdink et al. 
2016). However in these two studies, it was not clear for how many days extra light was 
needed to elicit the effects and which mechanisms were involved. In the current study we 
hypothesize that higher daytime light intensities, most likely via a larger amount of short 
wavelengths of light, will improve sleep consolidation and subjective sleep quality. 
Sleep timing and sleep quality can be modelled by the interaction of two processes: sleep 
need (commonly called process S) as it results from prior sleep and wakefulness, and the 
time of day as it is indicated by the biological clock (also called process C- Borbély 1982; 
Daan et al. 1984). According to this two-process model of sleep regulation, two mechanisms 
can be proposed to explain the impact of light on sleep quality. One is the possible influence 
of light on process S, the other one is the influence of light on process C. The biological clock 
(the SCN) is the origin of process C. Extra stimulation of the SCN by light during the day 
may lead to a more robust oscillation. This extra stimulation of the SCN during the day may 
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lead to a more pronounced day-night signal which may in turn lead to a more robust sleep-
wake rhythm with consolidated sleep. With increased amplitude of the electrical discharge 
rhythm of the SCN, the impact of the SCN on melatonin production in the pineal gland is 
also expected to change. A larger amplitude of the signal of the SCN likely leads to a larger 
amplitude of the melatonin rhythm. Data by Park & Tokura 1999, Takasu et al. 2006 and 
Geerdink et al. 2016 are consistent with this prediction. As a consequence of increased 
melatonin amplitude, melatonin concentration will reach the values to trigger downstream 
processes earlier in the night. It has indeed been shown that DLMO is earlier if subjects 
experience more light during the day (Hasimoto et al. 1997). If DLMO starts earlier during 
the night, sleep may start when melatonin levels are already higher.  
The second mechanism is based on the fact that light during the day stimulates areas in the 
brain involved in alertness (with connections to sleep areas, Mistlberger 2005). This may 
possibly result in a higher homeostatic sleep drive (Process S) and consequently deeper, 
more consolidated sleep. One indication for this mechanism is the finding that activation of 
melanopsin, the photopigment that is mainly responsible for the non-image forming effects 
of light (Berson et al. 2002, Hattar et al 2002), has a sleep-modulating function in mice 
(Altimus et al. 2008, Tsai et al. 2009).  This suggests that retinal projections to nonvisual 
brain areas affect not only the circadian timing of sleep, but also the homeostatic regulation 
of sleep, which is a theory that receives increasing support (Hubbard et al. 2013, Legates & 
Hattar 2014). 
Both mechanisms ascertain that with increased light levels during the day, daytime 
performance is better, sleep latency is shorter, sleep is more consolidated and more deep 
sleep is observed in the beginning of the sleep period (because of the increased homeostatic 
sleep pressure accumulated during wakefulness). The current study tested the effects of 
extra light during the day on melatonin production in the evening, objective sleep measures 
during the night and subjective sleepiness the next morning.  
Material and Methods
Subjects
Participants were recruited from the area near to Groningen University, the Netherlands, 
via newspaper advertisements, posters and flyers distributed within the faculties of the 
University of Groningen and internet advertisements. People were only included if they were 
suffering from mild insomnia complaints, such as sleep onset insomnia, wakefulness after 
sleep onset or early awakening. The reason that only people with mild insomnia complaints 
were included was the fact that good sleepers may not show any improvement of their 
sleep in response to daytime light exposure because of a ceiling effect. Simultaneously, 
people with mild insomnia complaints suffer from sleepiness and are likely to demonstrate 
lower performance ratings during the day (Altena et al 2008), again allowing for increased 
performance in response to light.  The selection criterion for mild insomnia was a score 
between 6-12 on the Pittsburg Sleep Quality index (PSQI, Buysse et al. 1989). Participants 
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had to be between 22-55 years old to exclude adolescents with aberrant sleep habits and to 
exclude aged people with reduced deep sleep (Dijk et al. 1989). 
Other selection criteria were: being healthy (checked with a health questionnaire), not using 
medication (also no sleeping aids), non-smoking, average ‘chronotypes’ determined by the 
mid-sleep on free days corrected for sleep debt (MSFsc; between 03:00-05:00, Roenneberg 
et al. 2003), not colorblind or visually impaired, not consuming too many drinks with caffeine 
(no more than 8 cups of 150 ml a day) or alcohol (no more than 10 glasses of 250 ml per 
week), not working in night shifts and not having travelled across multiple time zones in the 
preceding three months. In addition, participants needed to have enough computer work or 
deskwork to do from 09:00-17:00 on the three experimental days.  
After selection, dim light melatonin onset (DLMO, considered the most reliable phase 
marker of the clock, Lewy et al. 1989/1999, Burgess & Eastman. 2005, Benloucif et al. 2008) 
was first determined at home to confirm exclusion of early and late chronotypes. To assess 
DLMO, participants were asked to collect saliva samples in dim light at home, starting 6 
hours before sleep onset on a workday. Saliva was collected by chewing on a cotton swab 
(Salivette®, Sarstedt BV, Etten-Leur, NL). At least 1 ml. of saliva per sample was collected 
every hour. The saliva samples were stored in the fridge at the participant’s home until the 
next day and were then collected by the researchers. The samples were brought into the 
lab, centrifuged and frozen at - 80°C until further analysis. Melatonin concentration was 
assessed via radioimmunoassay (RK-DSM; Buhlmann Laboratories, Alere Health, Tilburg, 
The Netherlands). The limit of detection was 0.3 pg/ml Intra-assay variation was 15.9% at 
a low melatonin concentration (mean = 2.0 pg/ml, n = 17) and 13.1% at a high melatonin 
concentration (mean = 24.5 pg/ml, n = 15). Inter-assay variation was 13.1% at low melatonin 
concentration (mean = 2.0 pg/ml, n = 16) and 15.0% at high melatonin concentration (mean 
= 21.4 pg/ml, n = 16).  
 
Dim Light Melatonin Onset (DLMO) was calculated as the moment at which the melatonin 
rhythm crossed the 3 pg/ml concentration by linearly interpolating the raw values around 
the 3pg/ml concentration at the rising part of the curve.  For further participation in the 
experiment, in order to prevent phase-shifting of the circadian system as a consequence 
of the experimental light (09:00-17:00 AM), subjects were required to have their DLMO 
between 20.5h and 22.5h. The choice of this timeframe was based on the knowledge of 
the phase response curve for polychromatic white light as well as for short wavelength light 
(Khalsa et al. 2003, Rüger et al. 2013).
 
All subjects were fluent in Dutch, gave written informed consent, and were compensated 
for their participation. The experimental protocol was approved by the Medical Ethics 
Committee of the University Medical Center Groningen. 16 participants (6 females, 10 
males) were selected for this study with a mean age of 25.7 years (SD +- 4.5) 
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Experimental Design
The study consisted of a within subject design, wherein participants were assigned to 3 
different conditions in a random order. All conditions started with an acclimatization 
evening and night, followed by the experimental day and night (see figure 1). Participants 
spent the acclimatization night as well as the experimental day and night in our human time 
isolation facility (TIF). They started at the same day of the week in every condition. One day 
prior to entering the TIF, actigraphy was monitored at home (AW-spectrum, Respironics, 
Inc, Murrysville, USA) to check whether participants adhered to their habitual sleep-wake 
pattern, as was instructed.  If sleep onset or sleep offset would deviate more than 0.5 hours 
from their habitual sleep-wake pattern, they would have been excluded from participation. 
All participants adhered to this requirement and no participants were excluded.
Figure 1. Scheme of the experimental protocol. Each subject participated in all three conditions, in 
random order. 
Subjects arrived at the TIF just before 17:00. After dinner (17:30), 14 gold EEG electrodes 
were attached to the skin. Two reference electrodes were placed on the mastoids, a ground 
electrode on the forehead, 7 EEG electrodes on the derivations F3, F4, Cz, C3, C4, O1 and O2 
according to the 10-20 electrode system, and two EOG electrodes were placed on the cheek 
next to the left eye and below the right eye to register eye-movements and to control for 
eye-movement related artefacts. Two EMG electrodes were placed under the chin to record 
muscle tone.  All signals were sampled at 256Hz with a resolution of 16 bits. 
Saliva collection for melatonin analysis started at 18:30 and samples were collected every 
hour until 23:30, which resulted in 6 samples. Light levels were kept at a maximum of 40 lux 
from 17:00-23:30 at eye level to measure DLMO (see lighting conditions section).  Subjects 
were then allowed to sleep in the dark from 23:30 -07:30 and sleep EEG recordings were 
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made. At 7:30, lights were turned on at an intensity of 40 lux. After breakfast and showering, 
the subjects were asked to start their ‘working day’ at the desk at 09:00. From 09:00-17:00 
one of the three lighting condition were offered in the room (see below). Subjects were 
allowed to shortly leave their desk for a toilet visit, or to stretch their legs, but not longer 
than 5 minutes and not more than once every hour. Lunch was served at the desk at 12:30. 
At specific times during the experimental day: At 08:00, 10:00, 12:00, 14:00, 16:00 and at 
19:00, performance and sleepiness data were collected: 5 min after waking up sleepiness 
scoring started with the Karolinska Sleepiness Scale (KSS) (Akerstedt and Gillberg, 1990). The 
performance tasks were performed on the desk computer and consisted of a Psychomotor 
Vigilance Task (PVT), a number Stroop task, a Sustained Attention to Response Task (SART) 
and a 2-back memory task (data not shown in this paper). The simulated working day 
ended at 17:00 and light levels were then turned down to 40 lux until 23:30. From 17:00-
23:30, subjects were free to spend their ‘free time’ during these evenings, however they 
were not allowed to be physically active nor to leave their room. Saliva samples were to be 
taken every hour from 18:30-23:30, which resulted in 6 samples, also on the evening of the 
experimental day. Subjects were then again allowed to sleep, starting at 23:30 until 07:30 
and sleep EEG recordings were made. At 5 minutes after waking up, sleepiness was scored 
(KSS), electrodes were removed, subjects had breakfast and a shower and went home. 
There was at least one week and not more than two weeks in between sessions.
Lighting conditions 
The lighting conditions (see Table 1, melanopic lux calculations were based on a supplemental 
Excel sheet from Lucas et al. 2014) were applied by use of Philips TL tubes with different 
colour temperatures that were located in the ceiling of the experimental rooms. Light levels 
were kept low, at 40 lux, from 07:30 – 09:00 and 17:00- 23:30. The intensity of 40 lux (20 
melanopic lux) during the evening was chosen as it is low enough to  prevent an effect 
on sleepiness (Hommes & Giménez 2015), has minimal effects on melatonin suppression 
(Brainard et al. 2001, 2015) and is high enough to be  realistic compared to a real-life 
situation.
  
For the bright light situation, blue-enriched white-fluorescent tubes (Master TL-D® 18W/ 
452 ActiViva®, 17000K; Philips Lighting B.V., Eindhoven, NL) were used. In the ‘low office 
light’ situation, warmer light of 2700K (Master TL-D® 18W/827 Warm Wit®, 2700K; Philips 
Lighting B.V., Eindhoven, NL) was used, to mimic a common low-light office situation (130 lux 
at eyelevel) while keeping melanopic irradiance (60 mlux, Lucas et al. 2014) to a minimum. 
The bright light condition had an intensity of 1900 lux/ 1700 mlux (table 1) at eyelevel in the 
direction of gaze, which is similar to a cloudy day outside. 
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In the ‘low office light + blue light condition’ the low office light situation was combined with 
an extra blue LED - light strip (280x25 mm2; transmission 450-490nm; prototype developed 
by Philips, Drachten, NL), mounted on top of the PC/laptop monitor. The intensity at the 
cornea with ‘low office light’ was only 60mlux whereas it was 500mlux when the extra blue 
light from the blue light strip was included, with a peak wavelength of 480 nm, see also 
table 1. According to the responses of the Karolinska Sleepiness Scale to melanopic light 
intensities during the day, both 1700mlux and 500mlux fell in the saturation range (Hommes 
and Giménez 2015). 
Sleep analysis
All Polysomnography (PSG) signals were converted to European Data Format (EDF) and 
imported into Vitascore™ (version 1.60, TEMEC instruments BV™, Kerkrade, the Netherlands) 
together with the corresponding and synchronized time series of sleep stages.  All EEG, EMG 
and EOG signals were referenced to the contralateral mastoid reference signals as well as the 
Cz signal. All sleep recordings were manually scored according to the criteria of Rechtschaffen 
and Kales (1968) with a 50Hz notch filter, 0.3Hz high-pass filter and a 32Hz low-pass filter. 
Due to technical failures (no EEG night recording in one or more experimental nights) 13 
participants in the office- and office + blue group and 12 participants in the office- and bright 
light group have been analysed for sleep stage scoring. Segments in which artefacts could 
mask the sleep EEG power spectrum were manually annotated as artefacts and removed. 
Power spectra were computed per 4s epoch by applying a Fast Fourier Transform routine 
implemented in VitaScore (tapered, 20 second reporting epoch) and then power density 
was calculated per epoch in the delta band (slow wave activity, SWA, 1-4 Hz). Power values 
for the removed epochs that contained artefacts were replaced by the interpolated value of 
the previous and following epoch. 
The accumulation of delta power over time per individual per condition was then calculated 
for the whole sleep episode. The maximum accumulation of SWA in the ‘low office light’ 
condition was set as a reference from which percentage differences within individuals were 
calculated. To be able to compare the accumulation of SWA during non-REM sleep within 
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and between individuals the accumulation should be based on the same time in non-REM 
sleep for all individuals and conditions. Therefore the duration of the shortest amount of 
accumulated non-REM time was used as the duration for analysis. The shortest duration of 
non-REM sleep in one of the individuals was 313 minutes. This means that for each individual 
the accumulated amount of SWA after 313 minutes of non-REM sleep in the ‘low office light’ 
was set at 100%. On average 32 min. (± 6) in the office light condition, 31 min. (± 4) in the 
blue light condition and 45 min. (± 10) of non-REM sleep was not taken into account when 
sleep was cut-off at 313 minutes.  From this value all the percentages of the accumulation 
of SWA were calculated over time per individual for each condition. Due to technical failures 
(incomplete EEG recording in one of the 3 conditions), 10 participants have been analysed 
for the power accumulations. 
Statistical analysis
We hypothesized that the effects of the bright light condition and the condition with extra 
blue light were significantly different from the ‘low office light’ condition. Therefore we used 
either Repeated Measures ANOVA tests with simple contrasts (‘low office light’ as reference 
condition) or paired sample t-tests to test the differences between conditions regarding 
sleepiness scores, sleep parameters and differences in DLMO. 
To test differences in the accumulation of SWA over the total Non-REM duration between 
conditions, we used mixed-effect regression analysis using MLwiN software (Centre for 
Multilevel Modelling, Institute of Education, London, UK). The analysis takes the hierarchical 
structure of the design into account. In our case the SWA was nested within time i, once 
more nested within participants j (Twisk 2003). The following model equation was used to 
fit the data:  
SWAij = β0ij + β1Timeij + β2Timeij2 + β3Condition_2ij + β4Condition_3ij + β5TimeXCondition_2ij 
+ β6TimeXCondition_3ij + β7Time2XCondition_2ij + β8 Time2XCondition_3 ij. In this model, 
β0  represents the model intercept, ‘Time’ refers to the linear progression of time, the 
other β’s represent the various regression coefficients: ‘Condition 2’ the ‘extra blue light’ 
condition, ‘Condition 3’ the bright light condition; the ‘low office light’ condition was used 
as the reference condition. The ‘TimeXCondition’ terms represent the interaction effects 
of the time course of accumulated SWA per condition. In other words, the slope of the 
accumulation of SWA in the bright light and extra blue light condition, was tested against 
the slope of the accumulation of SWA in the ‘low office light’ condition.  The ‘Time’ and 
‘TimeXCondtion’ terms were also tested for quadratic slopes. Maximum likelihood was used 
to estimate the regression coefficients of which the statistical significance was evaluated 




Sleepiness (KSS) scores  
Sleepiness scores measured 5 min after waking up from the acclimatization night and the 
night after the experimental day, are depicted in figure 2. Overall, there were significant day 
X condition interactions for the blue condition compared to the office light condition (F1,15= 
5.28, P<0.05) as well as for  the bright condition compared to the office light condition 
(F1,15= 5.06, P<0.05). We next tested simple main effects to elucidate the nature of this 
interaction. The sleepiness scores in the blue condition and in the bright condition were 
significantly lower after waking up following the experimental days compared to after 
waking up from the adaptation nights (blue t16= 3.75, P<0.01, bright t16= 4.60, P<0.001) 
while this was not the case for the KSS scores directly after waking up following the office 
light condition compared to the baseline day (t16=1.64, P=0.12).
Figure 2. The average Karolinska sleepiness scores (KSS) 5 minutes after waking up (mean ± SEM). Left: 
After the adaptation night. Right: After the experimental night. Compared to the adaptation night, the 
KSS scores after the experimental night were significantly lower for the blue *P<0.05 and bright light 
condition *P<0.05 compared to the office light condition.
Sleep analyses: Polysomnography parameters 
Sleep parameters measured with EEG are shown in table 2. The office light condition was 
compared to the blue light condition as well as to the bright light condition with paired-
sample t-tests. Since some participants missed either a night in the blue light condition 
or in the bright light condition, the groups are slightly different in size. The difference in 
the subsets of subjects leads to slightly different average values for the two sets of the 
office light condition used for the comparison with the blue light condition or to the bright 
light condition (see table 2). None of the sleep parameters in the blue light condition 
differed significantly from the sleep parameters in the office light condition, while there 
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were significant differences when the sleep parameters in the bright light condition were 
compared to the sleep parameters in the office light condition. The percentage of time in 
which the participants were awake (%awake) was 3.3% lower and sleep efficiency (time 
asleep/total time allowed to sleep) was 3.7% higher during sleep in the bright light condition 
compared to sleep in the office light condition (table 2). The amount of REM sleep was also 
significantly higher (3.6%) during sleep in the bright light condition compared to sleep in the 
office light condition (table 2). 
Sleep analyses: Slow wave activity analysis 
Average slow-wave activity accumulations over minutes of non-REM sleep in the nights of the 
3 conditions are shown in figure 3A. The rise of SWA accumulation in the nights of the blue 
light condition and the bright light condition were significantly different (higher) compared 
to the rise of SWA accumulation in the night of the office light condition: Condition_2 X Linear 
Time = 0.061 (0.001)%  per 0.5 min, P<0.001 and Condition_2 X Quadratic Time= -0.00003 
(0.00001)% per 0.5 min.2 P<0.001; Condition_3 X Linear Time= 0.050 (0.001)% per 0.5 min, 
P<0.001 and Condition 3 X Quadratic Time= -0.00004 (0.00001)% per 0.5 min.2 P<0.001. See 
figure 3B for the model fits. In figure 3A it is shown that SWA activity accumulation during 
the beginning of the sleep episode does not differ between conditions. After approximately 
100 minutes of non-REM sleep, SWA accumulation in the blue- and bright light conditions 
seem to increase relative to the office light condition. To test if the slower build-up of SWA 
power accumulation in the office light condition was not a consequence of interrupted 
sleep at the beginning of the sleep episode, the number of epochs scored as ‘awake’ or 
as ‘movement’ in the first 250 minutes of sleep were compared between conditions.  No 
significant differences were found when the blue light condition (9.3 min. (± 3.4)) and office 
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light condition (7.2 min. (± 2.7)) were compared (t8= -1.6, P=0.15), or when the bright light 
condition (4.1 min. (± 1.1)) and office light condition (7.6 (± 2.6)) were compared (t8=1.3, 
P=0.23). The direction of the effect although not significantly different, was even negative, 
e.g. more awakenings in the blue light condition, when the office light condition and the 
blue light condition were compared. At the end of the total non-REM sleep period, the 
total amount of accumulated non-REM sleep power in the bright light condition and blue 
light condition were tested against the total amount of accumulated non-REM sleep power 
in the office condition. In this case there was only a trend for a higher total amount of 
accumulated non-REM sleep power  in the blue condition, which was 21.8% (± 11.6) higher 
compared to the office light condition (t8=1.9, P=0.10). In a similar analysis, there was also 
a trend for the bright light condition, with 12.9% (± 7.4) higher total amount of accumulated 
non-REM power compared to the office light condition (t8=1.8, P=0.12). 
Figure 3A. The relative mean accumulation of slow wave activity (SWA, EEG power density between 
1-4Hz) during the experimental nights. The total accumulation of SWA after 313 min of non-REM sleep 
(the shortest common time interval available) in the office light condition was set as the reference 
(100%). 
Figure 3B. The modelled mean relative accumulation of slow wave activity (SWA, EEG power density 
between 1-4HZ) according to the calculated estimates (see results section ‘sleep analysis: SWA 
analysis’) modelled by ML-wiN (Centre for Multilevel Modelling, Institute of Education, London, UK).
Dim light melatonin onset 
Timing of DLMO during the evenings prior to the adaptation night (office 22:14, blue 22:25, 
bright 22:18) was not significantly different between conditions (bright-office F1,14=0.11, 
P=0.75, blue-office F1,14=1.48, P=0.24). The phase of DLMO in the bright light condition 
after the experimental day compared to the evening prior to the adaptation night (+0.23h ± 
SE) was significantly advanced compared to the phase of DLMO in the office light condition 
(-0.11h ± SE; F1,14=4.77, P<0.05, see figure 4). The phase of DLMO was also advanced in the 
blue light condition (0.19h.) compared to the office light condition, but this difference was 
not significant (F1,14=3.00, P=0.10). Figure 4 shows the shifts in dim light melatonin onset 
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time after the experimental days compared to the days prior to the experimental days.
Figure 4. The shifts in dim light melatonin onset (DLMO) from the evening prior to the experimental 
evening to the experimental evening for the three conditions (mean ± SEM). Compared to the office 
light condition DLMO was significantly more advanced in the bright light condition *P<0.05. that the 
phase advance of DLMO in the blue light condition was not significantly different from the shift in the 
office light condition  P=0.1.
Discussion
This within-subjects-design study focused on the effects of extra light during a working 
day on sleep quality the subsequent night. Sleep after a day with extra light was more 
consolidated compared to sleep after a day with ‘low office light’, seen in being less awake 
and in having a higher sleep efficiency. Also the depth of sleep, calculated by the rise in SWA 
during sleep, was higher during parts of the night after a day with extra light compared to a 
day with ‘low office light’. Furthermore, the self-rated sleepiness in the morning was lower 
after a day with extra light followed by a night of sleep. Sleep could have been influenced 
by both the effect of light on the biological clock (SCN) and by the effect of light on sleep 
homeostasis. This will be discussed below.
Sleep quality in relation to the influence of light on the clock
Compared to the ‘low office light’ condition a significant phase advance of the melatonin 
rhythm was found for participants in the bright light condition and there was also a trend 
for a phase advance of the melatonin rhythm for participants in the blue light condition. 
Despite the fact that the light was timed in a neutral zone for the phase shifting effects of 
light, phase advances with extra light during the day were found.
 
It is known that extra light can increase SCN firing resulting in a more synchronized output 
of the SCN (Meijer et al. 1998, reviewed in Ramkisoensing & Meijer 2015), which can in turn 
result in a higher amplitude of the circadian rhythm. The melatonin rhythm is considered as 
the best output marker of the SCN (Lewy et al. 1999) and more light during the day is indeed 
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related to a higher amplitude of the melatonin rhythm (Park & Tokura 1999, Takasu et al. 
2006 and Geerdink et al. 2016).  
Several studies found a phase advance of the melatonin rhythm as well as an increased 
amplitude or area under the curve with morning light application (Hashimoto et al. 1997, 
Parry et al. 1997, Geerdink et al. 2016). This relationship may be caused by the definition of 
the threshold for the melatonin onset. If this is a fixed value, the steeper increase in melatonin 
production will advance the timing of DLMO by reaching the threshold for the melatonin 
onset criterion earlier. Hence, although we did not measure amplitude of the melatonin 
rhythm, the advanced onset of the melatonin rhythm after the extra light in the present 
study may be caused by a stronger clock signal and thus by a possibly higher amplitude 
of the melatonin rhythm (e.g. a stronger night signal when participants had to sleep). An 
optimal phase relationship between melatonin and sleep positively affects a variety of sleep 
quality parameters (reviewed in Dijk & Cajochen 1997): a shorter sleep onset latency is 
found (Zhdanova & Wurtman 1997, Rajaratnam et al. 2004), sleep is more consolidated with 
less awakenings during the night (Zhdanova & Wurtman 1997) and a higher sleep efficiency 
(Brzezinski et al. 2005). Similarly, though at the other end of the regulatory range, Lazar and 
colleagues (2013) found that if the phase angle between the dim light melatonin onset and 
habitual sleep onset is shorter (resulting in lower melatonin concentration at sleep onset) 
people have a higher insomnia score and longer sleep latency. 
In the present study, the percentage of time being awake during the sleep period is 
significantly lower and sleep efficiency is significantly higher in the bright light condition 
compared to the low office light condition. Also there is a trend towards a shorter sleep 
onset latency and less WASO in the bright light condition compared to the low office light 
condition. As mentioned above, these parameters of sleep consolidation are also improved 
when melatonin levels are higher. Because there is a phase advance of the melatonin onset 
in the present study, higher levels of melatonin are reached earlier and this may result in 
sleep consolidation being improved. 
Another finding that is consistent with the notion of a stronger clock signal in response 
to more light during the day is the effect on REM sleep. The percentage of REM sleep was 
significantly higher and there was a trend for an earlier REM sleep onset in the bright light 
condition compared to the office light condition in the present study. There are strong 
indications that the timing of REM sleep is mainly regulated by the biological clock (Czeisler 
et al. 1980, Endo et al. 1981, Dijk & Czeisler 1995, Dijk et al. 1997, reviewed in Dijk & Cajochen 
1997). In the present study, it is hypothesized that there is a stronger input to the clock after 
more light during the working day. The REM sleep results as well as the sleep consolidation 
results are in line with this hypothesis.  
One Japanese study (Takasu et al. 2006) showed however that higher light intensities during 
7 days did not result in better sleep quality. The largest difference with the present study is 
that the bright light exposure in the Takasu (2006) study lasted for 16 hours each day. Thus, 
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light was still bright during the evening while in the present study it was much lower in the 
evening. It is known that light in the evening can negatively influence sleep onset latency 
(Santhi et al. 2012) and deep sleep (Munch et al. 2006). In the study of Takasu et al. (2006), 
the long duration of light extending into the evening could have cancelled out the possible 
beneficial effect of the extra light during the day. Consistent with our data, Takasu et al. 
(2006) observed earlier melatonin onset times as well as an increase in melatonin amplitude 
after the days with bright light as opposed to dim light. 
 
Sleep quality in relation to the influence of light on homeostatic sleep drive. 
A steeper increase in slow wave activity accumulation was found if more light was received 
during the working day, no matter if the participants were exposed to bright light or 
extra blue light: a steeper increase in accumulation of SWA power in the delta band was 
found for the bright light condition and the extra blue light condition, respectively.  The 
observed increase in SWA accumulation resembles to some extent the increase in SWA as a 
consequence of sleep deprivation. In response to sleep deprivation, the homeostatic sleep 
drive is also higher which results in deeper sleep. This is sometimes, but not always best 
visible in the second/third cycle as is the case in our study (Dijk et al. 1991, Brunner et al 
1993, Dijk et al. 1993, Dijk & Czeisler 1995). Although the total amount of accumulated 
SWA was not different at the end of the common non-REM sleep duration, the results 
indicate that extra light during the day affects the pattern of the homeostatic sleep drive 
accumulation.  While these results are in line with previous mouse studies (Altimus 2008, 
Tsai 2009) and theories based on findings in mice (Hubbard et al. 2013, Legates & Hattar 
2014), this is to our knowledge the first study showing that light can affect the homeostatic 
sleep drive in humans. 
Differences between the effects of bright light and of extra blue light 
The effects of the bright light condition and the extra blue light condition on sleepiness, 
sleep and the melatonin pattern were always in the same direction and in some cases, 
like the accumulation of SWA, even quite similar. Yet, the effects of the extra blue light on 
melatonin onset and on other sleep (consolidation) parameters were not significant while 
they were for the bright light condition. There were several differences between the bright 
light and the extra blue light that might explain the observed differences in the effects. One 
possible explanation is that the melanopic irradiance is three times lower in the extra blue 
light condition as compared to the bright light condition. Although this difference would 
yield similar effects on alertness (Hommes and Giménez 2015), such difference might still 
have consequences for the strength of the signal to the clock in relation to sleep. Besides, 
the extra bright light condition caused also more (rod/cone) photoreceptor stimulation as 
its power spectrum spanned a broader range of wavelengths. It has recently been shown 
that the melanopsin receptor is not solely responsible for the signal to the clock but rod/
cone photoreceptors do also contribute to this signal (Enezi et al. 2011, Altimus et al. 2010, 
Gooley et al. 2012, Lucas et al 2014.). It has even been shown that colour transitions (from 
blue-yellow and yellow-blue) of light over the day, which will naturally happen during dawn 
and dusk, will strengthen the accurateness of the clock (Walmsley et al. 2015). Thus, it may 
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be that in this experimental protocol, the stimulation with only extra blue light for one 
working day was not effective enough in stimulating sleep consolidation via the clock, yet 
effective enough to cause an increase in homeostatic sleep pressure. 
Relationship between sleepiness in the morning and sleep quality 
Participants felt less sleepy after the night following the experimental ‘working’ days with 
either extra blue light or bright light compared to the day with low office light after waking 
up. Lower sleepiness scores are often correlated to better nights of sleep (Pilcher et al 1997, 
Viola et al. 2008). Furthermore, sleep continuity seems to be of high importance to feel 
alert during the day, even if sleep duration is not altered (Gillberg et al. 1995, Neu et al. 
2014). In the present study, sleep duration was the same between conditions. This finding, 
together with the reduced sleepiness scores, higher sleep efficiency and less percentage 
awake during the night, strengthens the conclusion that sleep continuity was better after 
the days with more light. 
Conclusion
This within-subject design study showed that extra light during a working day from 
09:00-17:00 improves subsequent sleep. This improvement was shown in better sleep 
consolidation, in trends for higher accumulation rate of deep sleep and in lower sleepiness 
scores the next morning. Extra light during the working day probably affects both the signal 
to the clock and the homeostatic sleep pressure. With this study we cannot disentangle the 
relative contributions of these processes. Despite that fact, it may be favorable to influence 
both processes at the same time as this can reinforce sleep quality. More research is needed 
about other aspects of light, such as spectral composition and exposure duration, which may 
contribute to the effects on sleep quality. Also the complete pattern of melatonin excretion 
must be investigated to conclude that a higher melatonin amplitude after one day with extra 
light may be one of the possible explanations of the better sleep continuity. Receiving extra 
light appropriately timed during the day may be an easy, practical and effective tool to help 
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In Western countries humans spend most of their time indoors. Since light levels indoors are 
much lower than the light levels outside, problems as a possible consequence of low daily 
light levels arise, like decreased alertness, performance and overall well-being.  Increasing 
light levels during office hours with artificial light seems an easy solution, however it is 
not known how light should be applied; what is the optimal timing, duration and spectral 
characteristic? It is also not clear which performance outputs are most affected as a result 
of light exposure. The present study examined the effects of either extra bright light or extra 
blue light compared to a medium intensity office light condition during a whole working day 
on sleepiness, performance outputs (reaction times and number of errors), and physiological 
measurements of alertness (EEG).  
Prolonged bright light exposure relative to the office light condition had advantageous 
effects on subjective and objective alertness and on simple reaction time tasks. This was not 
the case for prolonged blue light exposure. During the second half of the day, participants 
showed even an increase in sleepiness and number of errors under blue light exposure 
compared to the bright light condition. This may have been caused by a higher fatigue rate 




With the many indoor jobs in our working society, humans spend most of their working 
day under roofs with only light from windows and/or artificial lighting.  As a matter of fact, 
it is known that in western countries people spend over 85% of their time indoors (Leech 
et al. 2002, Schweizer et al. 2006). Humans have evolved under a natural light-dark cycle, 
with much higher light intensities and day/night contrasts. Low indoor light levels can lead 
to several problems. For instance, when light levels in offices are low, people report a lower 
overall well-being score (Borisuit et al. 2014; Boubekri et al. 2014). Also a decrease in sleep 
quality, and an increase in insomnia complaints when daytime light levels are low have been 
reported (Leger et al. 2011, Boubekri et al. 2014, Harb et al. 2014). Extra light during the day 
seems an easy solution to solve these problems. Indeed, the influence of light on well-being, 
as assessed with alertness and performance ratings, has been widely studied (Chellappa et 
al 2011). Under higher light intensities, alertness and performance can be increased, no 
matter if it is day (Phipps Nelson 2003, Rüger et al 2006, Viola et al. 2008, Smolders et al 
2012) or night (Rüger et al 2006, Cajochen 2007).  
 
There is some recent knowledge about the required amount of light that is needed to 
decrease sleepiness (reviewed in Hommes & Giménez 2015). It seems logical that if 
sleepiness is decreasing performance should increase. However, although sleepiness 
scores are often correlated to performance scores (Kaida 2006, 2012, Gorgoni 2014), they 
are not always completely in line with each other. In the study of Dinges et al. 1997 the 
increase in sleepiness was earlier noticeable than the decrease in performance, a finding 
that is observed more often (Akerstedt et al. 2014) and lead to an editorial comment on 
the relevance of the earliest sign of potential performance decrement in the near future: 
subjective sleepiness (Dijk 2014). It also depends on which performance test is used. It 
seems that reaction times on simple tasks will increase with higher sleepiness scores (Santhi 
et al. 2013) and are positively affected by light (Smolders & de Kort 2014). However in more 
demanding cognitive tasks, reaction times seem to stay stable even when sleepiness scores 
are high (Santhi et al. 2013) and can even be negatively affected by light (Smolders & de 
Kort 2014). 
 
Not only the intensity and duration of light exposure is important to affect sleepiness and 
performance scores, but also its wavelength. Specialized photosensitive retinal ganglion 
cells (pRGCs) in the retina are crucial for converting light signals to the brain (Berson et 
al. 2002, Hattar et al. 2002). These pRGCs contain the protein melanopsin, which is most 
important for transferring the non-image forming (NIF) information to the brain (reviewed 
in Hatori & Panda, 2010). Melanopsin is most sensitive to short wavelength light (peak at 
480 nm., Brainard et al. 2001, Thapan et al. 2001). This is probably the reason why the 
circadian system (Brainard et al. 2001, Thapan et al. 2001, Lockley et al 2003, Wright et al 
2004, Brainard et al. 2015) as well the alertness system (Cajochen et al 2005, Lockley et al 
2006, Vandewalle et al. 2007, Chellapa et al. 2011b) are also shown to be highly sensitive to 
blue light. Furthermore the influence of light on sleep may be regulated via the melanopic 
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system (Altimus et al. 2008, Tsai et al. 2009, Hubbard et al. 2015). Still, it should be noted 
that pRGCs will also respond to signals from rods and cones and will integrate light input 
from all photoreceptors with varying spectral sensitivities (reviewed in Hatori and Panda, 
2010).  
In spite of all the obtained knowledge with regard to the sensitivity of our brain to light, there 
is not much known about the light exposure characteristics needed to optimize performance 
during the day. The present study examined the effects of either extra bright white light 
or extra blue light compared to a medium intensity ‘office light’ condition during a whole 
working day on sleepiness, various performance tests, and physiological measurements of 
alertness (EEG).  
Material and Methods
Subjects
Participants were recruited from the area near to Groningen University, the Netherlands, 
via newspaper advertisements, posters and flyers distributed within the faculties of the 
University of Groningen and internet advertisements. People were only included if they were 
suffering from mild insomnia complaints, such as sleep onset insomnia, wakefulness after 
sleep onset or early awakening. The reason that only people with mild insomnia complaints 
were included was the fact that good sleepers may not show any improvement of their 
sleep in response to daytime light exposure because of a ceiling effect. Simultaneously, 
people with mild insomnia complaints suffer from sleepiness and are likely to demonstrate 
lower performance ratings during the day (Altena et al 2008), again allowing for increased 
performance in response to light.  The selection criterion for mild insomnia was a score 
between 6-12 on the Pittsburg Sleep Quality index (PSQI, Buysse et al. 1989). Participants 
had to be between 22-55 years old to exclude adolescents with aberrant sleep habits and to 
exclude aged people with reduced deep sleep (Dijk et al. 1989). 
Other selection criteria were: being healthy (checked with a health questionnaire), not using 
medication (also no sleeping aids), non-smoking, average ‘chronotypes’ determined by the 
mid-sleep on free days corrected for sleep debt (MSFsc; between 03:00-05:00, Roenneberg 
et al. 2003), not colorblind or visually impaired, not consuming too many drinks with caffeine 
(no more than 8 cups of 150 ml a day) or alcohol (no more than 10 glasses of 250 ml per 
week), not working in night shifts and not having travelled across multiple time zones in the 
preceding three months. In addition, participants needed to have enough computer work or 
deskwork to do from 09:00-17:00 on the three experimental days.  
After selection, dim light melatonin onset (DLMO, considered the most reliable phase 
marker of the clock, Lewy et al. 1989/1999, Burgess & Eastman. 2005, Benloucif et al. 2008) 
was first determined at home to confirm exclusion of early and late chronotypes. For the 
determination of DLMO see Geerdink et al. submitted for details.
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All subjects were fluent in Dutch, gave written informed consent, and were compensated 
for their participation. The experimental protocol was approved by the Medical Ethics 
Committee of the University Medical Center Groningen. 16 participants (6 females, 10 
males) were selected for this study with a mean age of 25.7 years (SD +- 4.5). 
Experimental Design 
The study applied a within subject design, wherein participants were assigned to 3 different 
conditions in random order. All conditions started with an adaptation evening and night, 
followed by the experimental day (see Figure 1) and night (for the analyses of the sleep 
data see Geerdink et al. submitted). Participants spent the adaptation night as well as the 
experimental day and night in our human time isolation facility. In every condition, they 
started on the same day of the week. One day prior to entering the facility, activity was 
monitored at home (AW-spectrum, Respironics, Inc, Murrysville, USA) to check whether 
participants adhered to their habitual sleep-wake pattern, as instructed.  If sleep onset or 
sleep offset deviated more than 0.5 hour from their habitual sleep-wake pattern, they were 
excluded from participation. All participants adhered to this requirement and no participants 
were excluded.
 
Figure 1. Scheme of the experimental protocol. Each subject participated in all three conditions, in 
random order 
Subjects arrived at the facility at 17:00. After dinner (at 17:30), 14 golden EEG electrodes 
were attached to the skin. Two reference electrodes were placed on the mastoids, a ground 
electrode on the forehead, 7 EEG electrodes on F3, F4, Cz, C3, C4, O1 and O2 according to 
the 10-20 electrode system. Two EOG electrodes were placed on the cheek next to the left 
eye and below the right eye to register eye-movements and to control for eye-movement 
related artefacts. Two EMG electrodes were placed under the chin to record muscle tone. 
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Saliva collection for melatonin analysis (see Geerdink et al. submitted) started at 18:30 and 
samples were collected hourly until 23:30. Light levels were kept at 40 lux at eye level from 
17:00 to 23:30 h to measure DLMO (see lighting conditions section).  Subjects were then 
allowed to sleep from 23:30 to 07:30 and sleep EEG recordings were made (results shown 
in Geerdink et al. submitted). At 7:30 h lights were turned on at an intensity of 40 lux. After 
breakfast and showering, the subjects were asked to start their ‘working day’ at the desk at 
09:00 h. From 09:00 to 17:00 h one of three lighting conditions were offered in the room (see 
below). Subjects were allowed to shortly leave their desk for a toilet visit, or to stretch their 
legs, but not longer than 5 minutes and not more than once every hour. Lunch was served 
at the desk at 12:30 h. At specific times during the day: 30 min after waking up, at 10:00, 
12:00, 14:00, 16:00 and at 19:00 h, performance and sleepiness data (Karolinska Sleepiness 
Scale KSS, Akerstedt and Gillberg, 1990) were collected. Sleepiness (KSS) was also scored 5 
min after waking up. The performance tasks were performed on the desk computer. For a 
detailed description of the performance tasks, see the ‘performance analysis’ paragraph. 
The simulated working day ended at 17:00 h and light levels were then turned to 40 lux until 
23:30 h. From 17:00 to 23:30 h subjects were free to spend their ‘free time’, however they 
were not allowed to be physically active and they had to stay in the room. Saliva samples 
were taken hourly from 18:30 to 23:30 h, also on the experimental day. Subjects were then 
again allowed to sleep, starting at 23:30 until 07:30 h and sleep EEG recordings were made. 
At wake up, electrodes were removed and the participants had breakfast, had a shower and 
went home. At least one week and not more than two weeks separated each of the sessions.
Lighting conditions 
Philips TL tubes, located in the ceiling of the experimental rooms, with different color 
temperatures were used to create different lighting conditions (Table 1).  For the bright 
light situation, blue-enriched white-fluorescent tubes (17000 K) (Master TL-D® 18W/ 452 
ActiViva®, 17000K; Philips Lighting B.V., Eindhoven, NL) were used. This condition had an 
intensity of 1900 lux (Table 1) at eyelevel in the direction of gaze, which is similar to a 
cloudy day outside. In the low ‘office light’ situation, warmer light of 2700K (Master TL-D® 
18W/827 Warm Wit®, 2700K; Philips Lighting B.V., Eindhoven, NL) was used, to mimic a 
common low-light office situation (130 lux at eye level) while keeping the melanopic lux 
intensity (Lucas et al. 2014) to a minimum. Light levels were kept low, at 40 lux, from 07:30 
to 09:00 h and 17:00 to 23:30 h, in order to prevent light exposure during the intervals in 
which the circadian clock is sensitive for phase shifts in response to light (Khalsa et al. 2003, 
Rüger et al. 2013).  Table 1 provides the photopic- and melanopic-lux values corresponding 
to all light conditions. 
 
In the ‘blue light‘ condition the low office light situation was combined with an extra blue 
LED - light strip mounted (280x25 mm2; transmission 450-490nm; prototype developed by 
Philips, Drachten, NL)on top of the PC/laptop monitor. 
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Figure 2. Photograph of the setup of the study at the office with the blue light strip mounted on the 
laptop monitor. 
Performance analysis 
At specific times during the day: at 08:00, 10:00, 12:00, 14:00, 16:00 and at 19:00 h, 
performance and sleepiness (KSS) data were collected with an E-Prime® (2.0 Professional) 
test battery on the desk computer (light intensity of the screen was minimal and included in 
the light measurements). Each batch of tests lasted for about 20 minutes. The test battery 
consisted of a KSS questionnaire, followed by a Sustained Attention to Response Task (SART), 
a 2-back memory task and a psychomotor Vigilance Task (PVT). See Table 2 for detailed 
information about the performance tasks. 
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All performance tasks contained measurements of reaction time (RT) and accuracy (Acc). 
To be able to compare these measurements between conditions, all output measurements 
were Z- transformed within subjects and corrected for the first session. This means that 
within a subject all values of a particular task in all conditions were scaled relative to the 
standard deviation of the values and then the value for session 1 (at 08:00 h prior to the 
experimental lighting) was subtracted from sessions 2, 3, 4, 5, 6 (at time points 10:00, 12:00, 
14:00, 16:00, 19:00). The average and SEM per condition per session of all subjects was 
calculated over these corrected values.
EEG analysis 
Directly after each test battery, a 1-minute wake EEG recording (eyes closed) started. 
Participants heard a sound signal when they had to close their eyes. They were then asked 
to press a marker. After 1 minute of closing their eyes, subjects heard again the sound signal, 
opened their eyes and pressed the marker again.  
All Polysomnography (PSG) signals were converted to European Data Format (EDF) and 
imported into VitaSCORE software 1.22 (Temec Instruments BV, Kerkrade, The Netherlands) 
together with the corresponding and synchronized time series of marked wake EEG intervals. 
Power spectra were computed per 4s epoch by applying a Fast Fourier Transform routine 
implemented in VitaScore and power density was calculated per epoch in the delta band 
(1-4 Hz), theta band (4-8 Hz), alpha band (8-12 Hz) and beta band (12-16 Hz). Only the alpha 
and theta bands were used for objective sleepiness analyses. To be able to compare alpha 
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and theta power between subjects, the power values were Z-transformed within subjects.
 
Statistical analysis
We hypothesized that the effects of the bright light condition and of the blue light condition 
were significantly different from the office light condition while possibly not significantly 
different from each other. For the sleepiness differences (KSS), performance differences 
(Z-scores) and EEG power differences (Z-scores) during light exposure we used Repeated 
Measures ANOVA tests. Differences between ratings in the office light and blue light 
condition, the office light and bright light condition and the blue light and bright light 
condition were tested separately.  Two factors were used; one for ‘condition’ (2 levels) 
and one for ‘time’ (4 levels; 10:00, 12:00, 14:00 and 16:00 h). Measurements during light 
exposure were corrected for the first test battery prior to the experimental light condition 
(Z-scores were subtracted from the other test blocks). For the differences in sleepiness and 
performance between conditions in the last session after the experimental light exposure, 
in the evening at 19:00 h (also corrected for the first test battery), a paired sample t-test was 
used. Significance level was defined as α =0.05. All parameters were tested two-tailed.  
Results
Subjective sleepiness over the day 
In general, participants became less sleepy after the first time point at 8 am (Figure 3). This 
decrease in sleepiness was significantly larger when the bright light condition was compared 
to the office light condition (see Figure 3 and Table 3A for statistics): during the whole 
experimental light period the sleepiness scores in the bright white light condition were 
lower than in the office light condition. Results for the blue light condition were in between; 
not significantly different from neither the office light nor from bright light condition (see 
Table 3B and 3C for statistics). However after light exposure at 19:00 h, participants showed 
a trend for feeling less sleepy after spending a day under blue light exposure (t15= 2.7, 
P<0.05) compared to spending a day under the office light condition; such a trend on the 
border of significance was also observed in the bright light condition compared to office 
light (t15= 2.1, P=0.06), (Figure 3, last point). 
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Figure 3. The delta (relative to 1st session) of the average Karolinska sleepiness (KSS) scores per session 
over the day (mean ± SEM) for all conditions (office light ‘office’, office light + blue light strip ‘blue’, 
bright light ‘bright’). The light exposure period is indicated by the vertical dashed bars. The sessions in 
the light exposure period were tested with a repeated measured ANOVA. An overall significant effect 
for condition is indicated by the horizontal line. The last session was tested with a paired sample t-test. 
**P<0.01, #P=0.06.
Reaction times over the day
The average delta reaction times (relative to the first session) for the PVT task are shown in 
Figure 4A. During light exposure participants responded faster in the bright light condition, 
while not different in the blue light condition compared to the office light condition 
(see Table 3A and 3B for statistics). Again, the results for the blue light condition were in 
between the results of the office light condition and bright light condition. However, in this 
case participants also significantly responded faster under bright light exposure compared 
to under blue light exposure (see Table 3C for statistics).  In the evening, when both the 
bright and blue exposures were ended, participants responded faster in both the conditions 
compared to the office light condition (blue t15= 2.3, P<0.05, bright t15= 3.3, P<0.01) (Figure 
4A). At this time no differences were found between the blue and bright light conditions 
(t15= 1.04, P=0.32).  
The average delta reaction times (relative to the first session) for the SART task are shown 
in Figure 4B. Overall, for the effect of condition no differences were observed between 
conditions (Table 3A, 3B, 3C) The interaction effect of condition X time was however shown 
to be significant between the bright and office light condition (Figure 4B, Table 3A). After 
light exposure, no significant differences for the SART reaction times were found (office vs. 
blue light condition: t15= 1.6, P=0.13; office light vs. bright light condition: t15= 1.4, P=0.17; 
blue light vs bright light condition: t15= 0.12, P=0.91).
The average delta reaction times (relative to the first session) for the N-back task are shown 
in Figure 4C. No significant differences were found for the N-back reaction times in the 
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office light and bright light conditions; not during light exposure (Table 3A) and not in the 
evening after light exposure (t15= 0.46, P= 0.66).  In the blue light condition there was a 
tendency that participants responded slower during the N-back test, when compared to the 
low office light condition (Table 3B) and after light exposure this trend was still there (t15= 
-1.9, P= 0.07). This effect after light exposure was significant when the blue light condition 
was compared to the bright light condition (t15= 2.7, P<0.05). 
Figure 4 A: The delta (relative to 1st session) of the average PVT reaction times per session over the day 
(mean ± SEM) for all conditions. An overall significant effect for condition is indicated by the horizontal 
line. B: The delta (relative to 1st session) of the average SART reaction times per session over the day 
(mean ± SEM) for all conditions. C: The delta (relative to 1st session) of the average N-back reaction 
times per session over the day (mean ± SEM) for all conditions. Conditions: office light ‘office’, office 
light + blue light strip ‘blue’, bright light ‘bright’). The light exposure period is indicated by the vertical 
dashed bars. The sessions in the light exposure period were tested with a repeated measured ANOVA. 
A significant interaction effect for condition X time is indicated by the arrow. An overall significant 
effect for condition is indicated by the horizontal line. The last session was tested with a paired sample 
t-test. *P<0.05, **P<0.01, ***P<0.001.
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Accuracy over the day
The average number of delta lapses of the PVT task (relative to the first session) are shown 
in Figure 5A. During light exposure no differences were observed between conditions (see 
Table 3A, Table 3B, Table 3C for statistics). After light exposure in the evening the number 
of lapses remained not significantly different between conditions (office light vs. bright light 
condition t15= -0.44, P= 0.67; office light vs. blue light condition t15= 0.03, P= 0.98); blue 
light vs. bright light condition t15= 0.57, P= 0.58. ) (Figure 5A). 
The average delta of omissions (relative to the first session) for the SART task are shown in 
Figure 5B. During light exposure no significant differences were found between conditions 
(see Table 3A, Table 3B. Table 3C for statistics). This was also the case after light exposure in 
the evening (office light vs. bright light condition t15= -1.7, P= 0.12; office light vs. blue light 
condition t15= -1.1, P= 0.31; blue light vs. bright light condition t15= -0.84, P= 0.42) (Figure 
5B). 
The average delta of accuracy (relative to the first session) for the N-back task are shown 
in Figure 5C. During light exposure no differences were observed between conditions (see 
Table 3A, Table 3B, Table 3C for statistics). After light exposure participants in the blue light 
condition had a trend for a better accuracy for the N-back task when compared to the office 
light condition (t15= -1.8, P=0.09). This was not the case when the bright light condition was 
compared to the office light condition (t15= -0.94, P= 0.36) and not the case when the blue 
and bright conditions were compared (t15= 1.07, P= 0.30).
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Figure 5 A: The delta (relative to 1st session) of the average PVT lapses per session over the day 
(mean ± SEM) for all conditions. B: The delta (relative to 1st session) of the average SART omissions 
per session over the day (mean ± SEM) for all conditions. C: The delta (relative to 1st session) of the 
average N-back accuracy (%) per session over the day (mean ± SEM) for all conditions. Conditions: 
office light ‘office’, office light + blue light strip ‘blue’, bright light ‘bright’). The light exposure period 
is indicated by the vertical dashed bars.  The light exposure period is indicated by the vertical dashed 
bars. The sessions in the light exposure period were tested with a repeated measured ANOVA. The last 
session was tested with a paired sample t-test. No significant differences were found.
EEG measures
With respect to the EEG power differences between the office light condition and the bright 
light condition, the interaction between condition and time was only shown to be significant 
for alpha power (Table 3A). This was probably caused by a smaller increase in alpha power 
in the morning directly after onset of light exposure and a decrease in alpha power in the 
third session of the bright light condition (Figure 6A). After light exposure (at 19:00 h) no 
significant differences were found for either alpha or theta power when the bright light 
condition and the office light condition were compared (Alpha; t12= 0.6, P= 0.57, Theta; 
t12= 1.6, P= 0.13).  
For the blue light condition no significant differences were found for either alpha or theta 
power in the 1-minute wake EEG when compared to the office light condition (Figure 6A, 
Figure 6B and Table 3B). Also after light exposure (at 19:00 h) no significant differences were 
observed (Alpha; t12= 0.6, P= 0.54, Theta; t12= 1.7, P= 0.11).
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When the blue and bright condition were compared for both alpha and theta power, a 
significant effect between conditions was found in theta power only during light exposure 
(Table 3C). This was probably caused by higher theta powers under blue light exposure later 
in the day (see Figure 5B); after light exposure, no differences were found (Alpha; t12= -1.5, 
P= 0.16, Theta; t12= -0.3, P= 0.77)
 
Figure 6 A: The delta (relative to 1st session) of the average standardized alpha power (8-12 Hz, 
Z-scored) per session over the day (mean ± SEM) for all conditions. B: The delta (relative to 1st 
session) of the average standardized theta power (4-8 Hz, Z-scored) per session over the day (mean ± 
SEM) for all conditions. Conditions: office light ‘office’, office light + blue light strip ‘blue’, bright light 
‘bright’). The light exposure period is indicated by the vertical dashed bars.  The light exposure period 
is indicated by the vertical dashed bars. The sessions in the light exposure period were tested with a 
repeated measured ANOVA. The A significant interaction effect for condition X time is indicated by the 
arrow. An overall significant effect for condition is indicated by the horizontal line. The last session was 
tested with a paired sample t-test. *P<0.05. 
Discussion
The set-up and purpose of this study was to quantify the effects of extra light on alertness 
and performance scores during the day and after light exposure in the evening, in addition 
to the effects on sleep the next night. The results of the effects on sleep are discussed 
elsewhere (Geerdink et al submitted). 
Alertness and Performance outputs during light exposure
As expected, bright light during the day significantly decreased subjective sleepiness when 
compared to sleepiness levels perceived during low office light exposure. Interestingly, the 
reaction times in the PVT and the SART tasks also decreased in bright light. It may be that 
the induced reduction in sleepiness led to better performance. A simultaneous decrease in 
sleepiness or increase in alertness and better performance under bright light exposure has 
been found before (Wright et al. 1997, Phipps-Nelson et al. 2003, Lo et al. 2012). However, 
this relationship cannot be generalized to all performance tasks. In the 2-back task, the 
pattern is quite different. Bright light does not improve reaction times here. 
112
In general, the largest and most positive impact of light was established on RT in simple 
sustained attention tasks, which is in line with the results of Lo et al. 2012 and of Santhi 
et al. 2013. They found that after either total or partial sleep deprivation, the effects were 
most pronounced on subjective sleepiness and most prominent in simple sustained reaction 
time tasks, like SART and PVT. Also in those studies the effects on the more challenging 
working memory tasks, like the N-back, were much smaller. With the progression of time, 
participants responded increasingly slower under extra blue light exposure as compared to 
low office light exposure alone, while they had a tendency to be more accurate. They may 
have made sacrifices in terms of RT to have a stable accuracy. Interestingly, in the study of 
Smolders & de Kort 2014, it was found that when people experience progressive fatigue, 
extra light can have negative effects on more demanding tasks like the N-back task and 
especially on reaction time. Since we found similar results in the blue light condition, it would 
be worthwhile to investigate if prolonged exposure to narrow bandwidth blue light leads to 
increased fatigue rate. It may also be not advantageous to be exposed to extra blue light if 
people are already in an alert state. In a recent study (Geerdink et al. submitted) we found 
that prolonged blue light exposure (3 hours) from this blue lightstrip was disadvantageous 
during the morning hours, but only in early chronotypes. This was not the case when people 
were exposed to this light during the afternoon, at the time when they normally experience 
sleepiness. These results together indicate that prolonged blue light is not always beneficial, 
and the effects depend on the time of the day and state of alertness. It further shows that 
mechanisms and regulation of alertness and cognitive performance is complex and that 
there is still much work to be done. 
Carryover effects of light during the day in the early evening
While the effects of blue light on performance were only minimal, there were some positive 
carryover effects of blue as well as bright light during the day on sleepiness and performance 
in the evening. Positive carryover effects after extra light exposure in the early evening have 
been found before (Gabel et al. 2015 and Figueiro et al. 2014, Münch et al. 2012). In the 
study of Figueiro et al. 2014, the authors also found no differences in performance during 
blue light exposure, while there were strong significant effects after blue light exposure. 
The difference between the current and their study is that they found significant effects 
during the late night hours (between 01:00-05:00), while the present study found these 
effects already at 19:00 h. The study of Münch et al. found that people were less sleepy 
after one day of bright light in the beginning of the evening around the same time as the 
present study. However they applied light from 12:00-18:00 h, thus a bit later and shorter. It 
is tempting to speculate about the mechanism behind these carryover effects. Why is there 
a long lasting effect of light on performance when the light is no longer there? Suppression 
of melatonin by light in the evening is not a reasonable explanation for the observation 
of better performance, since our participants had an intermediate chronotype with a 
melatonin rise only after 19:00. It was even found that these participants had an earlier 
increase of melatonin in the evening after the days with extra light exposure (Geerdink 
et al. submitted).  Maybe other brain structures are still affected after switching off the 
light. Besides the SCN, there are other brain structures that will respond to (blue) light 
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(Vandewalle et al. 2009). In mice it has even been found that different colours of light can 
either have a sleep promoting or arousal promoting effects (Pilorz et al. 2016). Furthermore, 
it has been found that neurons of the olivary pretectal nucleus (OPN) of rats sustain firing 
when a light source is switched off (Skudlarek et al. 2012). The OPN is innervated by pRGCs 
and has connections with the SCN (Hattar et al. 2006) as well as to other arousal structures 
(Hattar et al. 2006, Vandewalle et al. 2009).  However, in the study of Skudlarek et al. 2012, 
the OPN cells of rats continued to fire only for some minutes, after being exposed to only 
some minutes of light. Studies with longer measurement periods are needed to answer the 
question whether brain structures involved in promoting arousal and/or suppressing sleep 
will continue to fire long after being exposed to light.
Possible explanations for the differences between the effects of the bright and blue light 
condition
The effects of light on KSS and performance scores were always larger and always positive 
for the bright light condition compared to blue light condition. Although the melanopic lux 
intensities of both the bright light (1700 mlux) and blue light condition (500 mlux) should 
yield similar effects on sleepiness according to the KSS dose response curve (Hommes & 
Giménez 2015), there may be different dose-response curves for melanopic lux intensities 
and performance scores. Besides, it should be noted that the study of Hommes & Giménez 
2015 included mostly night studies. It may be that the KSS sensitivity for blue light is different 
during the day.  
There may also be other explanations for the minimal effects in the blue light condition. It 
has recently been shown that the melanopsin photopigment is not solely responsible for the 
signaling to the brain, as pRGCs also integrate signals from rod/cone photoreceptors (Enezi 
et al. 2011, Altimus et al. 2010, Gooley et al. 2012, Lucas et al 2014). 
Furthermore, the melanopsin protein seems to act as a photosensitive flip-flop protein 
(Mure et al. 2009). In the study of Mure et al. 2009, the authors showed that if the pupil is 
previously exposed to 5 min. of blue light it will be less responsive by another dose of blue 
light, while it will be more responsive if it was previously exposed to 5 min. of red light. In 
other words, it is possible that melanopsin was saturated by prolonged blue light exposure 
and can be regenerated by red light. Theoretically it could be that the simultaneous presence 
of short and long wavelengths in the bright light condition makes participants more sensitive 
to the effects of the short wavelengths than when exposed to mainly short wavelengths 
alone, although a direct test of this hypothesis showed negative results (Papamichael et al. 
2012) It is therefore not a definite explanation for the differences between the exposures to 
bright light or extra blue light.
Effects of extra blue and bright light on the wake EEG 
This study revealed only marginal effects of light on wake-EEG measures with eyes closed. 
There was a significant condition X time interaction for the effects of light on alpha power 
when the office light condition and bright light condition were compared. The progression 
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of alpha power in the wake EEG over time seemed stable in the office light condition, while 
more variable in the bright light condition. This difference seemed to be caused by the 
lowered alpha power scores in the early afternoon in the bright light condition. A lowered 
alpha power under higher intensities of light has been found before (Cajochen et al. 2000, 
Okamoto et al. 2014) and has also been correlated to caffeine consumption (Barry et al. 
2005). In the study of Barry et al. 2005, a decrease in alpha power was correlated to higher 
amounts of caffeine intake, which is in turn related to higher alertness (Wright et al. 1997, 
reviewed in Glade et al. 2010).  
Theta power was increased during prolonged blue light exposure, which might be another 
indication that participants experienced a faster rate of fatigue in the blue light condition. 
Higher theta power is correlated to higher sleepiness scores (Cajochen et al. 1999) and to a 
decrease in performance scores (Cajochen et al. 1999, Gorgoni et al. 2014).
Conclusion
Prolonged bright white light exposure during the working day has advantageous effects 
on alertness and performance. This is expressed in subjective sleepiness scores, in simple 
reaction time tasks like PVT and SART, and in objective measures for alertness like alpha 
power in wake EEG. The effects of bright light were however not shown in a more cognitive 
demanding 2-back task. These effects were consistent with previous studies. 
Prolonged blue light exposure during the day had no significant beneficial effects on 
sleepiness and performance scores. A possible explanation is that prolonged blue light may 
cause saturation of the melanopsin protein. Also higher theta powers were found after 
prolonged blue light exposure, which might indicate that it possibly induced fatigue at a 
higher rate than bright light exposure and low office light exposure.  
For a future, fundamental study, it would be worthwhile to examine a wider range of spectral 
compositions and different dynamics of light during the day. Since melanopsin is involved in 
many non-image forming effects of light, future studies may search for an optimal colour as 
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7.1 New insights in Light therapy
Over the last decade, light therapy has gained more and more popularity. It has been used 
over the range from treating winter depression (Meesters & Gordijn 2016) to decreasing 
neurodegenerative symptoms (reviewed in Shirani & Louis 2009). In addition, it has been 
extensively used in laboratory studies to phase shift the clock (chapters 1-3). This thesis 
provides indications that if light is optimally timed, it can even shift sleep and may improve 
objective sleep quality (chapter 3,5). 
It should be taken into account that we also found limits to the use of light therapy. While 
optimally timed, short blue light pulses were effective in phase shifting the circadian rhythm 
of melatonin concentration and sleep (chapter 2,3), with preservation of performance during 
the day (chapter 3), but longer periods of blue light during office hours seemed not beneficial 
and were sometimes even disadvantageous (chapter 4,6). In addition, we found indications 
that objective sleepiness increased over the day under blue light exposure compared to 
bright light exposure (more theta power) and compared to office light exposure (longer RT 
in the 2-back task) (chapter 6). The timing of periods with blue light during common office 
hours should also be taken into account (chapter 3): in real-life circumstances,  subjects will 
expose themselves to varying amounts of light with varying blue content at different times 
of the day, and therefore at different individual circadian phases.
7.2 A role for extra light exposure during the day 
towards increased melatonin production at night.
The first effect that deserves renewed attention is the influence of light during the day on 
sleep and on melatonin production during the night. In chapter 5 we measured melatonin 
at night after one day of extra light and in the study in chapter 2 with more days of extra 
light. In both cases we found indications for an increased melatonin production. Next to 
the increased melatonin production, these two studies found positive effects on sleep 
quality. The question arises whether or not increased melatonin production in an individual 
is an indication of a higher circadian amplitude of the clock and whether it is related to the 
observed improved sleep quality. A long lasting debate is going on about the relationship 
between melatonin and sleep. While researchers seem to agree on the chronotherapeutic 
effects of melatonin (Cajochen et al. 2003, van Geijlswijk et al. 2010, van Maanen et al. 2016), 
effects on sleep quality parameters have not always been found. When sleep consolidation 
parameters were tested, positive effects of a higher melatonin concentration during 
sleep have indeed been found (to note: these studies use different dosages and various 
timing of melatonin administration): melatonin can reduce sleep onset latency (Zhdanova 
& Wurtman 1997, Cajochen et al. 2003, Rajaratnam et al. 2004), can reduce awakenings 
during the night (Zhdanova & Wurtman 1997), can to some extend increase sleep efficiency 
(Brzezinski et al. 2005, Wyatt et al. 2006) and in a few studies an increase in REM sleep has 
been found (Dijk et al. 1997, Dijk & Cajochen 1997). However when homeostatic variables 
were tested, such as effects on slow wave sleep (Wyatt et al. 2006, Arbon et al. 2015) no 
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effects have been found. Thus, it seems that a higher melatonin concentration promotes 
sleep during the night probably by inhibiting the wake promoting drive (Wyatt et al. 2006, 
Skeldon et al. 2016). However it does not significantly influence the depth of sleep. In all 
of the previous studies mentioned above, sleep was analysed after exogenous melatonin 
ingestion. The melatonin concentration is then artificially and drastically increased, which 
may not reflect a normal melatonin rhythm. Indeed in blind people who needed doses of 
exogenous melatonin to stay entrained, lower doses appeared to be more effective than 
higher doses (Lewy et al. 2005). In addition, the timing and concentration of exogenous 
melatonin with respect to one’s own melatonin rhythm is important to elicit effects (Lewy 
et al. 2005, 2010, van Geijlswijk et al. 2010). 
If one’s own melatonin concentration is naturally increased during the night under the 
influence of light during the day, the effects on sleep consolidation may be much stronger as 
the amplitude is increased at just the right time. Manipulating light levels during the day may 
also influence sleep homeostasis processes. This will be discussed in the next paragraph. 
7.3 A role for light in sleep homeostasis in humans
In chapter 3 we found indications that not only sleep was shifted earlier after morning blue 
light therapy, but that sleep quality was also improved.  This raises the question whether 
sleep was more consolidated because of boosting the amplitude of the clock (as suggested 
by a larger area under the curve of melatonin concentration), or because blue light 
influenced sleep homeostasis, or both. Earlier mouse studies make this latter hypothesis 
worthwhile to investigate because it was found that the intensity and color of light can 
influence sleep homeostasis in mice, probably through the melanopsin pathway (Altimus 
et al. 2008, Tsai et al. 2009). Such a role for the melanopsin pathway is also suggested by 
Hubbard et al 2013 and Legates & Hattar 2014. In chapter 6 we tested the influence of 
light on sleep homeostasis in people with mild sleep problems. In good sleepers this has 
been tested before, however without yielding significant results (Takasu et al. 2006). In 
that study there might have been a ceiling effect on sleep quality. Another explanation is 
the light exposure period that lasted for 16 hours. This, therefore, included light exposure 
in the evening, where light can negatively influence subsequent sleep quality (Münch et 
al. 2006). In our study, presented in chapter 6 we applied light for 8 hours from 09:00-
17:00 and participants were only selected if the timing of this light was optimal for their 
chronotype (only boosting their circadian amplitude).  In our study, extra light during the 
day indeed increased sleep consolidation and lowered sleepiness scores the next morning. 
It also showed a trend towards a higher accumulation rate of deep sleep. However, we could 
not disentangle the relative contributions of the two processes: The influence of light on the 
clock and the influence of light on sleep homeostasis. This will be a new challenge in further 
research.
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7.4 Individual differences in the effectiveness of light 
therapy
While in chapter 3 of this thesis, a positive effect of morning blue light therapy was found for 
late chronotypes, in chapter 4 we revealed that blue light in the morning might sometimes 
be disadvantageous, maybe in particular for early chronotypes.  It suggests that identifying 
an individual’s circadian phase before starting with light therapy seems to be an important 
aspect in improving personalized light therapy. Until now the most common and easy way 
to assess circadian phase is calculating one’s chronotype with the MCTQ (Roenneberg et al., 
2003). Indeed, it is known that the timing of midsleep on freedays (MSF), is highly correlated 
to the timing of dim light melatonin onset (DLMO) (Kantermann et al. 2015). Still, a lot of 
variation is seen between DLMO and the phase angle of sleep. In the study of Chapter 3 
DLMO ranged from 5.40 hours before sleep onset to 0.26 after sleep onset. In our DLMO 
calculations we found that there are a lot of people with a relative early DLMO time and a 
late sleep onset (40% of the participants in the study of chapter 3 had a DLMO time that was 
earlier than 3 hours before sleep onset), which has been found before (Sletten et al. 2010). 
An intriguing question is why different chronotypes, defined by their sleep phase, exist for 
the same DLMO’s. Recent studies have searched for other DLMO predictors (Gil et al. 2013, 
Woelders et al. 2017). In both of these recent studies the amount of light during the day 
seems important for the timing of DLMO, which is a finding that is in consistence with our 
results in chapter 5. The answer may also be found in the dynamics of sleep pressure. Studies 
by Mongrain and Colleagues suggested that late chronotypes have different dynamics for 
sleep pressure compared to early chronotypes. The data revealed a lower amplitude of slow 
wave activity (SWA) in the first sleep cycles of late types (Mongrain et al. 2006b, Schmidt et 
al. 2012). This was interpreted as to demonstrate a lower built-up of sleep pressure during 
wakefulness as well as a slower decay of SWA during sleep (Mongrain et al. 2006a, Schmidt 
et al. 2012) in late types compared to early types. As a consequence of such characteristics 
of the regulation of sleep pressure, late types would sleep later in the evening, and they 
would wake up later in the morning, while their DLMO might not be late. In accordance 
with this work, being a ‘late chronotype’ would not always mean having a late endogenous 
clock.  
The data of Mongrain et al (2007) may also be explained in another way. The amount of 
SWA in the first cycle is not only dependent on the accumulation of sleep need during the 
day, but also on the duration of the cycle. This is caused by the fact that SWA rises in the 
beginning of the nonREM episode and reaches a high asymptote in the later part of the 
episode (Achermann et al. 1993). In short cycles, low values dominate, while in long cycles 
high values are more abundant. Hence episode duration influences slow wave activity 
independent from the built-up of sleep need. If chronotype is related to REM latency, this 
would explain Mongrain et al’s data (2007) without the need of assuming differences in 
the dynamics of process S.  Without complete knowledge of the relationship between 
chronotype and REM latency, it seems safe to suggest that it may also be a combination 
of a late endogenous clock and different dynamics of sleep pressure. The recent model of 
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Skeldon et al. (2016), developed with the purpose to explain why people tend to sleep later 
during adolescence and become earlier later in life, support the theory that clock- as well as 
sleep pressure dynamics should be part of the model.   
Recent literature also proposes another way by which sleep pressure dynamics influences 
sleep timing. This concerns the presence in the population of a polymorphism of the PER3 
clock gene, which is related to sleep pressure dynamics. The PER3 clock gene has a PER34/4 
form, which is linked to an evening preference and a PER35/5 form which is linked to a 
morning preference (reviewed in Dijk & Archer 2010). People with the PER34/4 gene have 
also a slower built up of sleep pressure compared to people with a PER35/5 gene (Viola 
et al. 2007, Dijk & Archer 2010, Hasan et al. 2014). Interestingly, people with a PER34/4 
polymorphism have stronger brain responses to blue light in the morning (Vandewalle et al. 
2011).  
All these observations strongly suggest that there exist different types of chronotypes, 
depending on the clock as well as on sleep architecture. The findings of the study of 
Vandewalle at al. 2011 also supportthat different chronotypes will not always react in the 
same way to (blue) light during particular moments of the day, which is in line with our 
finding in chapter 4. 
7.5 Future prospects: Optimizing light exposure 
patterns 
With the new insights gained from this thesis it seems evident that increasing daily light 
exposure is a practical and effective tool to increase performance and sleep quality. However, 
it has also revealed that it is worthwhile to investigate how extra light with different spectral 
intensities should be applied optimally in the individual, since the effects differ between 
individuals. Personalized light therapy is needed. Also gaining insight about the mechanisms 
behind the effects of light on boosting the circadian amplitude and about the effects of light 
on homeostatic sleep dynamics in humans will help to optimize light therapy.  In developing 
personalized light therapy, the next step would be to answer the question how to expose 
humans to an optimal individual light scheme. From the results in this thesis it is evident 
that only applying longer periods of extra blue light exposure is not the solution. Prolonged 
blue light exposure can have various effects at different times of the working day and the 
effects may differ between chronotypes. There may however be other general (bright) light 
schemes wherefrom people in general may benefit. On top of that, individual light therapy, 
with customized intensity and color exposure may be used, for instance when a phase shift 
of the clock is needed or performance needs to be optimized at certain times of the day. 
Although the multidimensionality of the system is a complicating factor and our knowledge 
is still limited, the studies in this thesis have made clear that optimizing light in humans is a 
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Under the influence of the earth’s rotation around the sun almost every organism has 
evolved an internal rhythm close to 24 hours. This internal rhythm of about 24 hours is called 
a ‘circadian’ rhythm and is generated by the biological clock. In mammals the biological 
clock is located in the suprachiasmatic nucleus (SCN). In humans, a robust output marker 
of the SCN is the rhythm of the hormone melatonin. The SCN inhibits the production of 
melatonin during the day. During the evening this inhibition stops and melatonin will start to 
be produced in the pineal gland. In general, the melatonin rhythm peaks during the middle 
of the night and declines in the early morning. Melatonin provides also feedback to the 
SCN together with other internal time signals, like the internal availability of nutrients and 
body temperature.  The SCN is also under influence of external signals called ‘Zeitgebers’. 
This adjustment by Zeitgebers is needed, because when there are none the SCN will ‘free-
run’ with its own endogenous period, which will lead to erroneous time of day signalling. 
Therefore the SCN needs to be synchronized daily. Light is the most important Zeitgeber to 
the SCN. 
In humans, the effect of light is gated via the eyes. Photoreceptors which are located in the 
retina will translate and transport the light signal to the biological clock (SCN) and to other 
areas of the brain i.e. areas for vision and alertness. While the classical photoreceptors for 
vision (rods and cones) do contribute to this signal they are not absolutely required. The 
most important cells for transferring the light signal to the clock are the photosensitive 
retinal ganglion cells (pRGC’s), because when these cells are not present, the clock is 
insensitive to light. They contain the protein melanopsin, which is mainly responsible for 
the translation of the light-signal. Melanopsin is most sensitive for blue light and blue light 
is therefore most effective for adjusting the clock. 
In general, light in the early morning will shift the clock to an earlier time and light in the 
evening will shift the clock to a later time. Light during the middle of the day will not have 
phase shifting effects, yet there are indications that light during the day can boost the 
amplitude of the circadian rhythm of the clock.  
In modern society there is a lot of variation between individuals in the pattern of the sleep-
wake cycle. In chronobiological research, humans are often classified according to their 
‘chronotype’, a term that is based on differences in sleep timing of the population. Chronotype 
can be quantified with the Munich Chronotype Questionnaire (MCTQ). If someone has an 
overall sleep timing that is earlier or later than a large part of the population (under the 
25th percentile or above the 75th percentile), then this person is called someone with an 
‘early chronotype’ or a ‘late chronotype’ respectively. A person with his/her sleep around 
the average (between the 25th and 75th percentile) is called someone with an ‘average 
chronotype’. 
In addition to this variation in sleep timing, the common habit of the majority of adults is 
that they like to sleep later on free days than on workdays. Apparently, work- and school 
schedules start earlier than what people prefer. These work- and school schedules may 
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lead therefore to a mismatch of endogenous circadian rhythms (generated by the clock, the 
SCN) and external environmental rhythms. As a result of the discrepancy in sleep timing on 
workdays and free days, many adults experience a so-called weekly ‘social jetlag’. As with 
a ‘normal’ jetlag resulting from travelling to different time zones, sleeping at the wrong 
internal phase can disturb bodily rhythms. This may lead to stress and health problems. 
A large number of people in the population could therefore theoretically benefit from a 
correction of their timing of sleep. 
One way to achieve this is by advancing the biological clock. Since light is a strong Zeitgeber, 
light therapy in the morning is often proposed as a tool to treat the phase of late sleepers. 
In a clinical setting, light exposure in the morning has already been shown to be effective. 
However, there is no generally accepted protocol, definitely not for using light therapy 
at home. For a practical and successful correction of the phase of late sleepers, optimal 
parameters about light exposure, like the timing, duration, intensity and color of light need 
to be specified. Also characteristics of individuals that influence the effectiveness of light 
therapy have to be identified.  
The data of this thesis can be useful to improve the treatment of sleep disorders with light 
therapy and at the same time fundamental questions about the underlying mechanisms 
related to the influence of light on physiology and behavior (such as sleep and alertness) 
may be answered.
In chapter 2 we combined some optimal light therapy parameters to see if the duration of 
light therapy can be shortened in a home situation, while maintaining the effect.  The timing 
of light exposure is one of the parameters we could optimize. For this purpose it is important 
to know when the melatonin concentration starts to rise in the evening under dim light (also 
called ‘dim light melatonin onset’, DLMO). Indeed, it is known that light is most effective 
9 hours after DLMO for phase advancing the clock. Since we measured the DLMO of the 
participants before the start of the experiment, we exactly knew when they had to start 
with light therapy in the morning. The light source itself was a small lamp (Philips Golite Blu) 
emitting high intensity blue light, which is the color and intensity that should maximize the 
effect. We examined if high intensity blue light pulses of 30 minutes were as effective as high 
intensity blue light pulses of 60 minutes. We indeed found that 30 minute blue light pulses 
were as effective as three blue light pulses of 60 minutes in phase advancing the clock (when 
they were applied once a day on three consecutive days at an optimal timing). We found 
also a decrease of sleepiness in the morning at waking up. Furthermore, we found some 
indications that sleep was shifted to an earlier phase.  
These last findings lead to the questions in the next study described in chapter 3. Here 
we focused on post-treatment effects on sleep itself, which hardly have been studied. Also 
effects on daytime functioning after light therapy treatment have hardly been reported. 
Therefore, post-treatment effects on sleep and performance were the main output 
measures in the study of this chapter. We made use of two light therapy protocols applied 
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in two groups of participants. These participants were suffering from a ‘social jetlag’ during 
workdays and wanted to advance their sleep. The two light therapy protocols were exactly 
the same, except from the light sources used. The light sources emitted either high intensity 
blue light (using the same lamp as in chapter 2), or amber colored light with the same 
visible brightness (lux). Melanopsin, and therefore the clock, is less sensitive to amber light. 
Therefore the amber light could function as a kind of placebo. Differences between the two 
groups with respect to sleep and performance had to be caused by the color of the light. The 
protocol consisted of 30 days in total and was performed at home. All participants started 
with 14 baseline days with no sleep instructions. This was followed by 9 intervention days 
with every morning either 30 minutes of blue light, or 30 minutes of amber light, along 
with a sleep advancing scheme. The scheme was based on the habitual sleep offset in 
the baseline period. Light therapy started at habitual sleep offset and was then advanced 
by 1 hour every 3 days. This scheme was followed by 7 post-treatment days (the period 
that measured the eventual preservation of the effects) without sleeping instructions and 
no use of light treatment devices. We analyzed saliva samples to estimate the start of 
melatonin production in the evening (DLMO) and to calculate the phase shift of the clock. 
Light exposure was recorded continuously to check the compliance. Sleep was monitored 
through an activity watch (sensitive for movement). Performance was measured with a 
reaction time task on a portable mini-computer. As expected, the phase advance of the 
melatonin rhythm was significantly larger in the blue light exposure group, compared to 
the amber light exposure group. Interestingly, the wake-up times were still a bit earlier in 
the post-treatment period in the participants who were exposed to blue light, while they 
were slightly later in the amber light group. In addition we found that the quality of sleep, 
measured with the activity watch, was somewhat reduced in the amber light group. This 
was accompanied with a worsened performance during the whole day in the amber light 
group. This was only the case in the morning during the post-treatment period in the blue 
light group. Thus, sleep and performance (to a large extend) were kept stable in the blue 
light group, despite the fact that the participants had to wake up earlier. We concluded that 
the blue light was able to compensate for the sleep quality reduction and to a large extent 
for the performance decrement that was observed in the amber light condition. From these 
results we could generate new questions for the next study. Was the effect of (blue) light on 
sleep due to the effective phase shifting of the clock or was there maybe also another effect 
of blue light on sleep quality? And are there also direct effects of blue light on performance 
during the day or is there only an indirect effect via the clock?  
This last question was addressed in Chapter 4. We examined if it was possible to fight a 
subjective energy dip at the office with 3 hours of extra blue light. The question was whether 
alertness and performance are affected by the timing of light exposure and whether these 
effects are dependent on someone’s chronotype. The study applied one experimental day 
and one control day, randomized across participants, in their own office environment. On the 
control day participants were exposed to their regular office lighting; on the experimental 
day, 3 hours of extra blue light was added to the regular office light. Blue light was provided 
by a blue LED-lightstrip at a distance of 60 cm. (280x25 mm2; peak transmission 480 nm; 
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500 mlux; prototype Philips, Drachten, The Netherlands) which was placed on top of the 
computer monitor. Participants showed their energy dip before the start of the experiment 
by drawing a line in a graph with the time scale of their working day. Lowered energy was 
indicated by a lowering of the line in this graph. The extra blue light was then applied around 
one’s energy dip either at the beginning, middle or end of the working day. We measured 
sleepiness with a specialized sleepiness scale (Karolinska Sleepiness Scale, KSS). Performance 
was examined with several performance tasks, varying from a simple reaction time task to 
a more cognitive memory task. The output measures, to compare the differences between 
conditions, were average reaction times and the number of errors. Extra blue light seemed 
beneficial for people that experienced an energy dip in the afternoon, because blue light 
stabilized cognitive performance during this time. At noon the blue light was effective in 
improving performance during light exposure, but after turning off the light, performance 
showed a deterioration. Participants also consumed less drinks with caffeine when they 
were exposed to light at noon. For those that suffer from reduced energy during the first 
morning hours at work, the extra blue light did not seem to be helpful. Interestingly it 
seemed that especially early types performed worse under morning light exposure. We 
indeed found an interaction between the moment of light exposure and chronotype for 
different energy dip groups. No significant effects of extra blue light exposure on sleepiness 
were observed, although there was a trend for being less sleepy under extra blue light in 
the afternoon. We concluded that extra blue light can have different effects during different 
energy dip moments, and early types performed different from late types during different 
blue light exposure moments.  
In chapter 5 we addressed the other question raised from the study in chapter 3: Is there a 
positive effect of extra light during the day on sleep quality during the night? Sleep is under 
the influence of two processes, namely a homeostat which is responsible for an increase 
in the need for sleep during waking and a decrease in that need during sleeping, and the 
biological clock, which sets daily optimal limits to wake up and to fall asleep. According to 
this two-process model of sleep regulation, two mechanisms can be proposed to explain the 
impact of light on sleep quality. One is the possible influence of light on the need for sleep, 
the other one is the influence of light on the clock. The possible influence of light on both 
these mechanisms was examined in a laboratory setting, described in chapter 5.
Participants were exposed to three conditions: Either to one simulated working day (09:00-
17:00) with moderate intensity ‘office light’, one working day with high intensity bright light, 
or to one working day with extra blue light (provided by the same lightstrip as used in chapter 
4) on top of the ‘office light’. We measured the influence of this daylight on the clock via 
melatonin analysis and we measured sleep quality/homeostasis after the experimental days 
with electroencephalography (EEG) measurements during subsequent sleep. If light had an 
effect on the need for sleep we expected to find an increase in the built-up of slow wave 
activity, in other words, we expected to find slow waves with more power at the beginning 
of the sleep period. If light had an effect on the clock, we expected to find changes in sleep 
consolidation (being less awake).  
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We found that the melatonin onset was earlier in the bright light condition as well as in 
the blue light condition compared to the office light condition. This result may not only 
be explained by an advance of the melatonin rhythm, but can also be explained by a 
higher amplitude of the clock in the conditions with extra light. Unfortunately, we could 
not determine which of the two explanations was right, because melatonin data was 
only available in the evening and not during sleep. More research is needed to confirm 
this potentially interesting finding. Sleep efficiency was higher in the bright light condition 
compared to the office light condition as well was the percentage of REM sleep. Also the 
build-up of slow wave activity was significantly higher in the bright- as well as in the blue 
light condition compared to the office light condition. From these results we concluded 
that light intensity during the day can influence sleep via the clock and via influencing 
sleep homeostasis; with higher light intensities leading to more consolidated and deeper 
sleep. 
The last study of this thesis is described in chapter 6. During the study of chapter 5, we 
were also interested in alertness and performance measures under the 3 different light 
conditions. Therefore, participants performed tests-batteries with various performance 
tasks (similar tasks as described in chapter 4) on the computers available in the rooms 
at different moments of the working day (8:00, 10:00, 12:00, 14:00, 16:00, 19:00). Also, 
physiological aspects of alertness were analyzed with help of EEG recordings, while the 
subjects were awake.
The results revealed that prolonged bright light exposure had advantageous effects on 
subjective and objective alertness as well as on performance, whereas prolonged blue 
light exposure showed no effects or even negative effects during the second half of the 
working day. The wake EEG under blue light exposure also showed an increase in sleepiness 
compared to the bright light exposure period. 
From this thesis it seems evident that increasing daily light exposure is a practical and 
effective tool to increase performance and sleep quality. However, it has also revealed that 
effects differ between individuals. Personalized light therapy is needed. From the results 
in this thesis it is evident that only applying several hours of extra blue light exposure is 
not the solution. Prolonged blue light exposure can have various effects at different times 
of the working day and the effects may differ between chronotypes. The combination of 
these degrees of freedom makes it extremely difficult to find the exposure schedule that 
for everyone leads to optimal performance during the day and to optimal sleep during the 
night. We cannot rule out that such a scheme exists. On top of that, individual light therapy, 
with customized intensity and color exposure may be used, for instance when a phase shift 
of the clock is needed or performance needs to be optimized at certain times of the day. 
Although the multidimensionality of the system is a complicating factor and our knowledge 
is still limited, the optimization of light exposure in humans is a powerful tool to improve 




Onder invloed van de dagelijkse rotatie van de aarde om de zon, heeft vrijwel elk organisme 
op aarde een intern ritme ontwikkeld dat dicht bij de 24 uur ligt. Dit interne ritme van 
ongeveer 24 uur wordt een 'circadiaan’ ritme genoemd en wordt gegenereerd door de 
biologische klok. Bij zoogdieren zit die biologische klok in de suprachiasmatische nucleus 
(SCN) in de hersenen. In mensen is het ritme van de SCN het beste af te lezen aan het ritme 
van het hormoon melatonine. De SCN remt de productie van melatonine gedurende de dag. 
‘S avonds stopt deze remming en melatonine zal dan worden aangemaakt in de pijnappelklier. 
Gemiddeld piekt het ritme van melatonine tijdens het midden van de nacht en daalt weer in 
de vroege ochtend. Melatonine geeft ook feedback aan de SCN samen met andere interne 
tijdsignalen, zoals interne bechikbaarheid van voedingstoffen en lichaamstemperatuur. 
De SCN staat ook onder invloed van signalen van buitenaf, genaamd 'zeitgebers'. Deze 
aanpassing van zeitgebers is nodig, want als ze afwezig zijn zal de SCN ‘vrij gaan lopen’ met 
een eigen interne periode, en zal niet meer accuraat de tijd van de dag kunnen doorgeven 
aan het lichaam. Daarom moet de SCN dagelijks worden gesynchroniseerd. Licht is de 
belangrijkste zeitgeber voor de SCN.
Bij de mens verloopt de invloed van licht via de ogen. Fotoreceptoren die zich in het netvlies 
bevinden, vertalen het lichtsignaal en transporteren dit signaal naar de biologische klok 
(SCN) en ook naar andere gebieden van de hersenen, zoals gebieden voor zicht en alertheid. 
Terwijl de klassieke fotoreceptoren voor zicht, de staafjes en kegeltjes, wel bijdragen aan 
het lichtsignaal naar de SCN, zijn ze niet absoluut noodzakelijk. De belangrijkste cellen voor 
de vertaling van het lichtsignaal naar de klok zijn de lichtgevoelige retinale ganglioncellen 
(pRGC's). Want wanneer deze cellen afwezig zijn, is de klok ongevoelig voor licht. Ze 
bevatten het eiwit melanopsine dat het signaal voor het grootste gedeelte bewerkstelligt. 
Melanopsine is het meest gevoelig voor blauw licht, daarom is blauw licht het meest effectief 
voor het bijstellen van de klok. 
In het algemeen zal licht in de vroege ochtend de klok vervroegen en licht in de avond de 
klok verlaten. Licht in het midden van de dag zal over het algemeen geen faseverschuiving 
teweeg brengen. Wel zijn er aanwijzingen dat licht overdag de amplitude van het circadiane 
ritme van de klok kan versterken.
In de moderne samenleving is er veel variatie tussen individuen in het patroon van de 
slaap-waak cyclus. In chronobiologisch onderzoek zijn mensen vaak ingedeeld volgens hun 
zogenaamd ‘chronotype’. Chronotype kan worden bepaald met de ‘Munich Chronotype 
Questionnaire’ (MCTQ). Als iemand over het algemeen eerder of later slaapt dan het 
merendeel van de bevolking (onder het 25ste of boven het 75ste percentiel), dan spreekt 
men over een ‘vroeg-‘ of ‘laat chronotype’. Mensen die hun slaap rondom het gemiddelde 
hebben (tussen het 25ste en 75ste percentiel) zijn dan een ‘gemiddeld chronotype’.  
Naast deze variatie in slaaptijden, is de overeenstemming tussen het merendeel van de 
volwassenen dat ze graag later op vrije dagen slapen dan op werkdagen. Kennelijk beginnen 
werk- en schooltijden meestal vroeger dan waar de meeste mensen de voorkeur aan geven. 
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Deze combinatie van een laat ritme op vrije dagen en de vroege werk- en schooltijden 
op werkdagen leiden vaak tot een miscommunicatie tussen endogene circadiane ritmes 
(gegenereerd door de SCN) en exogene ritmes uit de omgeving. Als resultaat van deze 
miscommunicatie ervaren veel mensen een zogenoemde ‘sociale jetlag’. Net zoals bij een 
standaard jetlag, veroorzaakt door het reizen door verschillende tijdszones, veroorzaakt het 
slapen op verkeerde fases van de klok een verstoring van lichaamseigen ritmes. Dit leidt tot 
stres en gezondheidsproblemen.  
Een groot aantal mensen in de bevolking zou daarom theoretisch profiteren van een correctie 
van de timing van de slaap. Een manier om dit te bereiken is door het vervroegen van de 
biologische klok. Licht in de vroege ochtend lijkt de sleutel om dit doel te bereiken. Maar 
om dit ochtendlicht ook op een praktische en succesvolle manier toe te passen, moeten 
optimale parameters met betrekking tot de blootstelling aan licht zoals: tijdschema, duur, 
intensiteit en kleur worden gespecificeerd. Ook moet men op de hoogte zijn van kenmerken 
van het individu die bepalend zijn voor een optimaal effect. De gegevens uit dit proefschrift 
kunnen nuttig zijn om de behandeling van slaapstoornissen met lichttherapie te verbeteren 
en tegelijkertijd kunnen er fundamentele vragen over de onderliggende mechanismen met 
betrekking tot de invloed van licht op fysiologie en gedrag (zoals slaap en alertheid) worden 
beantwoord.
In hoofdstuk 2 combineerden we een aantal optimale lichttherapie parameters om te zien 
of de duur van lichttherapie kan worden ingekort in een thuissituatie met behoud van 
effect. Het tijdstip van de blootstelling aan licht is één van de parameters die we konden 
optimaliseren. Hiervoor is het moment waarop melatonine begint met stijgen in de avond 
onder dim licht (ook wel ‘dim light melatonin onset’ DLMO genoemd) belangrijk om te 
weten. Het is namelijk bekend dat licht het meest effectief is voor het vervroegen van de 
klok 9 uur na de DLMO. Dat is vaak vroeg in de ochtend. Aangezien we de DLMO van de 
deelnemers konden meten voordat we met de studie begonnen, wisten we  wanneer ze 
moesten beginnen met lichttherapie in de ochtend. De lichtbron zelf was een lamp (Philips 
goLITE BLU) dat hoog intensiteit blauw licht uitstraalde, de kleur en de intensiteit die het 
effect op de klok zouden moeten maximaliseren. We onderzochten of blauwe lichtpulsen 
van deze lamp van 30 minuten net zo effectief waren als lichtpulsen van 60 minuten. We 
vonden inderdaad dat drie pulsen van 30 minuten blauw licht net zo effectief waren in 
het verschuiven van de klok als drie pulsen van 60 minuten blauw licht (eenmaal daags 
toegepast op drie opeenvolgende dagen op een optimaal tijdstip in de ochtend). We vonden 
daarnaast ook een daling van slaperigheid in de ochtend bij het wakker worden en we 
vonden bovendien aanwijzingen dat ook de slaap werd vervroegd. 
Deze laatste bevindingen leidden tot de vragen in de volgende studie, beschreven in hoofdstuk 
3. Want een ander probleem in het toepassen van lichttherapie is het feit dat het effect op 
de slaap na de lichttherapie nauwelijks is onderzocht. Ook over het functioneren overdag 
na de behandeling met lichttherapie is nauwelijks iets gepubliceerd.  Dit waren daarom de 
uitgangspunten voor de studie in hoofdstuk 3. Twee groepen deelnemers werden aan twee 
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lichttherapie protocollen blootgesteld. De deelnemers hadden last van een ‘sociale jetlag’ 
tijdens werkdagen en wilden graag hun slaap vervroegen. Er werden twee verschillende 
lichtbronnen gebruikt. De lampen die hiervoor werden gebruikt straalden ofwel blauw licht 
uit met een hoge intensiteit (met behulp van de lamp zoals beschreven in hoofdstuk 2), of 
straalden amberkleurig (oranje) licht uit met dezelfde zichtbare helderheid (lux).  
De lichttherapie werd op 9 opeenvolgende dagen toegepast. Men begon met lichttherapie 
op hun normale tijd van wakker worden en elke 3 dagen werd dit tijdstip een uur vervroegd. 
Melanopsine, en daarom ook de klok, is het minst gevoelig voor oranje licht. Derhalve 
kon het oranje licht fungeren als een soort placebo. We hadden de hypothese dat de 
verschillen tussen de twee groepen met betrekking tot de slaap en prestaties, veroorzaakt 
moesten worden door de kleur van het licht. Het protocol bestond uit 30 dagen in totaal 
en werd volledig thuis uitgevoerd. Alle deelnemers begonnen met 14 basisdagen zonder 
slaapinstructies. Dit werd gevolgd door de 9 dagen lichttherapie, met elke ochtend ofwel 
30 minuten blauw licht of 30 minuten oranje licht. Tijdens deze periode werd tegelijkertijd 
de slaap vervroegd. De tijd van slapen was in de eerste plaats gebaseerd op de slaaptijd 
in de referentieperiode. Tijdens de lichttherapie werd vervolgens de slaap elke 3 dagen 1 
uur vervroegd. De therapie werd gevolgd door 7 nabehandelingsdagen (de periode voor 
het meten van het uiteindelijke behoud van effect) zonder slaapinstructies en zonder het 
gebruik van de lampen. We analyseerden speekselmonsters om de start van het moment van 
melatonineproductie in de avond (DLMO) te bepalen en de faseverschuiving van de klok te 
berekenen. Lichtblootstelling werd continu geregistreerd om de naleving van de instructies 
te controleren. Slaap werd gecontroleerd door middel van een activiteitshorloge (gevoelig 
voor beweging). Prestaties werden gemeten met een reactietijdtaak op een draagbare 
minicomputer. Zoals verwacht, was de fase van het melatonineritme meer vervroegd in de 
groep met het blauwe licht, vergeleken met de oranje lichtgroep. Nog interessanter was de 
tijd van wakker worden, welke nog een beetje eerder waren in de periode na de behandeling 
met blauw licht, terwijl ze wat later waren in de periode na de behandeling met oranje licht. 
Daarnaast vonden we dat de kwaliteit van de slaap, gemeten met het activiteitshorloge, 
enigszins verminderd was in de oranje licht groep. Ook waren de prestaties gedurende de 
hele dag verslechterd in de oranje licht groep. Deze verslechtering van prestaties was voor 
de blauwe groep alleen het geval in de ochtend en alleen tijdens nabehandelingsperiode. 
Dus, de slaap en de prestaties werden (voor het grootste deel) stabiel gehouden in de 
groep met blauwe lichttherapie. Dit ondanks het feit dat de proefpersonen eerder wakker 
werden. We concludeerden dat het blauwe licht de vermindering van de slaapkwaliteit en 
grotendeels de verslechtering van de prestaties, die werden waargenomen met oranje licht, 
kon tegengaan. Hieruit ontstonden de vragen voor de volgende studies. Is dit effect van 
blauw licht op de slaap te wijten aan de effectieve invloed van blauw licht op de klok of is 
er misschien ook een ander effect van blauw licht op de kwaliteit van de slaap? En is er een 
directe invloed van blauw licht op de prestaties gedurende de dag of verloopt het effect van 
blauw licht op prestaties alleen via een indirect effect via de klok? 
Deze laatste vraag werd behandeld in de studie beschreven in hoofdstuk 4. Hierin werd 
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gekeken of een subjectieve energiedip op kantoor te bestrijden is met 3 uur extra blauw 
licht. De vraag was of alertheid en prestaties worden beïnvloed door de timing van 
de blootstelling aan licht en of deze effecten afhankelijk zijn van iemand zijn of haar 
chronotype. De studie werd uitgevoerd in de eigen kantooromgeving van de deelnemers 
en bestond uit één experimentele dag en uit één controle dag, (gerandomiseerd over 
proefpersonen). Op de dag van de controle conditie werden deelnemers blootgesteld aan 
hun reguliere kantoorverlichting; op de experimentele dag werd hier 3 uur extra blauw licht 
aan toegevoegd. Blauw licht werd geleverd door een blauwe LED-LightStrip op een afstand 
van 60 cm. (280x25 mm2; piek transmissie 480 nm; 500 mlux; prototype Philips, Drachten, 
Nederland), die op de bovenkant van de computermonitor werd geplaatst. Deelnemers 
tekenden hun energiedip voor de aanvang van het experiment door middel van een lijn 
in een grafiek met daarin de tijdlijn van hun werkdag. Een verlaagd energieniveau werd 
aangegeven door een verlaging van deze lijn. Het extra blauwe licht werd vervolgens rondom 
deze energie dip gegeven, hetzij aan het begin, midden, of einde van de werkdag. We maten 
slaperigheid met een gespecialiseerde slaperigheidvragenlijst (Karolinska Sleepiness Scale, 
KSS). Prestaties werden onderzocht met een aantal prestatietaken, variërend van een 
eenvoudige reactietijdtaak tot een meer cognitieve geheugen taak. Voor de vergelijking 
tussen de condities gebruikten we de gemiddelde reactietijden en de hoeveelheid fouten. 
Extra blauw licht leek het meest gunstig voor mensen die een energiedip in de middag 
ervoeren, omdat blauw licht cognitieve prestaties gedurende deze tijd stabiliseerde. Aan het 
begin van de middag was het blauwe licht ook effectief in het verbeteren van de prestaties, 
maar na het uitschakelen van het licht lieten de prestaties een achteruitgang zien. Wel bleken 
de deelnemers in deze groep minder caffeïne-houdende-dranken te hebben genuttigd. Voor 
degenen die aangaven dat ze een verlaagd energieniveau hadden in de eerste ochtenduren 
op het werk, leek het extra blauwe licht niet te helpen, soms was het effect zelfs negatief. 
Interessant hieraan was dat met name in vroege chronotypes het blauwe licht een negatief 
effect leek te hebben. We vonden inderdaad ook een interactie tussen het moment van 
blootstelling aan licht en het chronotype voor de verschillende ‘energiedip groepen’. Op de 
slaperigheid van de deelnemers werd alleen een trend waargenomen om minder slaperig 
te zijn onder extra blauw licht in de middag. We concludeerden dat extra blauw licht 
verschillende effecten tijdens vescheidende energiedip-momenten kan hebben, en dat de 
effecten anders zullen uitpakken in verschillende chronotypes.  
In hoofdstuk 5 werd de andere vraag die aan het einde van hoofdstuk 3 naar boven kwam 
behandeld: Is er een positief effect van extra licht gedurende de dag op de kwaliteit van 
de slaap tijdens de nacht? Slaap wordt beïnvloed door twee processen, namelijk een 
homeostaat die verantwoordelijk is voor een toename van slaapbehoefte tijdens het 
wakker zijn en een afname van die behoefte tijdens slaap, en de biologische klok, die de 
dagelijkse optimale grenzen van het wakker zijn en in slaap vallen bepaalt. Volgens dit twee-
processenmodel van de slaapregulatie kunnen er twee mechanismen worden voorgesteld 
om het effect van licht op de kwaliteit van de slaap uit te leggen. Eén daarvan is de mogelijke 
invloed van licht op de behoefte aan slaap, de andere is de invloed van licht op de klok.  De 
mogelijke invloed van licht op beide mechanismen werd onderzocht in het laboratorium, 
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zoals beschreven in hoofdstuk 5. 
Deelnemers werden aan 3 condities blootgesteld: Ofwel aan een gesimuleerde werkdag 
(09:00-17:00) met een matige intensiteit 'kantoorlicht', of aan eenzelfde werkdag maar 
dan met een hoge intensiteit wit licht, of aan eenzelfde werkdag met extra blauw licht 
(gegeven met dezelfde lichtstrip zoals gebruikt in hoofdstuk 4) samen met het 'office light'. 
We maten de invloed van het daglicht op de klok via melatonine analyse en we maten ook 
de slaapkwaliteit/homeostase na de experimentele dagen met elektro-encefalogram (EEG) 
metingen. Als licht effect zou hebben op de behoefte van de slaap verwachtten we een 
stijging van de opbouw van ‘slow wave sleep’, in andere woorden, verwachtten we langzame 
slaapgolven met meer vermogen aan het begin van de slaapperiode. Als licht een effect op 
de klok had, verwachtten we  een verbeterde  slaapconsolidatie (minder wakker).
We vonden dat melatonine eerder begon te stijgen in het felle licht- evenals in de blauwe 
licht conditie ten opzichte van het kantoorlicht. Dit kan duiden op een vervroeging van het 
melatonine ritme, maar deze waarnemingen passen ook bij een vergroting van de amplitude 
van het melatonineritme in de condities met extra licht.. Helaas konden we  niet met 
zekerheid vaststellen om welk van deze twee aspecten het gaat, omdat  melatoninegegevens 
alleen beschikbaar waren in de avond en niet tijdens de slaap daarna. Meer onderzoek is 
hier dus op zijn plaats. De slaapefficiëntie was ook hoger in de hoge lichtintensiteit conditie 
ten opzichte van de kantoorlicht conditie. Dit gold ook voor het percentage van de REM 
slaap. Ook de opbouw van ‘slow wave sleep’ was significant hoger in zowel de felle- als de 
blauwe lichtconditie ten opzichte van de kantoorlicht conditie. Uit deze resultaten konden 
we concluderen dat de lichtintensiteit tijdens de dag de slaap beÏnvloedt via de klok en via 
de slaap homeostase: een hogere lichtintensiteit leidt tot meer geconsolideerde en diepere 
slaap.
De laatste studie van dit proefschrift wordt beschreven in hoofdstuk 6. We waren tijdens 
studie van hoofdstuk 5, ook geïnteresseerd in de alertheid en prestaties onder de 3 
verschillende lichtcondities. Daarom voerden de deelnemers computertesten uit met 
diverse prestatietaken (soortgelijke taken zoals beschreven in hoofdstuk 4) op verschillende 
momenten van de werkdag (08:00, 10:00, 12:00, 14:00, 16:00, 19:00). Ook werden 
fysiologische aspecten van alertheid geanalyseerd met behulp van  EEG registraties terwijl 
de proefpersonen wakker waren.
Uit de resultaten bleek dat langdurige blootstelling aan fel licht voordelige effecten had 
op de subjectieve en objectieve alertheid, evenals op de prestaties, terwijl langdurige 
blootstelling aan blauw licht geen effecten had of zelfs negatieve effecten liet zien, vooral in 
de tweede helft van de dag. De wakker EEG’s onder blauw licht lieten zelfs een stijging van 
slaperigheid zien als deze vergeleken werd met de felle lichtconditie. 
Uit dit proefschrift blijkt dat het verhogen van de dagelijkse blootstelling aan licht een 
praktisch en een effectief instrument kan zijn om prestaties en de kwaliteit van de slaap 
te verhogen. Er is echter ook gebleken dat de effecten verschillen tussen individuen. Het 
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geven van gepersonaliseerde lichttherapie is nodig. Uit de resultaten van dit onderzoek 
blijkt dat urenlange blootstelling aan alleen blauw licht gedurende een dag niet de oplossing 
is. Langdurige blootstelling aan blauw licht kan verschillende effecten op verschillende 
tijdstippen van de werkdag teweeg brengen en de effecten kunnen verschillen tussen 
chronotypes. De combinatie van deze vrijheidsgraden maakt het uitermate moeilijk om het 
belichtingsschema te vinden dat voor  iedereen leidt tot optimale prestaties gedurende de 
dag en tot optimale slaap gedurende de nacht. We kunnen niet uitsluiten dat zo’n schema wel 
bestaat. Daarbovenop kan individuele lichttherapie worden gebruikt, met een aanpassing 
van intensiteit en kleur, bijvoorbeeld wanneer een faseverschuiving van de klok nodig is of 
wanneer prestaties moeten worden geoptimaliseerd op bepaalde tijden van de dag.
Hoewel het systeem met meerdere dimensies gecompliceerd is en onze kennis nog beperkt 
blijft, lijkt het er wel op dat het optimaliseren van de blootstelling aan licht bij de mens 
een krachtig hulpmiddel kan zijn om prestaties te verbeteren, de klok te verschuiven en de 





Graag wil ik dit boek afsluiten met het bedanken van mensen die me op welke manier dan ook 
hebben bijgestaan in mijn periode als PhD student. 
Marijke, natuurllijk ga ik beginnen met jou als eerste te bedanken. Vanaf het moment dat ik je vroeg 
of je mijn bachelor scriptiebegeleidster wilde zijn in 2009 (met als onderwerp: waarom er mensen 
zijn die lang of kort slapen), ben ik niet meer van jouw zijde geweken. Dit komt niet alleen door jouw 
alwetendheid op het gebied van chronobiologie en slaap, maar ook omdat ik me altijd enorm op mijn 
gemak voel bij je. Bedankt dat ik altijd bij je terecht kon en nog steeds kan, met welke vraag dan ook 
en wanneer dan ook. Bedankt dat je altijd tijd maakt voor een gezellig praatje voordat we aan het 
echte werk beginnen. Bedankt dat je mij altijd betrekt in alle evenementen die er zijn, van verjaardag 
tot congres. Bedankt dat je altijd in mij hebt geloofd, ook op momenten dat ik wat minder in mezelf 
geloofde. Ik hoop dat ik nog erg lang met je samen kan werken. 
        
Domien, het is erg fijn als je promotor niet alleen een hele wijze man blijkt te zijn maar ook een 
enorm vriendelijke en geduldige man, waarbij ik op elk moment kon aankloppen. Ook bij jou voelde 
ik me altijd erg op mijn gemak en vond ik onze werkoverleggen heel prettig. Naast de werkoverleggen 
luisterde ik erg graag naar jouw vakantieverhalen die veelal gingen over de prachtige biologische 
vondsten. Niek en ik vonden het ook erg bijzonder dat we zelfs een privébezoekje mochten brengen, 
waarin we alle uitleg kregen over onze vakantiebestemming (de Provence), in de prachtige setting van 
jullie tuin.  
Roelof, bedankt dat je vrijwel direct toen je professor werd mijn tweede promotor wilde zijn. Dit is 
nog niet zo lang geleden en we hebben daarom ook niet veel samen gewerkt. Maar ik ben je natuurlijk 
wel veel tegengekomen tijdens alle sociale- en werkgerelateerde bijeenkomsten. Ik heb jouw scherpe 
vragen en discussies tijdens de ‘Show & Tells’ altijd erg boeiend gevonden en ook meegenomen in 
mijn eigen werk. Verder beschik je over een flinke dosis scherpe humor, wat je als professor ook erg 
toegankelijk maakt. 
Christian, Eus & Robert, I’m proud and grateful that you were in my reading committee. 
Emma, vanaf het eerste moment dat ik je zag dacht ik ‘zij zou een vriendin van mij kunnen zijn’. En 
deze gedachte is niet meer weg gegaan. Ik denk dat we over dezelfde soort humor beschikken en 
daarnaast allebei expressieve persoonlijkheden zijn (die dit ook graag uiten op de dansvloer :) ). Ik ben 
erg dankbaar voor de vele grappige momenten die ik met jou heb beleefd. Maar ik wil je natuurlijk ook 
bedanken voor het feit dat je ‘het Engels’ als ‘native speaker’ zo toegankelijk voor me hebt gemaakt. Jij 
wilde beter Nederlands leren praten en ik beter Engels. Zodoende konden we elkaar helpen en vonden 
we het prima als we (hele kleine ieniemienie) foutjes maakten. Ook heb je mij nog geholpen met de 
laatste stukken van het proefscrhift en met het ‘office light project’. Zonder jou had ik die enorme 
hoeveelheid getallen nooit kunnen verwerken. 100000000000000000000 maal dank daarvoor en ik 
vind het een eer dat je mijn paranimf wilt zijn.
 
Tom, tukker buddy :)  Ook met jou had ik gelijk vanaf het eerste moment dat jij PhD student werd al 
die vriendschap. Ik denk dat we allebei over die droge tukker humor beschikken (jij hebt nog wel iets 
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meer droogheid dan ik) en ook wij houden van gekke (droge) dansjes op de dansvloer. Verder kunnen 
we over veel dingen goed praten en goed samenwerken. Dat hebben we dan ook veel gedaan in met 
name de ‘tijdvrije ruimte’. Wat hebben wij daar in totaal veel mensen met EEG-electroden beplakt :)! 
Ook bedankt voor al het ‘R’ werk wat je voor me hebt gedaan. Je bent met recht mede-auteur van 
meerdere stukken en ik vind het ook een eer dat je mijn paranimf wilt zijn. 
Bonnie, je bent al vele jaren (sinds 2009) mijn ‘labjuf’ waarvoor ik je heel dankbaar ben. Zonder jou 
was ik nooit zo goed geworden in al die melatonine- en cortisolanalyses en nog steeds hebben we 
geregeld overleg om die analyses zo goed mogelijk te maken. Je bent niet alleen een heel geduldig en 
nauwkeurig persoon, maar ook een heel prettig persoon in de omgang. Ik vind het altijd gezellig en fijn 
als je tegelijk met mij in het lab bezig bent. 
Sjaak, wat ken ik jou al lang! Wat ben jij enorm gegroeid :) vanaf het moment dat je in 2004 mijn 
‘baarkind’ was tot nu toe als ook bijna Dr. Riede. Ik heb genoten van al jouw slimme vragen tijdens de 
‘Show&Tells’ en onze discussies daarna en ik vind het leuk dat ik je al die jaren heb kunnen volgen. 
Vincent, jou ken ik ook al zo lang! Inmiddels ben je al klaar met jouw PhD en zit je in Amerika. Toevallig 
zag ik je laatst nog even en ben blij dat het goed met je gaat. Jij ook bedankt voor alle praatjes die we 
hebben gemaakt, werkgerelateerd of kroeggerelateerd.
 
Kees, voor jou geldt dat ik je nog net iets langer ken dan Sjaak en Vincent! We zijn samen gestart met 
studeren in 2003. Zo leuk en bijzonder dat jij en Sjaak nog steeds vrienden zijn en dat ik je ook nog 
vaak tegen kom.
 
Giulia & Theresa, I have to thank you as a duo. I think you two have become best friends over the past 
years and you do many things together. Both of you are very social and I interacted with both of you 
quite a lot. With Theresa mostly in chats as my office neighbor :) and with Giulia because we had quite 
some similarities in the work we did (blue lamp, working with humans :), melatonin analysis). And of 
course you two were always there at our fun nights out. Thank you both for all the good moments!
Renske, Als een soort van opvolger van mij had ik me geen betere kunnen wensen. Jij komt er wel! 
Simone, Laura, Sjoerd, jullie ken ik iets minder lang maar heb alle momenten die we toch nog hebben 
gehad als prettig ervaren. 
 
‘Mijn’ Masterstudenten over de jaren, Thijs, Jeri, Niels en Chiel, bedankt voor jullie inzet en het mede-
mogelijk maken van dit boekje. Stuk voor stuk waren jullie erg gemotiveerd en dat vond ik fijn. 
Margien & Jasper, jullie zijn helaas al een aantal jaren niet meer bij de chronobiologie groep, maar 
wat zijn jullie goede ‘ouders’ voor me geweest in het begin van mijn PhD tijd. Met name het eerste 
EBRS congres in Oxford vond ik lastig. Maar jullie hebben me perfect op sleeptouw genomen en 
volgens mij hadden we met z’n drieën ook erg veel lol! Later heb ik met Margien en Maria deze trend 
voortgezet en zijn we naar nog een prachtig SRBR congres in Florida geweest (en daarna ook nog even 
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NYC bezocht). Heel erg bedankt voor die mooie tijden! Ik hoop dat het goed met jullie gaat.
 
Maan, ook jij bent al een tijdje niet meer bij chronobiologie in Groningen. De tijd dat je er nog wel was 
vond ik het altijd erg gezellig en fijn om met je te kletsen en jou eerdere ervaringen als PhD student bij 
chronobiologie te horen. 
Marlies, wat heb je in de begintijden veel voor me klaargestaan als secretaresse. Jij had altijd veel 
belangstelling voor mij en ik kon met wat dan ook bij je terecht. Heel erg bedankt daarvoor!
Pleunie, Maria, ook bij jullie kon ik met vanalles terecht. Ook bedankt daarvoor! 
 
Martha, Menno, Serge, grote namen in de chronobiologie uit Groningen. Jullie hebben mij persoonlijk 
niet begeleid maar ik heb tijdens bijeenkomsten erg van jullie expertise genoten.
 
Marina, Paulien, ik ben erg blij met zulke prettige personen als collega’s bij Chrono@Work. Ik vond het 
erg gezellig met jullie bij het ISMC (2015) en hoop dat we nog lang samen kunnen werken. En Marina jij 
nog extra bedankt als mede-auteur van hoofdstuk 6 en met je hulp bij de laatste fase van het boekje.
Vanja, fijn dat jij mijn contactpersoon bij Philips was. Niet alleen een uitstekende schakel tussen de 
universitaire wereld en de bedrijfswereld, maar ook een warm en menselijk persoon.
 
Karin, leuk dat je even bij ons hebt gewerkt en ik je nog beter heb leren kennen. Ook jij bent een heel 
warm persoon, die tussen je drukte van werk en zwangerschap ook nog voor mij klaar stond om een 
programma voor de detectie van lichtpulsen te schrijven. Bedankt daarvoor! 
Tijdens al mijn PhD jaren zijn onderstaande personen mijn goede vrienden geweest, geworden en 
gebleven, waarvoor ik heel dankbaar ben.  
Merlin, al vanaf groep 1 basisschool onafscheidelijk. 
Eline, Laura, voor jullie geldt dat ook maar dan vanaf de middelbare school en vanaf paardrijden. Ik 
hoop dat we altijd het groepje ‘Borne leu bint leuke leu’ vriendinnen zullen blijven.  
Amanda, Sharon en Annelise, de ‘hondenbingomoeders’, wij zijn vriendinnen geworden bij toevallige 
ontmoetingen met onze honden.  Nu zijn we een hecht groepje met dezelfde passie voor onze hond 
en natuurlijk zo veel meer :).
 
Berber, ik ben blij dat ik jou alweer een aantal jaren ken. Heerlijk om onze liefde voor dieren en Disney 
te kunnen delen. 
Lydia, Niet alleen onze honden zijn dikke maatjes, wij zijn ook wel echte (frisbee)maatjes geworden. 
De gehele VrijMiBo groep: Jouke & Sandra, Jos & Svenja, Klaas Heine & Mariëlle, Robbin & Felien, 
Robert & Gerlinde & Tobias. En IJle & Jeanne, Steven & Rianne. Ik ben blij dat Niek zulke leuke vrienden 
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heeft en dat het ook erg goed klikt met alle dames. Van vrijdagmiddagborrels tot aan bruiloften, met 
jullie is het allemaal één groot plezierig avontuur. Rianne jij nog extra bedankt voor het ontwerpen van 
de layout van dit proefschrift. 
Esther, Kim, Jocelyn, met mij erbij ‘EsKiMoJo’, mijn dierbare studievriendinnetjes. Wat is het altijd 
een feest om met jullie af te spreken, ‘best days of my life’, en wat zijn we na al die jaren nog steeds 
hecht met elkaar. Fijn dat ik in moeilijkere PhD tijden lekker tegen jullie aan mocht klagen en wat een 
vreugde dat we deze mooie afsluiting samen mogen vieren.
Mijn lieve familie en schoonfamilie.
 
Lieve ouders, Arnold en Annelies, Bedankt dat jullie altijd trots op me zijn gebleven. Ookal heb ik een 
compleet andere weg bewandeld dan jullie misschien voor ogen hadden. Ik ben blij dat jullie er zijn en 
dat we zoveel leuke dingen samen doen.  
Lieve Chantal, wat fijn dat onze band weer hecht is en dat we samen leuke dingen doen, bezoekjes 
aan elkaar brengen en nog steeds veel gemeen blijken te hebben. Die bezoekjes brengen we natuurlijk 
ook aan Hugo (die met zijn familie altijd voor ons klaar staat voor de auto, waarvoor dank) en aan 
grote kleine neef Jim. Ik ben een trotse tante en ik vind het erg mooi om te zien wat voor een leuk 
gezinnetje jullie zijn. 
 
Lieve schoonfamilie, Arien, Luuk & Neža, Wim & Ria. Jullie voelen als een eigen familie en ik voel me 
bij jullie thuis als we samen zijn, erg fijn!  
Lieve Balou, wat een bijzondere band kan je met een dier hebben, dat bewijs jij en daarom verdien 
je een plek als een-na-laatste (ik denk niet dat je het erg vindt als ik jou geliefde baasje als laatste 
noem). Jij hebt me bijna letterlijk door de wat moeilijkere tijden heen gesleept. Als ik eenzaam aan het 
schrijven was, bracht je me door een gekke actie altijd weer aan het lachen. We zijn ook sportmaatjes 
en straks ook een beetje werkmaatjes. Daarnaast help je mij de laatste stelling te verantwoorden. 
Sinds ik jou heb slaap ik namelijk veel beter! Meer licht en beweging zullen hier vast aan ten grondslag 
liggen. Mijn eigen verstoorde slaap was een reden om dit te gaan onderzoeken. En nu het boekje klaar 
is, is mijn slaap ook hersteld. Bijzonder… 
Lieve Niek, mijn dierbare trouwe metgezel. Ik kan je om zoveel bedanken, maar het komt er op neer 
dat je er altijd voor me bent en dat ik helemaal mezelf bij je kan zijn. Dat we alles delen, goede en 
slechte tijden. Dat we elkaar door en door kennen en elkaar precies goed aanvullen. Dat als ik dingen 
te emotioneel bekijk jij het voor mij meer rationeel maakt en hopelijk doe ik dat voor jou andersom. 
Dat je me af en toe precies het liefelijke zetje gaf :)die ik nodig had. Ik hoop dat we er altijd voor elkaar 
zullen zijn en dat de promotie één van de vele mooie momenten is die nog komen gaan. Love you liefi!
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